Zurueck zur Suche

Reporte zur Charge 042J21A

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

476Reporte angezeigt
1Todesfaelle
50Hospitalisiert
3Lebensbedrohlich
2Bleibende Schaeden
CA 145 WY 39 NY 32 MI 29 IL 27 VA 22 MA 20 SC 15 OR 10 FL 9 TX 9 PR 8

VAERS 2667672

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

kritisch
Staat
-
Alter
69,0
Geschlecht
M
Eingang
08.08.2023
Impfdatum
06.02.2022
Beginn
24.03.2022
Tage bis Beginn
46,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Chronic respiratory failure Respiratory failure

Symptomtext

ACUTE RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2639602

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

kritisch
Staat
-
Alter
30,0
Geschlecht
M
Eingang
01.06.2023
Impfdatum
27.01.2022
Beginn
09.09.2022
Tage bis Beginn
225,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure

Symptomtext

ACUTE RESPIRATORY FAILURE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2622367

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

kritisch
Staat
-
Alter
84,0
Geschlecht
F
Eingang
27.04.2023
Impfdatum
31.03.2021
Beginn
10.06.2022
Tage bis Beginn
436,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Hypertension Urinary tract infection

Symptomtext

ACUTE ON CHRONIC RESPIRATORY FAILURE 8/24/2022 ACUTE UTI ACUTE ON CHRONIC RESPIRATORY FAILURE 8/24/2022 HTN (HYPERTENSION)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2429379

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

kritisch
Staat
-
Alter
80,0
Geschlecht
M
Eingang
05.09.2022
Impfdatum
07.02.2022
Beginn
21.08.2022
Tage bis Beginn
195,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Acute respiratory failure Anaemia macrocytic Angiogram Body temperature increased COVID-19 COVID-19 pneumonia Constipation Cutaneous vasculitis Dyspnoea Exposure to SARS-CoV-2 Haematoma Hyperlipidaemia Hypertension Hypoxia Pancytopenia Productive cough SARS-CoV-2 test positive

Symptomtext

Narrative: Pt presented to ED on 8/21/2022 at 2245 with c/o productive cough x 3-4 days and SOB, occurring over past day. Pt reports COVID exposure through family friend. Pt admitted with primary diagnosis of: Acute COVID 19 infection Acute on chronic hypoxic respiratory failure AKI on stage IIIb CKD RUE hematoma - resolving Pt hospitalized 8/22/22 - 8/26/22. ADDITIONAL DIAGNOSES: Type II DM HTN HLD Chronic hypoxic respiratory failure on 4 liters 02 due COPD Chronic CHF due diastolic dysfunction Stage IIIb CKD ETOH dependence Leukocytoclastic vasculitis Macrocytic anemia/pancytopenia Chronic Constipation: h/o Tubular Adenoma HOSPITAL COURSE: Patient is a 79 yo gentleman with Stage IIIb CKD, Chronic CHF due to diastolic dysfunction,chronic hypoxic respiratory failure due to COPD, Type II DM, parosymal afib/aflutter, alcohol dependence who was admitted on 8/21/22 with acute COVID 19 pneumonia. He was admitted to the medical floor on airborne precautions and started on decadron and remdesivir. There was concern for PE given hypoxia, COVID and indeterminate V/Q (unable to obtain CTA due to AKI on admission). However the patient could not anticoagulation due to RUE hematoma at blood pressure cuff site. BLE US were negative for DVT. Hypoxia resolved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
COVID positive 8/21/2022 Vital Signs * Temperature 100.7 F (38.2 C) Pulse 59 Respirations 24 Blood Pressure 153/62 Pain scale recorded: 0 Pulse Oximetry 97 Oxygen 3 L/Min Nasal Cannula
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278360

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

kritisch
Staat
MI
Alter
80,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
26.01.2022
Beginn
01.05.2022
Tage bis Beginn
95,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Brain death COVID-19 Cough Haemorrhage intracranial Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

pt presented with cough and sore throat 1 day after discharge from hospital . Was discharged then presented again 2 weeks later with intracranial bleed, pt is not expected to survive, brain death being confirmed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Brain death
Hospital-Tage
-
Labordaten
COVID positive on 5/1/22 and 5/14/22
Aktuelle Erkrankungen
-
Vorgeschichte
diabetes, CHF, HTN, CKD, pacemaker, MI, CAD, anemia, TIA
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2157928

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

kritisch
Staat
NC
Alter
48,0
Geschlecht
M
Eingang
04.03.2022
Impfdatum
22.02.2022
Beginn
23.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Abdominal X-ray Anticoagulant therapy Axillary pain Blood magnesium decreased Chills Computerised tomogram thorax abnormal Dyspnoea Echocardiogram Fatigue Flank pain Laboratory test Pain Pulmonary embolism Pyrexia Thrombosis Ultrasound Doppler abnormal

Symptomtext

Hours after receiving the vaccine booster and into the night of February 22, 2022 at approximately 12:00pm, patient began experiencing the typical side effects to include body aches and fatigue. By the following morning, February 23, 2022, his symptoms included fever, chills, body aches, and fatigue. At 10:00pm of February 23, 2022 (approximately 34 hours after the booster) patient had a sudden onset of excruciating right sided pain that radiated from his axilla down to the bottom of his ribcage. With this he was also noted to be gasping with each breath due to the intensity of the pain. At that time, we discussed the potential for the need to call EMS for transport, but was able get relief from the pain with over the counter analgesics. The following day, February 24, 2022 at 2:00pm (approximately 50 hours after the booster) the excruciating pain returned at which time we went ER. An initial work up which included lab work and xrays was completed to r/o the gall bladder. They then completed a CT scan of the chest which revealed pulmonary embolus bilaterally. A heparin infusion was started immediately and patient was then admitted and moved to inpatient status. While inpatient he also had an ECHO and an ultrasound of his legs which revealed blood clots in both legs as well. He was placed on a NC at 3L and 100% O2. On Saturday, February 26, 2022, the heparin was dc'd and he was started on Lovenox injections BID. On February 27, 2022, his oxygen was dc'd and later that same day he was discharged to home with orders to follow up with his primary care provider and hematology.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
4,0
Labordaten
Abdominal xrays 2/24/2022 Routine labs 2/24/2022 Low Mg CT of chest 2/24/2022 bilateral pulmonary embolism Genetic lab to be sent out 2/25/2022 Echo 2/25/2022 WNL Ultrasound of legs 2/25/2022 Blood clots bilaterally
Aktuelle Erkrankungen
NONE
Vorgeschichte
Left sided hemiplegia
Andere Medikamente
Tegratol, Baclofen, Zyrtec, Atorvastatin, Flonase, Albuterol (PRN) and One a Day Men's Multivitamin
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2147571

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

kritisch
Staat
OH
Alter
60,0
Geschlecht
M
Eingang
27.02.2022
Impfdatum
11.02.2022
Beginn
24.02.2022
Tage bis Beginn
13,0
Dosis
3
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Death Myocardial infarction

Symptomtext

I was informed on 2/24/22 at 9:46pm by patient's son who I work with via text that patient had a heart attack and patient left for the hospital on an ambulance. I was informed via text that patient died on 2/24/22 at 10:53pm. Patient's son came in to the pharmacy on 2/26/22 around 5pm and told me that they are looking in to if Moderna was related to patient's cause of death.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
flucelvax quadrivalent
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2081985

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

kritisch
Staat
CA
Alter
54,0
Geschlecht
F
Eingang
14.02.2022
Impfdatum
01.01.2022
Beginn
01.02.2022
Tage bis Beginn
31,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Anaphylactic shock Dysphagia Dyspnoea Throat tightness

Symptomtext

Anaphylactic shock EpiPen Auto-injection emergency room care

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic shock
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Nothing
Vorgeschichte
Radial styloid tenosynovitis [de Quervian] surgery on October 18 2021
Andere Medikamente
I took ibuprofen one day before the vacation
Allergien
I had no allergies
Vorherige Impfungen
Headiq

VAERS 2085517

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

kritisch
Staat
OH
Alter
48,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cardio-respiratory arrest Chest discomfort Dyspnoea Electrocardiogram Pharyngeal swelling Dysphagia Heart rate increased Rash Throat irritation

Symptomtext

Patient had an itchy throat, neck rash, elevated heart rate, trouble swallowing and taking a deep breath. Gave Benadryl 25mg and standard Epinephrine dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardio-respiratory arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2634910

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
-
Alter
73,0
Geschlecht
M
Eingang
22.05.2023
Impfdatum
25.01.2022
Beginn
04.08.2022
Tage bis Beginn
191,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Symptom recurrence Thrombotic stroke

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE DUE TO THROMBOSIS OF UNSPECIFIED ARTERY 8/23/2022 -- RECURRENCE OF SAME SYMPTOMS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombotic stroke
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2626486

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
-
Alter
31,0
Geschlecht
F
Eingang
04.05.2023
Impfdatum
05.02.2022
Beginn
31.08.2022
Tage bis Beginn
207,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Deep vein thrombosis

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT, UNSPECIFIED VEIN

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2621166

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
MI
Alter
-
Geschlecht
U
Eingang
25.04.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Cardiac function test abnormal Carditis Chest X-ray normal Chest pain Dyspnoea Electrocardiogram normal Immunisation reaction Impaired work ability Myocarditis Palpitations Pericarditis

Symptomtext

After taking the Moderna booster shot after work around 6:00 PM at the Pharmacy, by the time I got to work the next morning at 8:00 AM I had heart palpitations, severe chest pain and trouble breathing. I immediately left work and my husband drove me to the local Emergency Room. The run an ekg and chest X-ray and tell me I am fine and send me home, saying that I had a bad reaction to the Moderna vaccine. On 2/13/2023, I?m rushed into the Same hospital ER for the same reason heart palpitations, chest pains and trouble breathing and the hospital admitted me and I was in the cardiac unit for 48 hours. The heart doctor ran every test on my heart and said that I have myocarditis and pericarditis; due to having had Covid 19 three times in the last three years and then taken the Moderna shot three times caused the inflammation of my heart.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
2,0
Labordaten
3/16/2022, 2/13/2023, 2/14/2023, pending echocardiogram on 5/5/2023.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2581579

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
NJ
Alter
49,0
Geschlecht
M
Eingang
14.02.2023
Impfdatum
08.02.2022
Beginn
18.10.2022
Tage bis Beginn
252,0
Dosis
N/A
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Accident at work Activated partial thromboplastin time Activated protein C resistance Anticoagulant therapy Beta-2 glycoprotein antibody Blood fibrinogen Blood gases Cardiac telemetry Cardiolipin antibody Differential white blood cell count Electrocardiogram Fibrin D dimer Full blood count Gene mutation identification test International normalised ratio increased Laboratory test Meniscus injury Metabolic function test

Symptomtext

After work injury on 10/4/22, detected blood clot in lower left leg on 10/18/22. Injury to pes anserine plus small tear in medial meniscus. Doppler confirmed clot on 10/26/22. 5mg of Eliquis prescribed by Local Medical Center on 10/26/22. Drove to alternate Medical Center on 11/24 with pain. New clots detected in hospital. Now it was 4 clots in the lower left leg and 1 clot in the left wrist. Hospital said Eliquis failure. INR was 1.0. Spent 6 days in hospital transitioning from heparin IV to Warfarin, 5mg given. INR climbed to 3.25, then warfarin lowered to 4mg. Current INR remains around 2.7. Next doppler to be given on 4/17/23, expect clots to be gone by then. Current orthopedic states that timing and

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
6,0
Labordaten
initial doppler done by Local Medical Imaging on 10/26/22. Tests done on 10/26/22 by Local Medical Center: Blood Gas, venous 3, CBC wit
Aktuelle Erkrankungen
unknown
Vorgeschichte
minor heart aorta issue - monitored by Dr.
Andere Medikamente
multivitamin
Allergien
unknown
Vorherige Impfungen
-

VAERS 2497745

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
NY
Alter
35,0
Geschlecht
F
Eingang
03.11.2022
Impfdatum
02.02.2022
Beginn
03.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Atrial tachycardia Blood test Cardiac ablation Cardiac electrophysiologic study Chest pain Dizziness Dizziness postural Echocardiogram Electrocardiogram ST segment depression Electrocardiogram T wave abnormal Electrocardiogram ambulatory abnormal Fear Impaired work ability Iron deficiency anaemia Loss of personal independence in daily activities Medical diet Orthostatic hypotension Presyncope

Symptomtext

The morning after receiving the Moderna COVID-19 vaccine I woke up with severe dizziness and near-syncope upon standing. I made an appointment to see my Primary Care Doctor and had an appointment scheduled for February 11, 2022. Dr decided to do vitals, blood work, EKG and exam. My blood pressure lying was 98/60 lying and 130/80 standing with associated dizziness. My EKG showed Sinus Tachycardia with Nonspecific ST depression and Diffuse nonspecific T-abnormalities. Dr decided to start me on a high sodium diet with increased fluid intake. On Monday February 14, 2022 I followed up with Dr and I had less dizziness complaints over the weekend. Dr advised me that I had a severe iron deficiency anemia and recommended starting on an Iron supplement and Vitamin C supplement. He also recommended follow-up with Dr MD, a Cardiologist. I had an appointment with Dr on Monday February 21st, 2022. I went to work as an Emergency Room Registered Nurse and felt Chest Pain on February 17, 2022, so I was admitted to the hospital under Observation Status. I was discharged the same day. I advised Dr of my hospital stay and he wanted me to follow with the Cardiologist. I saw Dr on 2/21/22 and he performed vital signs which showed orthostatic hypotension, an EKG which was abnormal and a one-week Holter monitor. After returning the Holter monitor, Dr called to inform me that I had episodes of severe tachycardia shown on the Holter and I should see Dr MD, an electrophysiologist. I made an appointment with Dr on March 16, 2022. I also returned to a follow up appointment with my PCP who started me on Midodrine 2.5mg three times a day for the orthostatic hypotension. I then saw Dr who had looked over my Holter monitor and advised that I had atrial tachycardia, and he recommended a Cardiac Ablation. I followed up with Dr again on April 5th, 2022 who advised me my iron levels had returned to normal and to increase Midodrine to 5mg three times a day. I underwent an Electrophysiology Study and a successful Cardiac Ablation on April 19, 2022 at Hospital and had to stay overnight. Following the procedure, I continued to have orthostatic hypotension and associated dizziness. I followed up with Dr on Monday May 9, 2022, who I advised of my continuing symptoms, so he had me do an event monitor for a month. I returned to my PCP on May 2, 2022 who advised me to start Fludrocortisone 0.1mg once a day, increase Midodrine to 10mg three times a day, and to follow with a nephrologist, Dr. D.O. I saw Dr. on May 12, 2022 who advised to start eating small meals throughout the day. I saw Dr again on June 15, 2022. He explained the monitor showed no abnormalities, so my ablation was successful, so he suggested follow-up with my PCP Dr. I finally returned to work due to running out of disability time on Friday June 17, 2002, after having been out on medical leave since February 17, 2022. I saw Dr again on July 25, 2022 for a follow-up. I have since continued to the current date, the Florinef 0.1mg and Midodrine 10mg three times a day and still have episodes of dizziness upon standing along with a number of syncopal episodes. The events following my vaccine administration has changed my ability to work, as I am unable to stand quickly or to stand for long periods of time as a Registered Nurse. It also impacts my daily life, as I feel dizzy often, fear passing out and now have heat intolerance.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
1,0
Labordaten
Bloodwork 12-lead EKG Echocardiogram Medications Electrophysiology Study Cardiac Ablation
Aktuelle Erkrankungen
None
Vorgeschichte
Major Depression Obsessive Compulsive Disorder Anxiety Attention Deficit Disorder Mirgraine
Andere Medikamente
Vyvanse 70 mg Klonopin 1mg in am and 0.5mg at pm Cymbalta 100mg Abilify 7mg
Allergien
Shellfish
Vorherige Impfungen
-

VAERS 2251874

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
TX
Alter
30,0
Geschlecht
F
Eingang
26.04.2022
Impfdatum
23.03.2022
Beginn
24.03.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Anaphylactic reaction

Symptomtext

Systemic: Allergic: Anaphylaxis-Severe, Additional Details: Patient develop reaction 1-2 days after recieving the shot. patient was admitted into ER. She called the pharmacy on 4/22/22 to report incident

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2220468

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
IA
Alter
70,0
Geschlecht
M
Eingang
07.04.2022
Impfdatum
05.04.2022
Beginn
06.04.2022
Tage bis Beginn
1,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abnormal sensation in eye Eyelid ptosis Facial paralysis

Symptomtext

Patient developed drooping of the right side of his face with drooping of the corner of the mouth and scratchy sensation with droopiness of the right eye. Symptoms started yesterday and presented to the office today. Has a history of Bell's Palsy in 2020. 2nd booster vaccine was given earlier this week at a health department.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
-
Labordaten
No medical tests or lab tests obtained. Prescription medication given with recheck needed in 1 week.
Aktuelle Erkrankungen
None
Vorgeschichte
Diabetes Mellitus Type II, atrial fibrillation, BPH, HTN, OSA
Andere Medikamente
Amiodarone, Vitamin D3, Farxiga, furosemide, lopid, hydrea, metformin, MVI, primidone, flomax and xarelto
Allergien
None
Vorherige Impfungen
-

VAERS 2189665

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
MI
Alter
71,0
Geschlecht
F
Eingang
29.03.2022
Impfdatum
03.02.2022
Beginn
01.02.2022
Tage bis Beginn
-
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Condition aggravated Electrocardiogram ambulatory Fatigue Headache Loss of consciousness Interchange of vaccine products SARS-CoV-2 antibody test Palpitations SARS-CoV-2 test negative Somnolence Syncope

Symptomtext

woke up at 5AM on 4Feb2022 and passed out in her bathroom.; her first primary series was J&J vaccine; slept for the next 24 hours; woke up with a headache for 2-3 days afterwards.; Extreme fatigue for 2-3 days afterwards; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (COVID-19 (had it in Nov2020), was reported.) in November 2020. Previously administered products included for Product used for unknown indication: J&J vaccine (First primary series was J&J vaccine was reported.) and J&J vaccine (First primary series was J&J vaccine was reported.). Past adverse reactions to the above products included No adverse event with J&J vaccine and J&J vaccine. On 03-Feb-2022 at 2:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2022 at 2:00 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTERCHANGE OF VACCINE PRODUCTS (her first primary series was J&J vaccine). On 04-Feb-2022 at 5:00 AM, the patient experienced LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.) (seriousness criterion medically significant). In February 2022, the patient experienced SOMNOLENCE (slept for the next 24 hours), HEADACHE (woke up with a headache for 2-3 days afterwards.) and FATIGUE (Extreme fatigue for 2-3 days afterwards). At the time of the report, LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.), SOMNOLENCE (slept for the next 24 hours), HEADACHE (woke up with a headache for 2-3 days afterwards.) and FATIGUE (Extreme fatigue for 2-3 days afterwards) outcome was unknown and INTERCHANGE OF VACCINE PRODUCTS (her first primary series was J&J vaccine) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, SARS-CoV-2 antibody test: negative (Negative) Took a COVID-19 test and it came out negative. No concomitant medication was reported. No treatment medication was reported. Patient weight was reported as 150 without units. Company Comment: This is a spontaneous case of interchange of vaccine products for this 71-year-old, female patient with past drug history of administration of two doses of the Johnson&Johnson COVID-19 vaccine, who experienced the unexpected, serious (medically significant) event of loss of consciousness and other associated unexpected and expected, non-serious events. The event loss of consciousness occurred 15 hours after administration of the booster dose of the Moderna mRNA-1273 vaccine. The start dates of the other events were not provided. Fifteen hours after vaccination, the patient woke up and passed out in the bathroom. She then slept for the next 24 hours. She woke up on an unspecified date with headache and extreme fatigue for 2 to 3 days. The patient stated that the side effects felt similar to when she had COVID-19 in Nov2020. However, she took a COVID-19 test and the result was negative. Treatment information was not provided. The outcomes of the events were unknown at the time of the report. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.; Sender's Comments: This is a spontaneous case of interchange of vaccine products for this 71-year-old, female patient with past drug history of administration of two doses of the Johnson&Johnson COVID-19 vaccine, who experienced the unexpected, serious (medically significant) event of loss of consciousness and other associated unexpected and expected, non-serious events. The event loss of consciousness occurred 15 hours after administration of the booster dose of the Moderna mRNA-1273 vaccine. The start dates of the other events were not provided. Fifteen hours after vaccination, the patient woke up and passed out in the bathroom. She then slept for the next 24 hours. She woke up on an unspecified date with headache and extreme fatigue for 2 to 3 days. The patient stated that the side effects felt similar to when she had COVID-19 in Nov2020. However, she took a COVID-19 test and the result was negative. Treatment information was not provided. The outcomes of the events were unknown at the time of the report. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Test Date: 202202; Test Name: COVID-19 Test; Test Result: Negative ; Result Unstructured Data: Took a COVID-19 test and it came out negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19 (COVID-19 (had it in Nov2020), was reported.)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2189665

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
MI
Alter
71,0
Geschlecht
F
Eingang
29.03.2022
Impfdatum
03.02.2022
Beginn
01.02.2022
Tage bis Beginn
-
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Condition aggravated Electrocardiogram ambulatory Fatigue Headache Loss of consciousness Interchange of vaccine products SARS-CoV-2 antibody test Palpitations SARS-CoV-2 test negative Somnolence Syncope

Symptomtext

woke up at 5AM on 4Feb2022 and passed out in her bathroom.; her first primary series was J&J vaccine; slept for the next 24 hours; woke up with a headache for 2-3 days afterwards.; Extreme fatigue for 2-3 days afterwards; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (COVID-19 (had it in Nov2020), was reported.) in November 2020. Previously administered products included for Product used for unknown indication: J&J vaccine (First primary series was J&J vaccine was reported.) and J&J vaccine (First primary series was J&J vaccine was reported.). Past adverse reactions to the above products included No adverse event with J&J vaccine and J&J vaccine. On 03-Feb-2022 at 2:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2022 at 2:00 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTERCHANGE OF VACCINE PRODUCTS (her first primary series was J&J vaccine). On 04-Feb-2022 at 5:00 AM, the patient experienced LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.) (seriousness criterion medically significant). In February 2022, the patient experienced SOMNOLENCE (slept for the next 24 hours), HEADACHE (woke up with a headache for 2-3 days afterwards.) and FATIGUE (Extreme fatigue for 2-3 days afterwards). At the time of the report, LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.), SOMNOLENCE (slept for the next 24 hours), HEADACHE (woke up with a headache for 2-3 days afterwards.) and FATIGUE (Extreme fatigue for 2-3 days afterwards) outcome was unknown and INTERCHANGE OF VACCINE PRODUCTS (her first primary series was J&J vaccine) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, SARS-CoV-2 antibody test: negative (Negative) Took a COVID-19 test and it came out negative. No concomitant medication was reported. No treatment medication was reported. Patient weight was reported as 150 without units. Company Comment: This is a spontaneous case of interchange of vaccine products for this 71-year-old, female patient with past drug history of administration of two doses of the Johnson&Johnson COVID-19 vaccine, who experienced the unexpected, serious (medically significant) event of loss of consciousness and other associated unexpected and expected, non-serious events. The event loss of consciousness occurred 15 hours after administration of the booster dose of the Moderna mRNA-1273 vaccine. The start dates of the other events were not provided. Fifteen hours after vaccination, the patient woke up and passed out in the bathroom. She then slept for the next 24 hours. She woke up on an unspecified date with headache and extreme fatigue for 2 to 3 days. The patient stated that the side effects felt similar to when she had COVID-19 in Nov2020. However, she took a COVID-19 test and the result was negative. Treatment information was not provided. The outcomes of the events were unknown at the time of the report. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.; Sender's Comments: This is a spontaneous case of interchange of vaccine products for this 71-year-old, female patient with past drug history of administration of two doses of the Johnson&Johnson COVID-19 vaccine, who experienced the unexpected, serious (medically significant) event of loss of consciousness and other associated unexpected and expected, non-serious events. The event loss of consciousness occurred 15 hours after administration of the booster dose of the Moderna mRNA-1273 vaccine. The start dates of the other events were not provided. Fifteen hours after vaccination, the patient woke up and passed out in the bathroom. She then slept for the next 24 hours. She woke up on an unspecified date with headache and extreme fatigue for 2 to 3 days. The patient stated that the side effects felt similar to when she had COVID-19 in Nov2020. However, she took a COVID-19 test and the result was negative. Treatment information was not provided. The outcomes of the events were unknown at the time of the report. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Test Date: 202202; Test Name: COVID-19 Test; Test Result: Negative ; Result Unstructured Data: Took a COVID-19 test and it came out negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19 (COVID-19 (had it in Nov2020), was reported.)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2161664

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
NJ
Alter
52,0
Geschlecht
M
Eingang
05.03.2022
Impfdatum
05.03.2022
Beginn
05.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Loss of consciousness Syncope

Symptomtext

The patient fainted and unconscious for a few minutes. She woke-up after tapping and calling her name. Contacted emergency services.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2160927

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
OR
Alter
52,0
Geschlecht
F
Eingang
05.03.2022
Impfdatum
31.01.2022
Beginn
01.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood oestrogen Blood oestrogen decreased Blood pressure increased Blood pressure measurement Chills Heart rate Heart rate increased Myocarditis Nasopharyngitis Palpitations Pericarditis Pyrexia SARS-CoV-2 test Vaccination complication Vaccination site induration Vaccination site movement impairment Vaccination site pain Vaccination site swelling

Symptomtext

Myocarditis; Pericarditis; my blood pressure was sky high/y blood pressure 166/139.; pulse was high/My pulse was 116; my heart was pounding bad; really sick with the shot; hurt so bad couldn't lift arm.; estrogen was low; arm got hard/arm was rock hard; arm got very swollen/very swollen/arm was huge and very swollen; arm was tender/arm hurt; fever; chills; like getting a cold; This spontaneous case was reported by a nurse and describes the occurrence of MYOCARDITIS (Myocarditis) and PERICARDITIS (Pericarditis) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. On 31-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2022, the patient experienced NASOPHARYNGITIS (like getting a cold), PYREXIA (fever) and CHILLS (chills). On an unknown date, the patient experienced MYOCARDITIS (Myocarditis) (seriousness criterion medically significant), PERICARDITIS (Pericarditis) (seriousness criterion medically significant), BLOOD PRESSURE INCREASED (my blood pressure was sky high/y blood pressure 166/139.), HEART RATE INCREASED (pulse was high/My pulse was 116), PALPITATIONS (my heart was pounding bad), VACCINATION COMPLICATION (really sick with the shot), VACCINATION SITE MOVEMENT IMPAIRMENT (hurt so bad couldn't lift arm.), BLOOD OESTROGEN DECREASED (estrogen was low), VACCINATION SITE INDURATION (arm got hard/arm was rock hard), VACCINATION SITE SWELLING (arm got very swollen/very swollen/arm was huge and very swollen) and VACCINATION SITE PAIN (arm was tender/arm hurt). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] on 01-Feb-2022 at an unspecified dose and frequency; LORAZEPAM on 01-Feb-2022 for Anxiety, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 01-Feb-2022 at an unspecified dose and frequency. At the time of the report, MYOCARDITIS (Myocarditis), PERICARDITIS (Pericarditis), BLOOD PRESSURE INCREASED (my blood pressure was sky high/y blood pressure 166/139.), HEART RATE INCREASED (pulse was high/My pulse was 116), PALPITATIONS (my heart was pounding bad), VACCINATION COMPLICATION (really sick with the shot), NASOPHARYNGITIS (like getting a cold), VACCINATION SITE MOVEMENT IMPAIRMENT (hurt so bad couldn't lift arm.), BLOOD OESTROGEN DECREASED (estrogen was low), VACCINATION SITE INDURATION (arm got hard/arm was rock hard), VACCINATION SITE SWELLING (arm got very swollen/very swollen/arm was huge and very swollen), PYREXIA (fever), CHILLS (chills) and VACCINATION SITE PAIN (arm was tender/arm hurt) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, SARS-CoV-2 test: positive Positive. On an unknown date, Blood oestrogen: low (Low) Low. On an unknown date, Blood pressure measurement: around 90/58 aroung 90/58 and 166/139 it was 166/139. On an unknown date, Heart rate: 116 116. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient reported that it was almost time for second shot and stated that she was very concerned about, patient woke up around 1 am her heart was pounding bad. Patient pulse was 116 and stayed like that for three hours scared. Patient stated that caller took treatment and it calmed down and slowly started subsiding. Reporter stated that prescribed estrogen this past friday, Patient got myocarditis and pericarditis symptoms because her estrogen was low. Patient reported that wear heart monitor for 48 hours and awaiting results. Also having a stress test done this month. Patient took lorazepam during episode of high blood pressure and increased pulse. Reporter stated that it helped. Concomitant medication included: vitamins. CC: This case concerns a 52-year-old, female patient with past medical history of Covid-19 infection, who experienced the expected serious AESI events of Myocarditis and Pericarditis. The event occurred on an unknown dates after the first dose of mRNA-1273 (Moderna covid-19 vaccine). The patient woke up in the morning with a pounding heart, pulse of 116. Patient was also reported to have low estrogen level and was prescribed estrogen for treatment. This patient's past history of Covid-19 infection and low estrogen level remains a confounder. The benefit-risk relationship of mRNA-1273 (Moderna covid-19 vaccine) is not affected by this report. This case was linked to MOD-2022-499057 (Patient Link).; Sender's Comments: This case concerns a 52-year-old, female patient with past medical history of Covid-19 infection, who experienced the expected serious AESI events of Myocarditis and Pericarditis. The event occurred on an unknown dates after the first dose of mRNA-1273 (Moderna covid-19 vaccine). The patient woke up in the morning with a pounding heart, pulse of 116. Patient was also reported to have low estrogen level and was prescribed estrogen for treatment. This patient's past history of Covid-19 infection and low estrogen level remains a confounder. The benefit-risk relationship of mRNA-1273 (Moderna covid-19 vaccine) is not affected by this report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
-
Labordaten
Test Name: estrogen; Result Unstructured Data: Low; Test Name: Blood pressure; Result Unstructured Data: aroung 90/58; Test Name: Blood pressure; Result Unstructured Data: it was 166/139; Test Name: pulse rate; Result Unstructured Data: 116; Test Date: 202108; Test Name: COVID-19 virus test; Result Unstructured Data: Positive
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151102

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
CA
Alter
22,0
Geschlecht
M
Eingang
01.03.2022
Impfdatum
19.01.2022
Beginn
19.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypotension Syncope

Symptomtext

Systemic: Hypotension-Mild, Systemic: Fainting / Unresponsive-Mild

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2122903

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
NJ
Alter
42,0
Geschlecht
F
Eingang
18.02.2022
Impfdatum
11.02.2022
Beginn
12.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Pyrexia Sleep disorder Syncope

Symptomtext

Fever and chills started at 4am on Saturday, February 12th. This led to me walking in the middle of the night and getting up and passing out on the floor. I woke back up but was not 100% for 2 more days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Nonr
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2109342

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
NY
Alter
35,0
Geschlecht
M
Eingang
12.02.2022
Impfdatum
26.01.2022
Beginn
06.02.2022
Tage bis Beginn
11,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Anaphylactic reaction Full blood count Metabolic function test Pruritus Urticaria

Symptomtext

First generalized itchiness, then hives, then difficulty breathing. I went to the ER and was given epinephrine and was treated emergently for concerns over anaphylaxis. Since 02/08/22, I have been to the ER twice and have used my epi pen once. I am still breaking out into hives and have no idea what it could be from aside the vaccine. I have never had hives or allergies in the past, I was always healthy and since the booster this has since changed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
CBC, CMP 02/11
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
Vitamin D
Allergien
NONE
Vorherige Impfungen
-

VAERS 2084905

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

schwer
Staat
AZ
Alter
20,0
Geschlecht
M
Eingang
03.02.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Dizziness Flushing Hyperhidrosis Syncope Tinnitus Unresponsive to stimuli Visual impairment

Symptomtext

Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Tinnitus-Mild, Systemic: Visual Changes/Disturbances-Mild, Systemic: Weakness-Mild

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2083038

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
NY
Alter
33,0
Geschlecht
F
Eingang
02.02.2022
Impfdatum
31.01.2022
Beginn
01.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Chills Hospitalisation Laboratory test Vomiting

Symptomtext

I started vomiting at 2 AM and continued until hospitalization at around 9 AM. I also had severe chills and a body temperature around 94 degrees when I am usually around 97. I was throwing up every 15-20 min. Was treated with plenty of fluids, plus magnesium, NS bolus, Pepcid, potassium chloride, Toradol, and Zofran.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hospitalisation
Hospital-Tage
-
Labordaten
Electrolytes we?re checked and off so given magnesium and potassium to correct them.
Aktuelle Erkrankungen
Potential omicron exposure (more than 14 days prior)
Vorgeschichte
None
Andere Medikamente
Birth control (Ortho tricyclin lo) Antidepressant (Lexapro 25mg)
Allergien
None
Vorherige Impfungen
My second dose of Phizer I also threw up but not as severely. Due to symptoms such as nausea, weakness, fatigue, severe headache

VAERS 2059377

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

schwer
Staat
CA
Alter
22,0
Geschlecht
F
Eingang
24.01.2022
Impfdatum
24.01.2022
Beginn
24.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cold sweat Feeling cold Hyperhidrosis Seizure like phenomena Syncope Tremor

Symptomtext

Patient had syncopal episode approx. 7-10 minutes post vaccination while sitting in waiting area. Partner reports patient had seizure-like episode and was shaking. Duration is unknown, partner reports about 30 seconds. Then notified clinic staff. Patient was brought into clinic room and had return of consciousness. She was diaphoretic, with cool and clammy skin. Kept laying inclined on patient on exam table for post monitoring. A/Ox3, vital signs stable. She reports hx of fainting in past post blood draw but has not experienced with vaccination. Skin tone returned to normal. Patient reports feeling better after post monitoring. Partner will transport home via personal vehicle.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure like phenomena
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2057824

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

schwer
Staat
CA
Alter
32,0
Geschlecht
F
Eingang
23.01.2022
Impfdatum
22.01.2022
Beginn
22.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope Unresponsive to stimuli

Symptomtext

Systemic: Fainting / Unresponsive-Mild, Additional Details: The patient has a long history of fainting with vaccines but she did not tell us this. We gave her the moderna vaccine and she seemed fine. As we were about to inject the Flu vaccine she fainted. She was fine right away though. She stayed for 30 minutes and drank water.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2645320

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
-
Alter
85,0
Geschlecht
M
Eingang
14.06.2023
Impfdatum
03.05.2022
Beginn
19.04.2023
Tage bis Beginn
351,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Barrett's oesophagus Chronic respiratory failure Hyponatraemia Hypotension

Symptomtext

I95.9 HYPOTENSION 4/22/2023 HYPONATREMIA J96.10 CHRONIC RESPIRATORY FAILURE 1/17/2023 HYPONATREMIA I95.9 HYPOTENSION 4/22/2023 BARRETTS ESOPHAGUS J96.10 CHRONIC RESPIRATORY FAILURE 1/17/2023 BARRETTS ESOPHAGUS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypotension
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2625001

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 042J21A

moderat
Staat
-
Alter
68,0
Geschlecht
M
Eingang
02.05.2023
Impfdatum
31.12.2021
Beginn
10.06.2022
Tage bis Beginn
161,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Hypotension Metabolic encephalopathy

Symptomtext

I95.9 HYPOTENSION 6/24/2022 METABOLIC ENCEPHALOPATHY

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypotension
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2619326

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
MD
Alter
78,0
Geschlecht
F
Eingang
21.04.2023
Impfdatum
20.04.2022
Beginn
17.02.2023
Tage bis Beginn
303,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
COVID-19 Chills Feeling cold Pain Pyrexia SARS-CoV-2 test positive Tremor Urinary tract infection Urine analysis abnormal

Symptomtext

I was on a shopping trip with my granddaughter on 2/17/2023, and I was suddenly seized by chills, and I was shaking all over and felt cold. I then went out to the car and turned on the heated seat. While I was in the car waiting on my granddaughter, I fell asleep at one point. I was the driver, but when my granddaughter saw me, she insisted on driving me home. At this point, I felt pretty sure that I had COVID-19. When I got home,though, I took a home antigen test and got a negative result. I then took some Tylenol and went to bed. The following morning on 2/18/2023, I took another home antigen test and got another negative result. I had a fever of 100 and intermittent chills. I called the 24-hour number for the medical group that runs the practice where my PCP works. They told me that I needed to go to the ER or a walk-in clinic. I then called the on-call doctor at the practice and spoke to her personally. I had previously gone to the clinic and had a urinalysis done earlier in the week, and the on-call physician informed me that I had a urinary tract infection. The on-call doctor was concerned on account of my chills and fever. I remembered that when I had had a kidney infection many years before, I had had chills and fever. The doctor was unsure whether I should go to the ER. I didn't really want to go to the ER, so the doctor ordered an antibiotic whose name I don't recall. She then instructed me that if I didn't feel better the following day, I should go to the ER. I took two doses of the antibiotic, and the following morning, I didn't feel better, so I went to the ER on 2/19/2023. They did a COVID-19 test, other bloodwork, and a urinalysis. They also started an IV. They gave me something for pain, because I hurt all over, and I felt like I had flank pain. A few hours later, I was told that I had tested positive for COVID-19. Interestingly, though, I tested negative for a urinary tract infection when the urinalysis was done. I was then discharged, but before I left, I asked for Paxlovid. However, they refused to prescribe it to me because of the medications I was taking. I ended up calling my PCP's practice and then getting the Paxlovid prescription. I was given low-dose Paxlovid. The doctor told me to stop taking atorvastatin while I was on the Paxlovid and to watch my blood pressure and blood sugar. I took the Paxlovid for five days, and I started feeling better by 2/21/2023. I isolated for five days from the time I was diagnosed. During my illness, I had no cough or other respiratory symptoms. After 2/21/2023, I steadily got better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Diabetes, Type II; Hypertension; High Cholesterol; Hypothyroidism; History of Heart Valve Replacement
Andere Medikamente
Levothyroxine; Metoprolol; Spironolactone; Metformin; Pantoprazole; Baby Aspirin; Loratadine; Atorvastatin; Fenofibrate; Famotidine; Multivitamin; Vitamin B12; Vitamin B Complex
Allergien
None
Vorherige Impfungen
-

VAERS 2583574

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
IL
Alter
50,0
Geschlecht
F
Eingang
17.02.2023
Impfdatum
28.12.2021
Beginn
01.03.2022
Tage bis Beginn
63,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Asthenia Cervical radiculopathy Computerised tomogram abdomen abnormal Diarrhoea Disturbance in attention Emotional poverty Faeces discoloured Hepatic steatosis Hypothyroidism Impaired work ability Insomnia Laboratory test Magnetic resonance imaging neck Malaise Medical diet Mobility decreased Musculoskeletal disorder

Symptomtext

I was very sick from the 1st shot had to miss work for 2 days. Nauseous, extreme pain all over. 2nd shot I was sick for a whole week and missed work because of it. Nauseous and even more extreme pain than the first shot. Could barely move and couldn't sleep because of the pain. Adverse events started right away but didn't get diagnosed until March 2022 for Hypothyroidism, now on levothyroxine for that. No energy, couldn't focus, no feeling (emotions) at all. Later 2022 was diagnosed with fatty liver disease and cervical radioculapthy. Have changed lifestyle and eating habits to help with fatty liver disease. Chiropractor for musculoskeletal issues. Symptoms for fatty liver chronic diarrhea that was green and watery or very mushy. Chronic abdominal pain, nausea, my skin feels like it's on fire and like glass in my hands. Severe neck pain so I bought a new pillow and try to stretch it out every day. Chiro helps with pain management. The new diet has helped some with the abdominal pain and I've lost 17 lbs. Still have to watch what I eat and I cut out Mt dew and anything with high fructose corn syrup. I also am using stevia instead of sugar for a sweetener. More raw protein like eggs, bacon, steak, and less carbohydrates.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
11/23/2022 CT scan abdomen day liver disease. 12/14/2022 MRI of neck radioculapthy. Lab tests Oct 19 2022
Aktuelle Erkrankungen
N/A
Vorgeschichte
High blood pressure anxiety depression migraine
Andere Medikamente
Zegerid topomax gabapentin Tylenol ibuprofen losartan
Allergien
Latex poison ivy
Vorherige Impfungen
Flu shot

VAERS 2505690

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
MI
Alter
76,0
Geschlecht
M
Eingang
11.11.2022
Impfdatum
16.01.2021
Beginn
15.09.2022
Tage bis Beginn
607,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Chest pain SARS-CoV-2 test positive

Symptomtext

09/15/22 presents to ED for "chest pain". PMHx of "CAD (on plavix) and previous stents, Ischemic CMP with ICD"

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
09/15/22 SARS-CoV-2 (COVID-19) detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2422796

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
MI
Alter
27,0
Geschlecht
M
Eingang
29.08.2022
Impfdatum
15.04.2021
Beginn
15.08.2022
Tage bis Beginn
487,0
Dosis
3
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Asthenia COVID-19 Chest pain Chills Dizziness Fatigue Feeling abnormal Pain Pyrexia SARS-CoV-2 test positive Sepsis

Symptomtext

Pt to ED 8/14 for weakness/fatigue/chills/fever for several days. Pt COVID+ 8/15, rx for Decadron/remdesivir. 8/16 pt a+Ox4, denies any pain, pt repositioned for comfort, no sob noted. 8/17 pt blood pressure is 84/48., , Pt denies any pain, pt A & O x 4. 8/19 Pt "I don't feel good" and then complained of left chest pain that radiates down side and dizziness. 8/20 pt remains A&Ox4. 8/25 pt Aox3, sepsis BPA firing score 7. Vital signs stable. 8/26 Pt cleared for discharge. IV removed, no complications. Pt discharged 8/26.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
13,0
Labordaten
see above
Aktuelle Erkrankungen
None
Vorgeschichte
Tracheocutaneous fistula following tracheostomy (CMS/HCC) Tracheocutaneous fistula following tracheostomy (CMS/HCC) Chronic asthma without complication Pneumonia Colitis Nausea & vomiting Ileus (CMS/HCC) Constipation, chronic Decubitus ulcer of left ankle Hypotension Debility Anxiety and depression Primary hypertension Paraplegia (CMS/HCC) Hyponatremia H/O tracheostomy Asymptomatic bacteriuria History of tracheostomy Quadriplegia (CMS/HCC) Bicytopenia Hyperglycemia Bilateral diffuse ground glass opacities on imaging of the lung Bullous eruption, localized to the abdomen Bilateral hydronephrosis Nephrolithiasis Neurogenic bladder Seizure (CMS/HCC) Urinary tract infection associated with indwelling urethral catheter (CMS/HCC) Urinary tract infection with hematuria Fecaloma (CMS/HCC) Peripheral vascular disease of extremity (CMS/HCC) Ulcer of right foot with muscle involvement without evidence of necrosis (CMS/HCC) Obstruction of suprapubic catheter (CMS/HCC) Sepsis secondary to UTI (CMS/HCC) History of DVT (deep vein thrombosis) on Xarelto Gram negative septicemia (CMS/HCC) Chronic suprapubic catheter (CMS/HCC) Hydronephrosis of right kidney Developmental delay Seizure disorder (CMS/HCC) E. coli and Proteus UTI Nonadherence to medication-- >needs encouragement to take laxatives Bacteremia due to Escherichia coli Tracheostomy dependent (CMS/HCC) Gross hematuria Decubitus ulcer of left thigh, stage 4 (CMS/HCC) Abrasion of left leg Alteration in skin integrity due to moisture Excoriation of periwound skin Fever Osteomyelitis of right foot (CMS/HCC) General weakness SIRS (systemic inflammatory response syndrome) (CMS/HCC) Protein-calorie malnutrition, mild (CMS/HCC) Fecal incontinence Xerosis cutis Incontinence associated dermatitis Decubitus ulcer of right ischium, stage 4 (CMS/HCC) Decubitus ulcer of ischium, unstageable, left (CMS/HCC) Diarrhea Chills Decubitus ulcer of sacral region, unstageable (CMS/HCC)
Andere Medikamente
acetaminophen (TYLENOL) 325 MG PO Tab acetaminophen (TYLENOL) 325 MG PO Tab albuterol (PROVENTIL, VENTOLIN, PROAIR) HFA 108 (90 Base) MCG/ACT INHAL Aero Soln albuterol-ipratropium (DUONEB) 0.5-2.5 (3) MG/3ML INHAL Solution amLODIPine (NORVA
Allergien
None
Vorherige Impfungen
-

VAERS 2394979

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
-
Alter
74,0
Geschlecht
M
Eingang
28.07.2022
Impfdatum
24.02.2022
Beginn
23.07.2022
Tage bis Beginn
149,0
Dosis
4
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dyspnoea Rhonchi

Symptomtext

SOB, ronchi

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2394946

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
-
Alter
74,0
Geschlecht
M
Eingang
28.07.2022
Impfdatum
17.02.2022
Beginn
17.07.2022
Tage bis Beginn
150,0
Dosis
3
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dyspnoea

Symptomtext

SOB

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2391418

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
OR
Alter
51,0
Geschlecht
F
Eingang
26.07.2022
Impfdatum
25.04.2022
Beginn
10.07.2022
Tage bis Beginn
76,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Dyspnoea Fatigue Feeling abnormal Headache Lower respiratory tract infection Oropharyngeal pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Sleep disorder

Symptomtext

On July 10, 2022 in the middle of the night I woke up and felt congested with runny nose and it was hard to breathe. I went back to sleep. The next morning I had sore throat and headache as well. I also experienced foggy brain. I used Sudafed and drank Gatorade and got back in bed. The following day I used Nyquil and Dayquil to help with symptoms. I was able to work from home but I had super low energy. The major congestion subsided on day 4. I had the sore throat, headache and runny nose for about 7 days. I tested positive again on July 16th. I still had fatigue, sore throat and headache. I tested negative on July 20th. I felt good enough to ride my bike. As of today I still have a little cold in my chest. I just don't feel 100% yet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Home COVID-19 test, positive
Aktuelle Erkrankungen
N/A
Vorgeschichte
Anxiety
Andere Medikamente
Iron
Allergien
N/A
Vorherige Impfungen
-

VAERS 2388249

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
MI
Alter
83,0
Geschlecht
M
Eingang
25.07.2022
Impfdatum
01.02.2022
Beginn
01.07.2022
Tage bis Beginn
150,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Asthenia Atrial fibrillation CHA2DS2-VASc-score COVID-19 COVID-19 pneumonia Condition aggravated Dementia General physical health deterioration Haematuria Mental impairment Montreal cognitive assessment abnormal Pneumonia Pyrexia SARS-CoV-2 test positive

Symptomtext

Provider D/C note: "83-year-old male with a past medical history significant for persistent atrial fibrillation not on anticoagulation, dilated cardiomyopathy with history of have breath that was recovered, aortic stenosis, hypothyroid, hypertension, BPH and dementia who presented with weakness and fever. Patient was treated for a right lower lobe pneumonia but ultimately was found to have COVID prior to discharge. Patient defervesced and was in isolation for 10 days. Patient had no acute events and was doing well. Patient has had a recent decline per the hospital visits and a recent decline in mental status as well. Moca 2/30 was repeated this hospitalization as well the last patient has severe dementia. Patient was discharged for rehab unlikely placement. Hospital Course: COVID PNA, resolved - patient was treated with antibiotics prior to COVID(+), completed course with possible right lower lobe pneumonia - COVID positive 07/07/2022, discontinued precautions 07/17/2022 Persistent Atrial fibrillation, CHADS-VASC=5 - not on anticoagulation due to intermittent hematuria - rate controlled with metoprolol Dilated Cardiomyopathy w/ Hx of HFrEF, recovered - continue home bb, mra, ace-i - stopped home lasix as patient is euvolemic, monitor weights, can restarted patient needs. Severe Aortic Stenosis - follows with cardiology they were monitoring progression Hypothyroid - continue home levothyroxine HTN, controlled - continue ace-i BPH - continue home tamsulosin Severe Dementia with Depression, High risk delirium - seroquel nightly - sertraline, bupropion - MOCA 2/30 - Severe dementia Issues Requiring Follow Up: PCP - post hospital follow-up and to help with placement with PACE"

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19 pneumonia
Hospital-Tage
21,0
Labordaten
COVID detected PCR 07/07/22.
Aktuelle Erkrankungen
-
Vorgeschichte
Hypothyroidism Anxiety and depression Benign localized prostatic hyperplasia without lower urinary tract symptoms (LUTS) Cancer of prostate with intermediate recurrence risk (stage T2b-c or Gleason 7 or PSA 10-20) (*) HTN (hypertension) Hyperlipidemia, unspecified Hypertensive heart disease without heart failure Mitral valve disorder Nonrheumatic aortic valve stenosis Gait disorder Obesity Paroxysmal atrial fibrillation (HCC) DCM (dilated cardiomyopathy) (*) Dementia (*)
Andere Medikamente
Wellbutrin Drisdol Xalatan Synthroid Prinivil Toprol XL Miralax Seroquel Senna S Zoloft Aldactone Flomax
Allergien
Vicodin
Vorherige Impfungen
-

VAERS 2375838

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
OR
Alter
37,0
Geschlecht
F
Eingang
21.07.2022
Impfdatum
28.02.2022
Beginn
02.03.2022
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain upper Condition aggravated Decreased appetite Diarrhoea Dizziness Headache Inflammation Migraine Nausea Pain Polyp Pyrexia

Symptomtext

Much milder fever for same number of days (3) as full shot gave me. Possibly from the pain and fever it exaggerated/worsened/increased the pain and inflammation of the polyps in/on my skull/brain WHICH in past 10 years I had only inflamed that bad 2x, if not counting years 2018-2022. Once the fever and pain went down it wasn't as severe (to the point I had to put a lot of "advil" cream on 1/2 to 3/4 my head to be able to see and even think). My appetite came back, but not as well as year before when I got the full dose covid shot. Like as in migraines, I get an inflamed other times strong dull pain top of stomach (1st thought was my liver or pancreas, still can't say they are fine because not getting any priority care done first that should been done 10 or 15 years ago) sometimes with nausea which I hadn't had those effects since 2017. I know I'm ALSO having nausea And diarrhea because of a main side-effect of the pain cream I have to use or else I get a 12 to 48 hour migraine or experience inflammation light headedness & lights like I'm having one. So the booster might have increased/brought back/worsened the string of effects from the fever/headache/inflammation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
Moderate to severe occasional inflammation of polyps in left side skull/brain causing migraine like side-effects (lights, sensitivity to light, dull pain like sewing needle in nerve/s of eyes jaws sinus mostly on left side. Happening because can't get a intelligent medical place with neurologist to fix what I know is causing it, attempts for 1 taking 4 months they still aren't saying what form/s or references to send them! Whoever "they" are in online messages).
Vorgeschichte
Seizures, BUT they may be brought on by the prescription for them (possible side effect)& the brain polyps the slow med places around me (insurance has on the list & can't see any others or else less coverage of course) don't know how to get a neurologist to see on the CT scan I had to DEMAND to get from basic practitioner.
Andere Medikamente
Keppra 1000mg 2x/day; Lamictal 100mg 1x/day (instructed by a moron, should been 2x day), Aleve 2 to 3x week, Diclofenac Sodium Topical Gel/cream (1%) 1 or 2x/day 3 or 4x week, CoQ10 & Zinc (50mg)1x that week.
Allergien
Most meats, gluten, most herbal remedies
Vorherige Impfungen
Severe fever (105), very weak and lightheaded, inflammation of head, temporary loss of hearing & sight, loss of appetite, minor

VAERS 2362988

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
GA
Alter
68,0
Geschlecht
F
Eingang
08.07.2022
Impfdatum
07.04.2022
Beginn
15.06.2022
Tage bis Beginn
69,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
COVID-19 Chills Cough Fatigue Headache Pharyngeal paraesthesia Pyrexia SARS-CoV-2 test positive Secretion discharge

Symptomtext

June 15, 2022 I had a bad headache and was coughing, a low grade fever , chills and felt fatigue. I felt a lot of mucus congestion in my throat, like making it hard to talk without having to cough. I took a home test and it was positive. I went to ER. I was prescribed Paxlovid and took it for a week. I felt better on that third day. On June 27th, 2022 I started to feel the symptoms again and tested on a home test again. After consulting with my doctor I decided not to take another Paxlovid, I just waited it out at home. I currently have a tingling in my throat with a slight cough lingering.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pharyngeal paraesthesia
Hospital-Tage
-
Labordaten
Covid-19 PCR Test- 06/15/2022- Positive
Aktuelle Erkrankungen
None
Vorgeschichte
High Cholesterol; Hypothyroidism
Andere Medikamente
Crestor; Armor Thyroid; Vitamin D, Omega# Oil; CoQ10
Allergien
None
Vorherige Impfungen
-

VAERS 2290935

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
CA
Alter
67,0
Geschlecht
F
Eingang
23.05.2022
Impfdatum
05.04.2022
Beginn
11.05.2022
Tage bis Beginn
36,0
Dosis
4
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia COVID-19 Dyspnoea Exposure to SARS-CoV-2 Fatigue Head discomfort Headache Malaise Mobility decreased Nasopharyngitis Pulmonary congestion Pyrexia SARS-CoV-2 test positive

Symptomtext

I FIRST HAD SYMPTOMS WEDNESDAY EVENING MAY 11TH, THEY WERE MILD AND FELT LIKE A COLD. I KNEW I HAD BEEN EXPOUSED. ON THURSDAY I STILL FELT LIKE I HAD A COLD HEAD ACHE AND CHEST CONGESTION. I DID A COVID TEST AROUND 3PM AND IT CAME BACK POSITIVE. I WAS EXETERMLY TIRED AND COULDNT GET OUT OF BED.THEY HAD TO BRING ME MEALS. I WAS REALLY TIRED AND HAD ALOT OF SYMPTOMS LIKE HEAD ACHE AND CHEST AND HEAD CONGESTION. ON THE 16TH I STARTED FEELING I HAD ENOUGH ENERGY TO GET OUT OF BED. I WAS STILL TESTING POSITIVE. ON TUESDAY I STOPPED ISOLATING AND I WORE A MASK BUT I DIDNT GOT OUT I STAYED IN THE HOUSE. AND WOULD MEET FAMILY MEMEBERS OUTSIDE. I STARTED GOING OUT WEDNESDAY AND I REALIZED I GOT TIRED FAST AND THAT HAPPENED FOR THE NEXT FEW DAYS. SO NOW AM JUST TAKING IT EASY BECAUSE I STILL FIND MYSELF BEING TIRED AND SHORT OF BREATH. ON FRIDAY THE 20TH I THOUGHT I WAS RELAPSING BUT I WAS NEGATIVE. AND I ALSO HAD A FEVER WHILE I WAS IN BED AND ON THE 20TH BUT THAT HAS GONE AWAY.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
SYNTHRIOD WELLBURTON XL MEDROXY PROGESTERONE ESTROGEN PATCH
Allergien
Peanuts; tree nuts
Vorherige Impfungen
-

VAERS 2275616

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
MO
Alter
65,0
Geschlecht
F
Eingang
13.05.2022
Impfdatum
08.02.2022
Beginn
09.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Blood pressure increased Burning sensation Cardiac function test normal Echocardiogram Electrocardiogram Electrocardiogram ambulatory Eye pain Gait disturbance Head discomfort Headache Heart rate increased Joint swelling Loss of personal independence in daily activities Muscular weakness Musculoskeletal stiffness Ocular discomfort Ocular hyperaemia

Symptomtext

I experienced extreme head pressure, pain in my head, extreme pulsing in my head and sinuses, my heart was pounding and racing, my neck was stiff, I had difficulty walking, my eyes were bloodshot and painful, hard to focus my eyes, I had a burning sensation in my veins, stabbing joint pain, weakness in my legs, and two swollen pockets behind my knees. The two swollen pockets behind my knees have not resolved. I was an avid hiker and active person before the vaccine and it has greatly affected my life. After 2 months the head pressure, sinus pressure, elevated blood pressure, and eye pressure improved. The cardiologist ran tests and that there was no long term damage to my heart, but confirmed pulse rate and blood pressure were elevated. In the last 2 weeks my blood pressure is beginning to settle down a bit, but my pulse has not returned to normal range.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
echocardiogram on 2/18/2022, Doppler echo on 2/18/2022, EKG, wore a cardiac monitor for two weeks
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
multivitamin, probiotic, melatonin
Allergien
No
Vorherige Impfungen
-

VAERS 2259847

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
PR
Alter
71,0
Geschlecht
F
Eingang
30.04.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Chest X-ray Condition aggravated Electrocardiogram Hypertensive crisis Scan myocardial perfusion

Symptomtext

Hypertensive Crisis that required two visits to the emergency room, the immediate days after the fourth dose of Moderna's Vaccine. Hypertensive Crisis finally required hospitalization for one week and subsequent treatment to control pressure. Getting the pressure to be completely stabilized took more than a month.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
6,0
Labordaten
Chest X-rays, Electrocardiogram, Adenosine myocardial perfusion imaging.
Aktuelle Erkrankungen
Hypertension, Rheumatoid Arthritis
Vorgeschichte
Rheumatoid Arthritis
Andere Medikamente
Enalapril, Hydrochlorothiazide, Aspirin, Pepcid, trichord.
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2228565

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
NY
Alter
65,0
Geschlecht
M
Eingang
12.04.2022
Impfdatum
11.04.2022
Beginn
11.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Mobility decreased Pain in extremity

Symptomtext

SEVERE ARM/SHOULDER PAIN, UNABLE TO MOVE OR RAISE ARM

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2217910

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
ME
Alter
-
Geschlecht
M
Eingang
06.04.2022
Impfdatum
01.04.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Body temperature Mobility decreased Myalgia Pyrexia

Symptomtext

Could not move; Fever with temperature 101.5F; Body was aching like crazy; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Could not move), PYREXIA (Fever with temperature 101.5F) and MYALGIA (Body was aching like crazy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Could not move), PYREXIA (Fever with temperature 101.5F) and MYALGIA (Body was aching like crazy). At the time of the report, MOBILITY DECREASED (Could not move), PYREXIA (Fever with temperature 101.5F) and MYALGIA (Body was aching like crazy) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2022, Body temperature: 101.5 (High) 101.5 Fahrenheit. No concomitant medication was reported by reporter. Patient took second booster of Moderna on 01-Apr-2022. Patient did not take any treatments for side effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
Test Date: 202204; Test Name: Body temperature; Result Unstructured Data: 101.5 Fahrenheit
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2211350

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
MD
Alter
86,0
Geschlecht
M
Eingang
01.04.2022
Impfdatum
01.03.2022
Beginn
11.03.2022
Tage bis Beginn
10,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Asthenia Chronic obstructive pulmonary disease Condition aggravated Dyspnoea Pneumonia

Symptomtext

Patient presents to the emergency department with complaints of shortness of breath and associated weakness. He was subsequently admitted for management of pneumonia and COPD exacerbation. Patient was discharged home 4 days later in stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2190000

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

moderat
Staat
FL
Alter
45,0
Geschlecht
M
Eingang
21.03.2022
Impfdatum
03.02.2022
Beginn
07.02.2022
Tage bis Beginn
4,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest pain

Symptomtext

chest pains

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2189157

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

moderat
Staat
TX
Alter
34,0
Geschlecht
M
Eingang
19.03.2022
Impfdatum
01.02.2021
Beginn
19.02.1921
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Paraesthesia

Symptomtext

Patient complains of numbness and tingling in fingers and toes. Patient states he can bite his fingers and not feel it

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2174172

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

moderat
Staat
FL
Alter
37,0
Geschlecht
F
Eingang
11.03.2022
Impfdatum
03.02.2022
Beginn
03.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest pain Lymphadenopathy

Symptomtext

chest pains, swollen lymphnodes

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2157599

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
PR
Alter
56,0
Geschlecht
M
Eingang
04.03.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood creatine phosphokinase Dizziness Electrocardiogram Full blood count Laboratory test Metabolic function test Pyrexia SARS-CoV-2 test Tremor Troponin Urine analysis Vision blurred

Symptomtext

Patient goes to the emergency room a few hours after being vaccinated against Covid 19. Patient indicated to the nurse on duty " I have tremors, dizziness, fever and blurred vision after being vaccinated the symptoms began". Doctor on duty orders laboratories and treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
BMP, U/A, CPK, CBC, COVID 19 AG, TROPONIN, EKG (01/25/2022)
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Patient refers, "previous vaccine caused me allergy but I want to get vaccinated because they ask for the vaccine for everything
Vorherige Impfungen
MODERNA FIRST AND SECOND DOSES

VAERS 2149322

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21A

moderat
Staat
PR
Alter
27,0
Geschlecht
F
Eingang
28.02.2022
Impfdatum
28.02.2022
Beginn
28.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Exposure during pregnancy Palpitations

Symptomtext

The patient reports that after the administration of the vaccine she felt palpitations. Patient with 21 weeks of gestation. The Doctor recommends observing her for 30 minutes which she refers to feeling well and Doctor discharges her.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
It is unknown.
Vorgeschichte
It is unknown.
Andere Medikamente
It is unknown.
Allergien
NKA
Vorherige Impfungen
-

VAERS 2138046

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
OH
Alter
34,0
Geschlecht
F
Eingang
24.02.2022
Impfdatum
13.02.2022
Beginn
22.02.2022
Tage bis Beginn
9,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood glucose normal Migraine Visual impairment Vomiting

Symptomtext

Vision was white as if someone was shining a light in my eyes, had a migraine so bad that came next felt like someone was splitting my head with an axe, and started vomiting. Checked my blood sugar levels and it dropped to 60. Next episode started the same, checked again and it was 76. Keep having repeat episodes of blood sugar dropping, has no resolved yet. No prior history of diabetes or low blood sugars.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
Included above using blood glucose monitor
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Adderall 20mg 2x daily
Allergien
Acetaminophen
Vorherige Impfungen
-

VAERS 2132397

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
CA
Alter
44,0
Geschlecht
F
Eingang
22.02.2022
Impfdatum
11.02.2022
Beginn
12.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyspnoea Tachycardia

Symptomtext

PATIENT COMPLAINING OF TACHYCARDIA AND SHORTNESS OF BREATH. PATIENT CALLED HER PRIMARY CARE PHYSICIAN. PATIENT WILL TAKE PRESCRIPTON PRESCRIBED FOR HIGH BLOOD PRESSURE. PATIENT STATES BLOOD PRESSURE IS CURRENTLY 124/85.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
NO TESTS
Aktuelle Erkrankungen
NONE
Vorgeschichte
HIGH BLOOD PRESSURE
Andere Medikamente
UNKNOWN
Allergien
NONE
Vorherige Impfungen
-

VAERS 2130732

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
CT
Alter
57,0
Geschlecht
M
Eingang
22.02.2022
Impfdatum
24.01.2022
Beginn
24.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Limb injury Paraesthesia

Symptomtext

Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2118947

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
NY
Alter
20,0
Geschlecht
F
Eingang
17.02.2022
Impfdatum
02.02.2022
Beginn
04.02.2022
Tage bis Beginn
2,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dyspnoea Rash papular Swelling face

Symptomtext

Papular rash on face and arms started 5 days after booster dose some facial swelling Some intermittent shortness of breath on and off for 3 days after

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Mild Intermittent Asthma Anxiety Raynaud's
Andere Medikamente
Oral Contraceptive- Tri Sprintec
Allergien
Sun Block
Vorherige Impfungen
-

VAERS 2109321

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

moderat
Staat
VA
Alter
20,0
Geschlecht
M
Eingang
12.02.2022
Impfdatum
11.02.2022
Beginn
11.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Cough Dizziness Fatigue Hypoaesthesia Migraine Nausea Vomiting

Symptomtext

Numbness of right arm Aches and joint pain Migraine. Next morning Dizziness only an hour after. Fatigue. Nausea 4 hours after. Coughing 3 hours after. Puking. About 7 hours after vacc

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
HHT otherwise known as Osler Weber Rendu Syndrome
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2092597

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
CA
Alter
48,0
Geschlecht
F
Eingang
07.02.2022
Impfdatum
03.02.2022
Beginn
07.02.2022
Tage bis Beginn
4,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Dyspnoea Hyperhidrosis Myalgia Pain

Symptomtext

6 hours after injections chills and sweats started, 8-10 hrs after injection muscle pains started stronger in the gluts and hamstrings, but pain all over body, they all continue about 30 hrs after injection. 2/7/22 - 3 days after injection, started having shortness of breath intermittently.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
40 hrs of sever body pains,fever, headache, chills, sweats after 2nd Moderna Vaccine Covid19 on 2/4/21 - age 47 years old - 1-

VAERS 2092574

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
KY
Alter
19,0
Geschlecht
F
Eingang
07.02.2022
Impfdatum
03.02.2022
Beginn
04.02.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chest X-ray Chest discomfort Dehydration Dyspnoea Dyspnoea exertional Electrocardiogram Fatigue Heart rate increased Hypoacusis Laboratory test Painful respiration

Symptomtext

Pt was vaccinated on Thursday Feb 3rd. Reports that on Friday Feb 4that 6am she woke up with a rapid heartrate of 154, Shortness of Breath, heaviness in chest and pain with inhalation. She also reported that at times she could not hear well out of one ear. Her mother contacted the primarily medical provider and was advised to go to an Emergency room for cardiac workup. Patient went to a larger area Emergency Department where she underwent multiple EKG's, 2 Chest X-Rays and lab work over several hours. She received 2 bags of fluids for dehydration prior to discharge and was advised to make an appointment with cardiologist. Her symptoms had slightly improved but were still present on 2/5,2/6 and 2/7. After 2/5 she reported that her heartrate would elevate into the 130s with activity, And occasionally she would have elevated heartrate with rest. She also reported that she was tired and would get short of breath with walking long distances.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dehydration
Hospital-Tage
-
Labordaten
2/7/22- EKG
Aktuelle Erkrankungen
diagnosed with celiac disease and anemia late December 2021
Vorgeschichte
Celiac disease
Andere Medikamente
Oral Birth Control
Allergien
recently diagnosed gluten allergy
Vorherige Impfungen
-

VAERS 2091572

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
NY
Alter
26,0
Geschlecht
M
Eingang
05.02.2022
Impfdatum
03.02.2022
Beginn
04.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Chest pain Chills Fatigue Headache Lymphadenopathy Myalgia Nausea Pyrexia Vaccine positive rechallenge

Symptomtext

Patient developed fever up to 103.5 degrees Fahrenheit, chills, rigors, acute chest pain, diffuse joint and muscle pain, fatigue, nausea, severe headache, and lymphadenopathy of the left axial, total submandibular, and left supraclavicular regions. These symptoms lasted approximately 48 hours, and the lymphadenopathy is ongoing, as is the nausea and fatigue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Asthma
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
Exact same symptoms after second dose of moderna vaccine in 01/2021; Lot number 037K20A

VAERS 2088223

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
SC
Alter
74,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
04.02.2022
Beginn
04.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Paraesthesia oral

Symptomtext

Patient described odd sensation on tongue. Felt some tingling on tongue. No swelling or other ill effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia oral
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Ceclor, Penicillin
Vorherige Impfungen
-

VAERS 2072277

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
IN
Alter
30,0
Geschlecht
M
Eingang
28.01.2022
Impfdatum
28.01.2022
Beginn
28.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Nausea Paraesthesia Throat tightness

Symptomtext

The patient received a Moderna COVID booster. When he arrived he was sweaty. He was asked if he was sick and he stated no verbally and on his VAR. The vaccine was administered. Approximately 20 minutes after his vaccine he said he felt tingly all over and he said he might vomit. The patient also said he felt as if his throat was swelling shut. The patient was seated, and blood pressure and o2 assessed. BP was 157/94, O2 was 97. Cold compresses were applied to the patients neck and emergency was called. The patient was given oral diphenhydramine 50mg which he swallowed with water. He was then given epinephrine 0.3mg IM in the right thigh. The patient said he immediately felt better. The squad arrived and transported him to the ER. The patient informed the squad that he had started a new medication within the last 24 hours as well (med unknown). The patient was transported to the hospital. Upon follow up with the hospital, we received additional information. The patient was seen in a different ER this morning (1/28/22 8:58am electronic stamp) but did not disclose this information. The patient was assessed for a possible abscess, but the findings from the ER are not clear.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
None to report.
Aktuelle Erkrankungen
Possible abscess
Vorgeschichte
Anxiety, Arthritis, Asthma, Bipolar disorder, Chronic kidney disease, depression, diabetes, hypertension, obsessive compulsive disorder, postoperative nausea and vomiting, post-traumatic stress disorder, restless leg syndrome, schizoaffective disorder.
Andere Medikamente
Spravato 84mg, Invega Trinza 819mg, there are others but they are unknow to the pharmacy
Allergien
Ibuprofen, Aleve, Fentanyl
Vorherige Impfungen
-

VAERS 2047604

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

moderat
Staat
CA
Alter
36,0
Geschlecht
M
Eingang
19.01.2022
Impfdatum
18.01.2022
Beginn
19.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest discomfort Dyspnoea Pyrexia Vomiting

Symptomtext

About 1 hour after receiving the booster shot, fever set in. The fever has averaged 100 degrees or more the last 20 hours roughly, temperature is checked by infrared thermometer. Since 1AM this morning I have been throwing up, even when I drink water it comes right back up. Tightness in chest, and it?s hard to breathe.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Zoloft
Allergien
None
Vorherige Impfungen
Myocarditis

VAERS 2619935

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
OR
Alter
68,0
Geschlecht
F
Eingang
24.04.2023
Impfdatum
22.04.2022
Beginn
06.09.2022
Tage bis Beginn
137,0
Dosis
4
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Exposure to SARS-CoV-2 Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I was positive for COVID-19 on 06SEP2022, I had only a light sore throat nothing else. I only tested because my husband tested positive but I wasn't sick. I did speak to my doctor and prescribed me PAXLOVID, I started feeling better right away but it didn't make a difference because I wasn't sick.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Oropharyngeal pain
Hospital-Tage
-
Labordaten
06SEP2022 COVID-19 test, positive
Aktuelle Erkrankungen
N/A
Vorgeschichte
Diabetic; High cholesterol; Hypertension
Andere Medikamente
N/A
Allergien
Sulfa; latex
Vorherige Impfungen
-

VAERS 2484800

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
OR
Alter
64,0
Geschlecht
F
Eingang
20.10.2022
Impfdatum
18.04.2022
Beginn
26.08.2022
Tage bis Beginn
130,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Cough Fatigue Pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had cough, congestion, achy, fatigue, and running nose. I tested positive for COVID-19 at home. I emailed my doctors office and was sent a prescription for Paxlovid.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
COVID-19, 08/27/2022, Positive
Aktuelle Erkrankungen
N/A
Vorgeschichte
Hypertension
Andere Medikamente
Lisinopril; Metoprolol
Allergien
Penicillin
Vorherige Impfungen
COVID-19 1st and 2nd Moderna, Redness and Rash on arm, fatigue

VAERS 2480483

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
MD
Alter
76,0
Geschlecht
F
Eingang
17.10.2022
Impfdatum
13.04.2022
Beginn
28.08.2022
Tage bis Beginn
137,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Body temperature increased COVID-19 Pain SARS-CoV-2 test positive

Symptomtext

I did not have a reaction to the vaccine. I tested positive with a home test for COVID-19 on 08/28/2022. I had a temperature and felt achy. No congestion. I contacted my doctor and got the prescription for PAXLOVID.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
28AUG2022 COVID-19 test positive.
Aktuelle Erkrankungen
Urinary Tract Infection
Vorgeschichte
Myositis
Andere Medikamente
ZYRTEC; PEPCID; vitamin D; temazepam; AIRBORNE; TYLENOL
Allergien
Iodine; seafood
Vorherige Impfungen
-

VAERS 2439496

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NJ
Alter
65,0
Geschlecht
M
Eingang
10.09.2022
Impfdatum
27.01.2022
Beginn
01.01.2022
Tage bis Beginn
-
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bone disorder Pruritus Rash Sensitive skin

Symptomtext

Small bumps on forehead under the skin. Bumps on eyebrow bones Eyebrow bones becoming more pronounced at corners and sensitive to the touch , also itchy . Also, before this (1st booster) shot , I experienced itchy face and eyes for about 3 or 4 weeks up until the shot .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
1) Eczema around 4 years prior 2) earclog sin ce 2002
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
Penicillin?
Vorherige Impfungen
-

VAERS 2407159

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
MI
Alter
74,0
Geschlecht
M
Eingang
10.08.2022
Impfdatum
04.02.2022
Beginn
04.08.2022
Tage bis Beginn
181,0
Dosis
3
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Pain Pyrexia SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough COVID infection. Generalized body aches and fever with unsure onset. Tested positive 08/04/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
4,0
Labordaten
Positive SARS-COV-2 (COVID-19) by NAA on 08/04/2022
Aktuelle Erkrankungen
-
Vorgeschichte
End stage renal disease, type 2 diabetes mellitus, hypertension
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2402951

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
MI
Alter
25,0
Geschlecht
M
Eingang
05.08.2022
Impfdatum
04.01.2022
Beginn
30.07.2022
Tage bis Beginn
207,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia COVID-19 Computerised tomogram thorax normal Fatigue Inflammatory marker increased Malaise Pyrexia SARS-CoV-2 test positive Ultrasound Doppler normal

Symptomtext

7/30--8/3 25 yo gentleman with history of obesity, mitral regurgitation admitted with fever, malaise, fatigue, weakness and hoome test positive for COVID 19. Currently on room air. Non-hypoxic. Elevated inflammatory markers. Patient mid to the hospital seen by infectious disease placed in COVID isolation received IV Decadron remained stable and continued to improve had lower extremity venous Doppler CT of the chest negative for pulmonary embolism or DVT continue to improve was felt to be stable for discharge

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
4,0
Labordaten
7/30 -- SARS-CoV-2 by NAA, detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2400357

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
TX
Alter
69,0
Geschlecht
F
Eingang
03.08.2022
Impfdatum
01.02.2022
Beginn
01.07.2022
Tage bis Beginn
150,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Chest discomfort Cough Hyposmia Nasopharyngitis Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

7/1/2022 sore throat, felt like I was coming down with a cold. After dinner there was a tightness of the chest felt. 7/2 fever of 99.9, tested with at home COVID 19 test, negative. Symptoms were worse that day with more congestion and some light coughing. 7/3 fever 101.6, and tested with at home COVID 19 test, positive. Went to urgent care clinic and saw doctor. They prescribed PAXLOVID. 7/4 felt nauseous but coughing subsided. Sense of smell very diminished but sense of taste remained. 7/5 fever broken, generally felt better. Felt at about 80%. 7/7 felt nearly 100% but still had some chest tightness. 7/9 tested with at home COVID 19 test, negative.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Oropharyngeal pain
Hospital-Tage
-
Labordaten
7/2 tested with at home COVID 19 test, negative. 7/3 tested with at home COVID 19 test, positive. 7/9 tested with at home COVID 19 test, negative.
Aktuelle Erkrankungen
No
Vorgeschichte
Asthma; High Cholesterol; Arthritis; Acid Reflux
Andere Medikamente
NAC; magnesium; vitamin K2; turmeric; omega oil; glucosamine sulfate; olive leaf extract; selenium; seriphos; gaba plus; omeprazole; ZYRTEC; SINGULAIR; ZOCOR; CELEBREX; FUSENRA
Allergien
Seasonal
Vorherige Impfungen
-

VAERS 2395169

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
CA
Alter
72,0
Geschlecht
F
Eingang
28.07.2022
Impfdatum
27.04.2022
Beginn
07.07.2022
Tage bis Beginn
71,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Headache Nasal congestion Pain Pulmonary pain SARS-CoV-2 test positive

Symptomtext

7/7/22 in the evening I started coughing a deep cough with pain in left lung. 7/8 Stuffy nose, deep cough, headache, and body aches progressed through 7/10. Took an at home Rapid COVID 19 test, strongly positive 7/09. Televisit with doctor on 7/10. Symptoms varied from very mild to moderate for about 2 weeks. One way was mild, and the next the symptoms were moderate. This lasted until 7/25, but symptoms are improving. Feeling better but still have a cough and stuffy nose, but mild.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
At home rapid COVID 19 test, strongly positive 7/09.
Aktuelle Erkrankungen
Cataract Surgery
Vorgeschichte
Gout; Asthma; COPD
Andere Medikamente
ENALAPRIL; metformin; metoprolol; aspirin; EXCEDRIN; BRONKAID; SUDAFED.
Allergien
CYRIL; BACTRIM
Vorherige Impfungen
-

VAERS 2393267

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
68,0
Geschlecht
F
Eingang
27.07.2022
Impfdatum
26.04.2022
Beginn
11.07.2022
Tage bis Beginn
76,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Nausea Rhinorrhoea SARS-CoV-2 test positive Throat irritation Vomiting

Symptomtext

Runny nose and scratchy throat on July 11, 2022. Positive home antigen test on July 11, 2022. Nausea with vomiting and cough on July 12, 2022. Started 5 day course of Paxlovid on July 12, 2022. Symptoms improved but then worsened again on July 21, 2022. Home antigen test was positive on July 21, 2022. Did NOT take more Paxlovid. Cough. Home test today, July 27, 2022, was very faintly positive.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nausea
Hospital-Tage
-
Labordaten
Just home antigen tests. I can?t remember the name of the initial test. Subsequent tests were on/go.
Aktuelle Erkrankungen
None
Vorgeschichte
Acid reflux High cholesterol
Andere Medikamente
Rosuvastatin, 10mg/day; Famotidine, 40 mg/day; fluticasone nasal spray; azelastine nasal spray; multi vitamin; aspirin, 81 mg/day
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2382795

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
PA
Alter
28,0
Geschlecht
F
Eingang
23.07.2022
Impfdatum
30.01.2022
Beginn
18.02.2022
Tage bis Beginn
19,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Acne Amenorrhoea Diarrhoea Vaginal discharge

Symptomtext

After the second dose in the initial series, I experienced amenorrhea for the subsequent menstrual cycle, which is extremely unusual. Instead of a normal bleeding, there was no blood and only strange gray discharge. I also experienced a strange acne-like rash on my face for months after both doses of the vaccine, which eventually faded. I also had loose stools starting after the first moderna dose that worsened after the second dose and went on for months until I started taking a probiotic. The menstrual cycle went back to normal the next month (March) and has remained normal. I have yet to get my booster. I do not take any form of birth control and never have. I really wish that women could be given the expectation that there may be menstrual (and other) disruption as a result of these vaccines, even if temporary. This experience has made me lose confidence in these vaccines and their safety. If women could at least be told that the vax may cause hormonal/menstrual disruption, then they could at least be saved the worry and stress brought on by then wondering whether they could have a gynecological condition or be pregnant. It truly is like the vaccine makers don't care about people who menstruate or have fluctuating hormones and how they may be affected, despite the fact that this is a large segment of the population.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Lyme disease.
Vorgeschichte
-
Andere Medikamente
Zinc, 25 mg every 1-3 days. Vitamin D, 1000 IU daily.
Allergien
none
Vorherige Impfungen
-

VAERS 2357885

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
VA
Alter
56,0
Geschlecht
F
Eingang
05.07.2022
Impfdatum
04.04.2022
Beginn
03.06.2022
Tage bis Beginn
60,0
Dosis
4
Route/Site
SYR / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Cold sweat Diarrhoea Malaise Nasal congestion Nausea Pyrexia SARS-CoV-2 test positive Vomiting

Symptomtext

Starting 06/03/2022, I was traveling and that morning I tested negative with a rapid antigen test. Later that day, I started getting very sick: nausea and diarrhea and vomiting. I spent the next 12 hours being sick but due to testing negative I didn't think it was COVID-19 so I went on a plane. On 06/05/2022, I tested myself at home and was positive. I called my doctor that day, but due to it being Sunday, we set up a virtual visit for 06/06/2022. I had lots of nasal congestion starting on 06/03/2022 starting after the nausea stopped and I started feeling clammy/feverish at this time but I did not take my temperature. On 06/06/2022, at the virtual visit, I was prescribed PAXLOVID which I started the same day and within 2 days I started feeling better and by the end of the week I was feeling much better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
At-home COVID-19 test (06/05/2022): positive; At-home COVID-19 test (06/16/2022): negative.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Atorvastatin; FLONASE; PROAIR; multivitamin; vitamin D; calcium; fish oil; turmeric; ibuprofen
Allergien
Cephalosporin; cashews; pistachios; macadamia; animal hair and dander; feathers
Vorherige Impfungen
-

VAERS 2341983

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NC
Alter
27,0
Geschlecht
M
Eingang
29.06.2022
Impfdatum
24.03.2022
Beginn
31.03.2022
Tage bis Beginn
7,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood pressure decreased Fatigue Feeling abnormal Pain

Symptomtext

He got his vaccine, everything that generally comes with it, brain fog, fatigue, soreness, all the general side effect. Within the week of the vaccine his blood pressure dropped where he was taking two medicines for it, this happened after the 2nd vaccine and then happened again. It is now 100/60 which is how it typically runs now and there is not much he can do to get it up. This happened last year after the 2nd vaccine, and did not come up until the week of September 15th, almost 6 months after the vaccine. He has a feeling that this is going to be the same way around this time. He is on a transplant list trying to get a kidney transplant and he keeps getting cancelled due to his BP being so low. He has spoken with his nephrologist who thinks that it is a good BP and wants to keep it low.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None.
Vorgeschichte
Kidney disease.
Andere Medikamente
Renvela, Pantoprazole, Sensipar, PhosLo.
Allergien
Latex, Tegaderm, Cefazolin and it's family, contrast dye, Epogen.
Vorherige Impfungen
-

VAERS 2320483

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
SC
Alter
52,0
Geschlecht
F
Eingang
15.06.2022
Impfdatum
28.01.2022
Beginn
12.06.2022
Tage bis Beginn
135,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain Abdominal pain upper COVID-19 Chills Cough Decreased appetite Diarrhoea Ear discomfort Fatigue Headache Hyperhidrosis Hypersomnia Malaise Nausea Ocular discomfort Pain Paranasal sinus discomfort Pyrexia

Symptomtext

On 6/12/2022, I woke up with a pounding, severe headache. I also had pressure in the ears and behind the eyes, congestion, body aches, and fever. I didn't take my temperature, but I'm certain that I had a fever, since I had chills and was sweating. I was extremely fatigued and slept until noon; this is unusual for me, since I'm usually up at 6 AM. On 6/13/2022, I had nausea with diarrhea. I never threw up, however, and I took an anti-nausea pill. My throat also felt scratchy and I would sometimes cough, but the cough wasn't constant. I also had no appetite, and at the time of this writing, I have not had an appetite since 6/12/2022. On the morning of 6/12/2022, I took a home test for COVID, and the result was positive. Later that afternoon, I took a PCR test at pharmacy, and it also yielded a positive result. I called my doctor's office on 6/13/2022 to notify him of my diagnosis via the receptionist, and I have not heard back from him. On the afternoon of 6/13/2022, I experienced an increase in head pressure, an increase in nausea, a constantly runny nose; at the time of this writing, the symptoms have continued in conjunction with diarrhea and fatigue. I have not vomited at any point, however. On 6/14/2022, I had abdominal pain, which consisted of sharp stomach pains. In 2019, I had a gastric sleeve surgically inserted; I don't know if this is in any way related to the abdominal pain, but I mention it, as I had never experienced the pain until I was infected with COVID. At 4 AM on 6/15/2022, I woke up with a dry cough. From 4 AM to about 5 AM, the cough was constant. After I took Tylenol, though, it became intermittent. Since I have been sick, I have taken Tylenol every 4-5 hours and anti-nausea medicine. The Tylenol helps reduce the head pain and pressure, though it doesn't completely alleviate it. The Tylenol alleviated much of the cough. It also made the body aches much less intense. I only take the anti-nausea medicine PRN, so I have only taken two doses: once on 6/13/2022 and once on 6/14/2022. It provided immediate relief for the nausea, though it didn't help the abdominal pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None.
Vorgeschichte
Chronic sinus infections, hypothyroidism, anxiety, depression.
Andere Medikamente
Wellbutrin, Synthroid, women's multivitamin, Zyrtec, Mucinex.
Allergien
Sesame seeds, Tramadol.
Vorherige Impfungen
-

VAERS 2319531

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
IL
Alter
34,0
Geschlecht
F
Eingang
14.06.2022
Impfdatum
25.01.2022
Beginn
26.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Ear discomfort Head discomfort Headache Nausea Tinnitus Vertigo

Symptomtext

I have been experiencing vertigo, dizziness, pressure in head, headaches, nausea, pressure, ringing, popping, cracking in ears post Covid vaccine and booster.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
Currently awaiting appointment with ENT & Allergists who are booked up for months in my area due to an increase in tinnitus cases and fluid in ears.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Wellbutrin
Allergien
None
Vorherige Impfungen
-

VAERS 2312093

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
OR
Alter
72,0
Geschlecht
M
Eingang
07.06.2022
Impfdatum
25.04.2022
Beginn
26.04.2022
Tage bis Beginn
1,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Blood test abnormal Diarrhoea Hypophagia

Symptomtext

On 4/25/2022, I received my second Moderna booster against COVID-19. On 4/26/2022, I began to have abdominal cramping and frequent watery diarrhea. Ever since then, I have been unable to eat as much in one sitting or in general as I was before the second booster. I also still have abdominal pains and frequent watery diarrhea. I went to an urgent care clinic that is run through the hospital system a week or two after receiving the shot, and a number of blood tests were ordered. I received news via email that I was diagnosed with eosinophilic gastroenteritis. On 6/7/2022, I saw my PCP for a follow-up. My doctor recommended a course of budesonide. However, as of now I am holding off on doing this. While I was at my doctor's office, I underwent more blood tests, and we're going to see if there have been any changes since my first blood test.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Lymphocytic colitis; eosinophilic gastroenteritis; arteriosclerosis; high cholesterol (under control); hypertension (under control)
Andere Medikamente
Metoprolol, diltiazem, atorvastatin, terazosin, Ativan, aspirin, fish oil, vitamin B12, vitamin D, vitamin C, vitamin B6, folic acid, iron, magnesium, calcium.
Allergien
Penicillin; sulfa drugs; cat dander; seasonal allergies; dust
Vorherige Impfungen
-

VAERS 2303553

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
OH
Alter
58,0
Geschlecht
F
Eingang
31.05.2022
Impfdatum
15.04.2022
Beginn
27.05.2022
Tage bis Beginn
42,0
Dosis
4
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Fatigue Headache Influenza like illness Malaise Nausea Pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

My husband developed symptoms on Monday, May 24th, we both were with our son on the weekend of the 21st. He tested positive on the 22nd, and also tested positive on Friday, the 27th after having tested negative on the 25th. That night of the 27th, I started with mild symptoms and by the 29th my symptoms were more severe of headache, runny nose, fever, achy, and I tested positive. My doctor started me yesterday on Paxlovid. But overall my symptoms are more like a flu and less of a cold. No cough, just nausea, fatigue, aches, etc.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
Covid test, positive result.
Aktuelle Erkrankungen
None
Vorgeschichte
High Blood Pressure; Diverticulitis; High Cholesterol
Andere Medikamente
Atorvastatin; pantoprazole; losartan; curcumin; magnesium; coQ10; vitamin D3
Allergien
None
Vorherige Impfungen
-

VAERS 2292737

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
23,0
Geschlecht
F
Eingang
24.05.2022
Impfdatum
27.02.2022
Beginn
11.03.2022
Tage bis Beginn
12,0
Dosis
3
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Mechanical urticaria Pruritus Urticaria

Symptomtext

12 days after receiving Moderna booster I have had daily itchy skin, hives, and red lines all over my body. Were told the red lines are called dermatographia. Despite being on several different medications (prednisone, Pepcid, and daily high dose 4x a day prescription Allegra, and seeing several allergists and dermatologists) I still have the hives and dermatographia daily.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mechanical urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2290599

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
AL
Alter
34,0
Geschlecht
F
Eingang
23.05.2022
Impfdatum
17.02.2022
Beginn
23.05.2022
Tage bis Beginn
95,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Blood test COVID-19 Chills Cough Ear pain Fatigue Feeling abnormal Headache Nasal congestion Oropharyngeal pain Pain Polymerase chain reaction Rhinorrhoea SARS-CoV-2 test positive Streptococcus test Urine analysis Vaccine breakthrough infection

Symptomtext

I was tested positive for breakthrough COVID today 05/23/2022. My symptom are moderate, I have a headache, chills, body ache, joint ache, sore throat and ears, fatigue, stuffing & running nose and a cough. I have been feeling bad. My doctor called me in something but I haven't went to pick it up as of yet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
PCR, urine, blood panel, and strep test.
Aktuelle Erkrankungen
No
Vorgeschichte
AST; Chron's
Andere Medikamente
No
Allergien
Banana; metformin
Vorherige Impfungen
-

VAERS 2286787

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
MT
Alter
70,0
Geschlecht
M
Eingang
14.05.2022
Impfdatum
22.03.2022
Beginn
23.03.2022
Tage bis Beginn
1,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Heart rate increased Lethargy Malaise Pyrexia

Symptomtext

101? Fever, High Pulse Rate ~ 110, Malaise & Lethargy x 4 Days. Symptoms Lasted x 4Days Not Experienced With Other Doses

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2273632

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
MA
Alter
73,0
Geschlecht
F
Eingang
12.05.2022
Impfdatum
09.02.2022
Beginn
18.04.2022
Tage bis Beginn
68,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Fatigue Hypersensitivity Interchange of vaccine products Oropharyngeal pain Pain SARS-CoV-2 test positive

Symptomtext

My first 3 doses were of Pfizer. I had allergies 2 weeks prior. Then, I started getting symptoms of achiness, tiredness, and sore throat. The next day I was more tired. I did a home COVID-19 test which was positive. I contacted my doctor and was prescribed Paxlovid due to being immune compromised. Within 24 hours, I was feeling better. It took a week to test negative. The only symptom that lingered more was the fatigue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
COVID-19 test
Aktuelle Erkrankungen
None
Vorgeschichte
Hip replacement surgery 12/2021, Arthritis, Immune Compromised due to medication Orencia and methotrexate medications
Andere Medikamente
Orencia, Methotrexate, Serevent, Flovent, Fluticasone nasal spray, Vitamin D3, Calcium, Aspirin 81mg, Folic acid, Propranolol
Allergien
Penicillin, Darvon, Some nsaids, Statins, Mites, mildew, molds
Vorherige Impfungen
Pfizer 1st dose - Tiredness for 2 days

VAERS 2267253

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
CA
Alter
53,0
Geschlecht
F
Eingang
06.05.2022
Impfdatum
07.01.2021
Beginn
04.02.2021
Tage bis Beginn
28,0
Dosis
UNK
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Antibody test Arthralgia Blood test COVID-19 Computerised tomogram Headache Inflammation Joint swelling Myalgia Red blood cell sedimentation rate Tinnitus

Symptomtext

Severe joint pain, swollen joints & Covid not hardly move. Severe inflammation Internally swollen, Headaches, Severe Tinnitus in both ears, ringing in both ears. Muscle aches (false (+) lupus)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
Blood work, sed rates, Antibodies testing, Ct Scans
Aktuelle Erkrankungen
-
Vorgeschichte
Psoriatic Arthritis/Gluten
Andere Medikamente
toporol xl 25, lasix 20. asprin 80 tumeric
Allergien
Gluten, Sulfa
Vorherige Impfungen
-

VAERS 2256754

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
DE
Alter
83,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
05.04.2022
Beginn
08.04.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Cerebral disorder Diplopia Eye pain Magnetic resonance imaging head abnormal Meningioma Vision blurred

Symptomtext

on 4/8 pt reports double vision and was admitted to the hospital that day for concern of 3rd cranial nerve palsy. Neurology to follow for improvement in 4-6 weeks states this is likely a chronic condition. per H&P to the hospital patient had been complaining of right eye pain/ blurry vision for 1 week

Weitere VAERSDATA-Felder
Praegender Schweregrund
Eye pain
Hospital-Tage
2,0
Labordaten
MRI: demonstrated chronic microvascular ischemic disease and meningioma which is known.
Aktuelle Erkrankungen
seen at PCP same day for right eye pain, sinus pain, and increased forgetfulness
Vorgeschichte
Raynaud's COPD HTN type 2 diabetes meningioma CAD
Andere Medikamente
atorvastatin cholecalciferol furosemide nifedipine losartan loratadine- pseudoephedrine
Allergien
sulfa drug ezetimibe
Vorherige Impfungen
-

VAERS 2254668

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
ID
Alter
52,0
Geschlecht
F
Eingang
27.04.2022
Impfdatum
26.04.2022
Beginn
26.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site induration Injection site reaction Injection site warmth Pain

Symptomtext

Site reaction with possible palpations. Palpations lasted a couple hours, resolved this am when seen. Right deltoid is hard and warm to touch with erythema. This area measures 12 cm x 8 cm. --Do not recommend she receive any further Moderna COVID shots. -To apply ice to the area x24 hours and then may rotate heat and ice. 2 ice packs given in clinic. -Naproxen 500 mg tablet. Take 1 tablet twice a day for pain. Take with food in stomach to prevent GI upset. Encouraged to take for at least 3 days routinely. After 3 days she can change taking naproxen to as needed. -Benadryl 25 mg capsule. 1 capsule every 4-6 hours as needed. May cause drowsiness. Explained that I do not think it is necessary that she take Benadryl at this point. But will provide it to her to use at her discretion. It will cause drowsiness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
none
Vorgeschichte
Obesity HTN DM type 2 hyperlipidemia Depression
Andere Medikamente
Fish-oil Metformin lisinopril
Allergien
PCN
Vorherige Impfungen
-

VAERS 2251993

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
FL
Alter
68,0
Geschlecht
F
Eingang
26.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Feeling abnormal Lethargy Pharyngitis streptococcal Rash Streptococcus test positive

Symptomtext

PATIENT STATES THAT ON 4/19/22 SHE WENT OUT TO EAT WITH FRIENDS AND BEGAN"FEELING FUNNY". SHE STATES THAT SHE DID NOT EAT AND RETURNED HOME. ON 4/20/22 SHE BEGAN FEELING "LETHARGIC" THAT CONTINUED THROUGHTOUT THE DAY. IN THE AFTERNOON OF 4/20/22 SHE STARTED TO GET "BUMPS" ON HER HAND AND BY 4/21/22 THE "BUMPS" CONTINUED TO SPREAD THROUGHOUT HER ENTIRE BODY. ON 4/22/22 THE "BUMPS WERE SIGNIFICANTLY WORSE" AND SHE SOUGHT TREATMENT AT LOCAL CARE WHERE SHE WAS DIAGNOSED WITH STREP THROAT AND TOLD TO REPORT HER REACTION TO THE LOCAL HEALTH DEPARTMENT. SHE STATES THAT SHE WAS GIVEN ANTIBIOTICS AND "ANOTHER MEDICATION" AND THAT SHE IS IMPROVING.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
PER PATIENT, SHE WAS DIAGNOSED WITH STREP THROAT ON 4/22/22.
Aktuelle Erkrankungen
DIAGNOSED WITH STREP THROAT ON 4/22/2022 CANCER
Vorgeschichte
HTN HYPERLIPIDEMIA RECENTLY DX WITH BREAST CANCER
Andere Medikamente
Simvastatin, Trimetazidine, Amlodipine, Fenofibrate
Allergien
NKA
Vorherige Impfungen
-

VAERS 2248165

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
78,0
Geschlecht
M
Eingang
22.04.2022
Impfdatum
13.04.2022
Beginn
15.04.2022
Tage bis Beginn
2,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pruritus Injection site swelling

Symptomtext

Swelling below the injection site that was raised and about the size of a softball and quite itchy. 4/15/22 Swelling and raised area had decreased in size but still visible 4/19/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Type 2 Diabetes
Andere Medikamente
Janumet XR 50/1000 Olopatadine Opthalmic solution Clopidogrel 75mg Potassium Citrate ER 10mEq Gemtesa 75mg Metoprolol ER 50mg Atorvastatin 80mg Fluticasone NS 50mcg Stiolto Respimat Albuterol HFA 90mcg inhaler Glimepiride 4mg Losartan 100
Allergien
NKA
Vorherige Impfungen
-

VAERS 2247969

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
VA
Alter
75,0
Geschlecht
M
Eingang
22.04.2022
Impfdatum
30.03.2022
Beginn
07.04.2022
Tage bis Beginn
8,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Feeling abnormal Pyrexia

Symptomtext

Foggy head starting 4 days after injection, low grade fever - 99.3 - one week after for one evening

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
metoprolol, atorvastatin, Vit D3, omeprazole, Zyrtec
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2240953

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
IL
Alter
57,0
Geschlecht
F
Eingang
19.04.2022
Impfdatum
18.04.2022
Beginn
18.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Cold sweat Dysgeusia Fatigue Headache Nausea Pyrexia

Symptomtext

HEADACHE, CHILLS, FEVER, MATALLIC TASTE, NAUSEA, FATIGUE, AND COLD SWEATS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2238694

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

mild
Staat
NY
Alter
69,0
Geschlecht
F
Eingang
18.04.2022
Impfdatum
15.04.2022
Beginn
17.04.2022
Tage bis Beginn
2,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site pruritus Rash erythematous

Symptomtext

developed red rash and itching around injection site. used heat to site and sx were almost gone in the morning

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pruritus
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
na
Vorgeschichte
diabetic HTN hyperchol OAB arthritis gerd
Andere Medikamente
atorvastatin (LIPITOR) 20 mg tablet cholecalciferol (D3 DOTS) 50 mcg (2,000 unit) tablet clobetasoL (TEMOVATE) 0.05 % ointment colesevelam (WELCHOL) 625 mg tablet cyanocobalamin, vitamin B-12, (Vitamin B-12) 1,000 mcg tablet extended re
Allergien
cortisone
Vorherige Impfungen
-

VAERS 2233788

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
CO
Alter
35,0
Geschlecht
M
Eingang
14.04.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Pain in extremity

Symptomtext

Patient had no adverse reaction. He stated that he felt normal just a sore arm. Patient was advised to come to clinic if new symptoms appeared.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
None needed.
Aktuelle Erkrankungen
None
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2226149

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

mild
Staat
CA
Alter
78,0
Geschlecht
F
Eingang
11.04.2022
Impfdatum
07.04.2022
Beginn
09.04.2022
Tage bis Beginn
2,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling Pyrexia Vomiting

Symptomtext

Patient phoned us this morning, to notify us that she had a reaction after her vaccine. Beginning on Saturday the 9th she awoke with slight fever, a red and swollen arm at injection site and some vomiting episodes. She is feeling better now, but wanted to let us know what happened.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2226129

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

mild
Staat
CA
Alter
84,0
Geschlecht
M
Eingang
11.04.2022
Impfdatum
07.04.2022
Beginn
09.04.2022
Tage bis Beginn
2,0
Dosis
4
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Vomiting

Symptomtext

Patient phoned in to let us know they had vomiting episodes on the second day after their vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2213684

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
-
Alter
48,0
Geschlecht
M
Eingang
03.04.2022
Impfdatum
31.03.2022
Beginn
31.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Burning sensation Rash Rash pruritic

Symptomtext

Patient noticed rash forming on both arms approximately 15 minutes after vaccination. Reported that rash was itchy and had a burning sensation. Provider recommended that patient go home and take diphenhydramine for the reaction and seek urgent care if SOB developed. Vital signs were normal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2154608

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
43,0
Geschlecht
M
Eingang
28.03.2022
Impfdatum
30.01.2022
Beginn
22.02.2022
Tage bis Beginn
23,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Allergy test Rash Urticaria

Symptomtext

Hives 3 weeks after administration of Moderna vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
-
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2154608

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
43,0
Geschlecht
M
Eingang
28.03.2022
Impfdatum
30.01.2022
Beginn
22.02.2022
Tage bis Beginn
23,0
Dosis
3
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Allergy test Rash Urticaria

Symptomtext

Hives 3 weeks after administration of Moderna vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
-
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2192173

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

mild
Staat
MS
Alter
64,0
Geschlecht
F
Eingang
22.03.2022
Impfdatum
08.02.2022
Beginn
08.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Laboratory test Lymphadenopathy Pruritus

Symptomtext

itching, swollen lymphnode lt side of neck

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
lab
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
hydrothiachlorizide, losartan
Allergien
cedeine, tramadol,
Vorherige Impfungen
-

VAERS 2179861

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
CA
Alter
36,0
Geschlecht
F
Eingang
15.03.2022
Impfdatum
11.03.2022
Beginn
15.03.2022
Tage bis Beginn
4,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Oedema peripheral Pruritus

Symptomtext

Itchy hands and feet and swollen armpit. Treating with Benadryl and symptoms are stable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Lamictal, lexapro, gabapentin
Allergien
None
Vorherige Impfungen
-

VAERS 2177160

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

mild
Staat
-
Alter
30,0
Geschlecht
F
Eingang
12.03.2022
Impfdatum
11.02.2022
Beginn
24.02.2022
Tage bis Beginn
13,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash SARS-CoV-2 test negative Urticaria

Symptomtext

Delayed urticaria hive like rash, generalized over body. Lasting in certain spots from 30 minutes to an hour at a time. Symptom relief with antihistamines. Was placed on prednisone 60mg x 5 days. Steroids helped but symptoms came back after I stopped taking them. Currently still taking Zyrtec

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
Negative Covid test (2 March)
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Multivitamin, oral birth control (nortrel)
Allergien
None
Vorherige Impfungen
-

VAERS 2174174

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
FL
Alter
45,0
Geschlecht
M
Eingang
11.03.2022
Impfdatum
03.02.2022
Beginn
07.02.2022
Tage bis Beginn
4,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Burning sensation Computerised tomogram Laboratory test Pain in extremity X-ray

Symptomtext

Right-side shoulder pain, aching in shoulder and burning sensation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
CT, lab and x-ray.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Lisinopril, Fenofibrate
Allergien
-
Vorherige Impfungen
-

VAERS 2168223

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
56,0
Geschlecht
F
Eingang
09.03.2022
Impfdatum
21.01.2022
Beginn
01.02.2022
Tage bis Beginn
11,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Allergy test Blood test Rash Vaccine positive rechallenge

Symptomtext

1st Dose 4/15/21 - Given post Covid - Rash on Forehead 2nd Dose 5/13/21 - Rash on Forehead worsened 3rd Dose 1/21/22 - (Booster) Rash covered entire face. Prednisone prescribed multiple times. Still getting rash as of 3/9/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
Dermatologist appointment on 2/10/22. Given Tacrolimus Ointment 0.03% 1x daily at night and Ketoconazole 2% cream 2x a day. Appointment 2/21/22 - Given 40 mg Prednisone daily for 7 days rash returned within 24 hours of ending treatment. General Practioner appointment 3/1/22. Given Prednisone 10 mg. 4 tabs per day decreasing by one tablet every third day. ( over 12 days) break through rash on day 7. Took Blood and tested for allergies. 3/9/22 ENT/Allergist appointment. Rash present. Sent for Autoimmune testing to rule everything else out. But believes due to timeline reaction is from shot.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2167983

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
IL
Alter
68,0
Geschlecht
F
Eingang
09.03.2022
Impfdatum
07.03.2022
Beginn
07.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Diarrhoea Headache Injection site pain Neck pain Pyrexia

Symptomtext

Fever, chills, headache, neck ache, injection site pain; diarrhea

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Thyroid; high blood pressure: high cholesterol; macular degeneration in right eye and cataract starting in left eye
Andere Medikamente
Levothyroxine; Atorvadtatin; Deloxetine; Hydrochlorothiazide; Losartan; Loratadine tablets; D3 vitamin; B-12 vitamin; eye vitamins adults 50+; multivitamin
Allergien
Lisinoprl; Tylenol with codeine; Cefdinir 300mg; Vicodin; Neosporin
Vorherige Impfungen
-

VAERS 2162567

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
SC
Alter
44,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
01.03.2022
Beginn
02.03.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Injection site cellulitis Injection site erythema Injection site induration Injection site warmth

Symptomtext

I have developed cellulitis in and around the injection site my left arm is inflammed, I have a 7*7 wheal that is hard, red, raised and red streaks going down my arm. I called the doctors office, they never called me back. I had to report to Urgent Care for treatment, the prescribed Cephaxelin 500mg QID

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site cellulitis
Hospital-Tage
-
Labordaten
Assessment only so far, will follow up with PCP this week per urgent care suggestion.
Aktuelle Erkrankungen
-
Vorgeschichte
Low back pain
Andere Medikamente
Butrans transdermal Xanaflex Gabapentin Linzess Relistor Fish oil Multivitamin Lexapro
Allergien
ASA
Vorherige Impfungen
-

VAERS 2160926

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
OR
Alter
67,0
Geschlecht
M
Eingang
05.03.2022
Impfdatum
31.01.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Pain in extremity Pyrexia

Symptomtext

Arm hurt; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), CHILLS (Chills) and PYREXIA (Fever) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. Concomitant products included LORAZEPAM for an unknown indication. On 31-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurt), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Arm hurt), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No medical history was provided by the reporter. No treatment information was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
LORAZEPAM
Allergien
-
Vorherige Impfungen
-

VAERS 2154881

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
MD
Alter
78,0
Geschlecht
F
Eingang
03.03.2022
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood glucose increased Decreased appetite Fatigue Feeding disorder Gait inability Malaise

Symptomtext

On Day 6 Post Vaccination of Booster dose Moderna, patient reports still feeling extremely fatigues, lack of appetite, unable to eat, elevated blood sugar level, unable to walk, and general feeling of being unwell. On Day 6, she is just starting to be able to eat small amounts of food. Patient advised to seek medical attention if symptoms persist. **Note--patient reported that with the previous dose her vaccinated arm not only hurt, but it swelled up x 6 weeks.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Mobility issues/ chair bound.
Vorgeschichte
Obesity, Mostly chair bound.
Andere Medikamente
Unknown
Allergien
Wasp allergy as a child, had anaphylactic reaction to wasp sting as a child
Vorherige Impfungen
With dose #2 of Moderna, patient reports her vaccinated arm swelled x 6 weeks.

VAERS 2154622

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NJ
Alter
38,0
Geschlecht
F
Eingang
03.03.2022
Impfdatum
03.02.2022
Beginn
07.02.2022
Tage bis Beginn
4,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dry skin Pruritus Scratch Sensitive skin

Symptomtext

It started with random itching, my scalp, my back, my neck so I wasn't sure if my skin was dry and it was patches all over my body. this past weekend at night I had a tremendous itching all over my body. Ever since then I notice that if I don't take Benadryl or Zyrtec I start itching right away, It doe gets worse at the evening and at night it keeps me up. There is nothing that I can do to get rid of it. within the next couple of days I notice that I have a deep scratch and I have lines, I've never been sensitive with my skin. I have an appointment on 03/09/2022 with Dr. which he is an allergist. I have met someone that has experience the same exact symptom after our booster, the pictures are identical.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
02/23/2021 COVID-19 Positive, coughing
Vorgeschichte
N/A
Andere Medikamente
Adderall 10MG 1 a day.
Allergien
N/A
Vorherige Impfungen
-

VAERS 2149086

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
PR
Alter
43,0
Geschlecht
F
Eingang
28.02.2022
Impfdatum
28.02.2022
Beginn
28.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypoaesthesia Injection site hypoaesthesia

Symptomtext

Patient reports that when vaccinated she feels numbness in her left arm and on the left side of her neck.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site hypoaesthesia
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
-
Vorgeschichte
Polycystic ovarian syndrome, sinusitis, hypoglycemia, hypertension.
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2140286

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
CA
Alter
49,0
Geschlecht
F
Eingang
25.02.2022
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Flushing Pruritus Skin warm Urticaria

Symptomtext

Patient c/o feeling warm and itching, VSS at 136/89, 02 97% with mask, HR 88. Flushing noted to chest and patient scratching UE bilateral. Dr. notified and gave orders for 8omg/ml x 1 dose and send patient to ED if symptoms do not resolve. Patient monitored 1 on 1 for 60 minutes, hives on chest resolving, scratching stopped. Patient had no SOB, no difficulty breathing, no sweating, N/V noted. VSS, family member, with patient and will go to nearest ED or call 911 if symptoms worsen. NP evaluated the patient prior to D/C.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Type 2 DM
Andere Medikamente
Norvasc, Metformin, Vitamin D, Atorvastatin, Prozac.
Allergien
None
Vorherige Impfungen
Moderna, same thing hives and itching.

VAERS 2131413

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
PR
Alter
41,0
Geschlecht
M
Eingang
22.02.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness

Symptomtext

patient reports feeling dizzy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Clonazepam
Andere Medikamente
Yes, Cannabis
Allergien
NKA
Vorherige Impfungen
-

VAERS 2128846

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
36,0
Geschlecht
F
Eingang
21.02.2022
Impfdatum
21.01.2022
Beginn
23.01.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eye swelling Mouth swelling Pruritus Rash Rash pruritic Swelling face Swelling of eyelid Swollen tongue Type IV hypersensitivity reaction

Symptomtext

Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Itch Generalized-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: Delayed allergic reaction. Itchy rash on chest, neck and eyelid. Eyelids moderately swollen.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2128403

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
MD
Alter
49,0
Geschlecht
F
Eingang
20.02.2022
Impfdatum
14.02.2022
Beginn
14.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Burning sensation Chills Diarrhoea Dizziness Headache Pain Rash

Symptomtext

On 2/14/22, burning sensation started an hour after injection. Also. rashes on both arms and legs. The burning sensation began in the left arm and spread to my chest, right arm and both legs. The strong burning sensation was without a fever and it continued until 2/17 along with body aches, headaches, chills. On 2/18/22, the aches went away with daily naproxen. The burning sensation subsided expect for a slight burning sensation on my legs. However, the rashes continued to spread on both arms and legs. Additionally, I became very dizzy and had diarrhea. Which made me go to my local Urgent care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
On 2/18/2022, I went to the Urgent care where the doctor examined me and prescribed a cortisone cream and Hydroxyzine.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Vitamin D3
Allergien
None known
Vorherige Impfungen
-

VAERS 2128348

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
AZ
Alter
37,0
Geschlecht
F
Eingang
19.02.2022
Impfdatum
18.02.2022
Beginn
19.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Headache Lymphadenopathy Nausea Pain Pyrexia

Symptomtext

Swelling of the L arm pit lymph node. Fever fatigue body aches headache nausea

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
Ibuprofen
Allergien
NA
Vorherige Impfungen
Covid vaccine moderna

VAERS 2124210

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NH
Alter
33,0
Geschlecht
F
Eingang
18.02.2022
Impfdatum
03.02.2022
Beginn
03.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Rash pruritic

Symptomtext

patient developed an extremely itchy rash all over her body and was prescribed prednisone to treat

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
lorazepam 0.5mg
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2114238

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NJ
Alter
45,0
Geschlecht
F
Eingang
15.02.2022
Impfdatum
30.01.2022
Beginn
02.02.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Hyperhidrosis Hypersensitivity Pyrexia Skin discolouration

Symptomtext

-1/30 (Sun): I had a low-grade fever and was sweating 12 hours after receiving my booster shot (at 2:15 Pm), but these symptoms were similar to the ones I experienced when I got the first 2 doses. These symptoms lasted for approx. 24 hours. - 2/2 (Wed): I started seeing skin discoloration on my left leg that did not disappear after a day. - 2/5 (Sat): I started noticing visible blood vessels on my chest and my face - 2/6 (Sun): I started seeing skin discoloration on my face - 2/16 (Wed): I started seeing skin discoloration on my chest

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-2/12 (Sat): I saw my PCP, who said my condition resembled something similar to Livedo reticularis, but this opinion conflicts with that of other doctors I saw. They took 5 blood samples and I am waiting on these results. -2/15 (Tues): I saw a dermatologist who believes these symptoms are the result of an allergic reaction. She prescribed an antihistamine and vitamin C.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Occasionally I?m allergic to shellfish
Vorherige Impfungen
1st Shot : No adverse event (44 Years, Covid19 (Moderna), Moderna) 2nd Shot: I had a high fever and chills, and I was sweating 1

VAERS 2113676

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

mild
Staat
IL
Alter
80,0
Geschlecht
F
Eingang
15.02.2022
Impfdatum
08.02.2022
Beginn
09.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Confusional state Pyrexia

Symptomtext

Reporting what I was told. The patient had a low grade fever of 100.4 F, weakness and confusion. Her assisted living facility sent her to the ER where they observed her for less than 24 hours for a discharge date of 2/10/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
1,0
Labordaten
Unknown to pharmacy
Aktuelle Erkrankungen
-
Vorgeschichte
Anxiety, hypertension,
Andere Medikamente
Clonazepam, Carvedilol, Topiramate, Fluoxetine, Bupropion XL
Allergien
Penicillamine, sulfa
Vorherige Impfungen
-

VAERS 2109278

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NC
Alter
24,0
Geschlecht
F
Eingang
12.02.2022
Impfdatum
10.02.2022
Beginn
11.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site reaction Rash erythematous Rash pruritic

Symptomtext

After showering the day after receiving the booster a red rash appeared below the injection site (2/11/22 10 pm). It is still there with few changes in size or color (2/12/22 11 am) and itches frequently.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site reaction
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Birth control
Allergien
Wasps
Vorherige Impfungen
-

VAERS 2107614

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

mild
Staat
MI
Alter
22,0
Geschlecht
F
Eingang
12.02.2022
Impfdatum
11.02.2022
Beginn
11.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Flushing Hyperhidrosis

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2105238

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
IA
Alter
46,0
Geschlecht
F
Eingang
11.02.2022
Impfdatum
01.02.2022
Beginn
04.02.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Head discomfort Malaise SARS-CoV-2 test positive

Symptomtext

I got sick w cough & stuffy head the same day . Kept getting sicker went to dr & was covid 19 positive

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
Dr took covid test
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Amitriptyline25, myrbetriq50, cetirizine10, ropinirole 2, top-rated 50, desvenlafaxine 50
Allergien
None
Vorherige Impfungen
-

VAERS 2105041

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
32,0
Geschlecht
F
Eingang
11.02.2022
Impfdatum
10.02.2022
Beginn
10.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Headache Pain Petechiae

Symptomtext

Petechiae on left arm below injection site and on right shoulder blade about 4 hours after injection. Continued petechiae in the same locations, headache, chills and full body aches the next morning (about 12 hours after injection), lasting all day. 1000mg PO Tylenol taken at 09:30am. All symptoms continued throughout the day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Hypothyroidism, mild asthma, eczema
Andere Medikamente
50mcg PO Synthroid daily
Allergien
None
Vorherige Impfungen
Headache and chills with second Moderna vaccination in March of 2021 (patient was 31 years old). Patient also contracted COVID 1

VAERS 2101831

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
59,0
Geschlecht
F
Eingang
10.02.2022
Impfdatum
25.01.2022
Beginn
26.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Allergy test positive Blood test normal Discomfort Erythema Hypersensitivity Pain in extremity Pruritus Rash Rash erythematous Rash morbilliform Rash pruritic

Symptomtext

Very sore arm beginning night of booster injection. Next day left flank became itchy. About a day later right flank became itchy. Thought it was dry winter skin. Over next few days redness with intermittent itching developed. Then a red, angry, bumpy measle type rash appeared on both sides. Then thought it was shingles. Went to General Practioner Friday 2/4/22. He diagnosed as possible contact dermatitis. Prescribed course of Prednisone and Cortosteroid topical cream. Monday 2/7 rash was no better and extremely uncomfortable and itchy. I have not changed any lotions soaps etc. I have never had a rash like this in my life. Called my dermatologist Dr and was able to get in that day. She diagnosed as allergic reaction to something.! Continue with Prednisone and changed topical to stronger one called Clobetasol. It is now a little over 2 weeks and I still have the rash on both sides. It might seem to be getting a bit better. Follow up with dermatologist in 3 weeks.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
Food and respiratory blood panel. 0 Food allergies. Mild allergy to grass and Maple trees.
Aktuelle Erkrankungen
-
Vorgeschichte
slight high blood pressure panic attacks Restless Leg Syndrome
Andere Medikamente
Paxil 20 mg. Toporol 10 mg Ropinirol 2 mg
Allergien
Penicillin Sulfur CAT scan dye
Vorherige Impfungen
-

VAERS 2099698

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
FL
Alter
54,0
Geschlecht
M
Eingang
09.02.2022
Impfdatum
07.02.2022
Beginn
08.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary pain Chills Injection site pain Oedema peripheral Pyrexia Rash

Symptomtext

rash and swollen left armpit. Armpit slightly painful. Injection site sore, chills and fever for one night.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Rosuvastatin 5mg
Allergien
no
Vorherige Impfungen
Moderna 2nd dose, had rash, chills, fever

VAERS 2095569

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
PR
Alter
42,0
Geschlecht
F
Eingang
08.02.2022
Impfdatum
08.02.2022
Beginn
08.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Pruritus

Symptomtext

PATIENT REFERS ITCHY SKIN AND REDNESS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
none
Andere Medikamente
NONE
Allergien
Benadryl Septra Watermellon Cherry
Vorherige Impfungen
MODERNA VACCINE FOR COVID, RASH, HIPERTENSION

VAERS 2095238

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
46,0
Geschlecht
F
Eingang
08.02.2022
Impfdatum
03.02.2022
Beginn
06.02.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site pruritus

Symptomtext

Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Medium

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2093601

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

mild
Staat
CA
Alter
20,0
Geschlecht
F
Eingang
07.02.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Heart rate increased Hypopnoea Nausea

Symptomtext

Pt first experience dizziness and increase heart rate. Patient observed to have shallowing breaths. pt also stated that she was experiencing nausea. First patient was advised to have her head down to help with the feeling of faint. after the shallow breaths did not resolve, rph called 911 to request paramedic assistance. Epi-pen was on stand by but did not have to be used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Not known.
Vorgeschichte
None.
Andere Medikamente
Not known.
Allergien
Stated allergic to previous pfizer vaccines.
Vorherige Impfungen
Pfizer covid vaccine.

VAERS 2092911

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
KS
Alter
37,0
Geschlecht
F
Eingang
07.02.2022
Impfdatum
04.02.2022
Beginn
05.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inflammation Lymph node pain Mass Oral pain Pain in extremity Stomatitis

Symptomtext

Orange size, painful, inflammed mass in axilla lymph node following day after receiving vaccination. Extremely sore entire arm for 2 days following injection- worst in life with vaccinations. Open and painful sore in roof of mouth also noted within 24 hours of receiving shot

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lymph node pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
Psoriatic Arthritis
Andere Medikamente
Remicade, prednisone, Arava, Cymbalta
Allergien
Sulfa, Wheat dust, Shellfish
Vorherige Impfungen
-

VAERS 2092772

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
CA
Alter
47,0
Geschlecht
M
Eingang
07.02.2022
Impfdatum
30.01.2022
Beginn
31.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthritis Chills Ear swelling Erythema Fatigue Hyperhidrosis Joint swelling Musculoskeletal stiffness Nausea Night sweats Pruritus Skin warm

Symptomtext

Vaccine given 1/30/22. On 1/31/22, he developed chills and nausea and fatigue. That night, he developed profuse night sweats. Felt tired 2/1/22 and had night sweats again that night. On 2/1/22, he developed right medial ankle redness and swelling and pruritis (itchiness there), which improved some by the next day. On 2/2/22 as his right ankle was improving, he developed left thumb arthritis (swelling, redness, stiffness), which started improving by the next day. On 2/3/22, he developed right ear (pinna) swelling, redness and warmth, which started improving by the next day. On 2/4/22, he developed left ear (pinna) swelling, redness and warmth, which started improving by the next day. He started taking naproxen about 1-2 tabs (220 mg each) about 1-2 times a day starting around 2/1/22 and continued through Friday 2/4/22. He was feeling overall better by 2/5/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
none done
Aktuelle Erkrankungen
-
Vorgeschichte
Psoriasis (chronic)
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
Was tired after 2nd Moderna COVID vaccine for about 1 day (vaccine given around April 2021)

VAERS 2091710

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
37,0
Geschlecht
F
Eingang
06.02.2022
Impfdatum
03.02.2022
Beginn
04.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site pruritus Injection site swelling

Symptomtext

Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Informed patient if worsened, call back or call physician. Patient informed to take ibuprofen, Benadryl and apply hydrocortisone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2088114

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
SC
Alter
65,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
01.02.2022
Beginn
02.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling

Symptomtext

Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2087580

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

mild
Staat
FL
Alter
43,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
01.02.2022
Beginn
02.02.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Flushing Injection site erythema Injection site pain Injection site pruritus Injection site swelling Lethargy Local reaction Malaise Pain Pruritus Pyrexia

Symptomtext

Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Additional Details: Pt came into the pharmacy after receiving the vaccine on 2/1 with a localized reaction. Itching, swollen area about 2 inches below the injeciton site. Pt is flushed, has fatigue, fever and does not feel well. I instructed her to ice the area, take benadryl and ibuprofen and to monitor area for worsening of symptoms. Also to seek medical attention if airway is compromised.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2087578

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NJ
Alter
54,0
Geschlecht
M
Eingang
04.02.2022
Impfdatum
31.01.2022
Beginn
02.02.2022
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site erythema Injection site pain Injection site swelling

Symptomtext

Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2087575

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
CA
Alter
35,0
Geschlecht
M
Eingang
04.02.2022
Impfdatum
03.02.2022
Beginn
03.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus

Symptomtext

Systemic: Allergic: Itch Generalized-Mild, Additional Details: mild itching, benadryl was given and patient was completely fine after 30minutes

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2085391

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

mild
Staat
MD
Alter
60,0
Geschlecht
F
Eingang
03.02.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Injection site swelling

Symptomtext

Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2079486

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
DE
Alter
63,0
Geschlecht
M
Eingang
01.02.2022
Impfdatum
04.01.2022
Beginn
16.01.2022
Tage bis Beginn
12,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Diarrhoea Pyrexia

Symptomtext

Fever, chills, and diarhea...self-treated with Tylenol and plenty of fluids. Effects lasted for 2 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None.
Vorgeschichte
Refer to medications section in Item #9.
Andere Medikamente
Implanted pacemaker (bradycardia), Olmasartan (high blood pressure), Atorvorastatin (high cholesterol), Jardiance (borderline diabetic), Eliquis (blood thinner), Metoprolol (tachacardia).
Allergien
Penicillin causes swelling and rash in legs, as of 18 yrs old result of double viral pneumonia - hospitalized for 12 days.
Vorherige Impfungen
-

VAERS 2075924

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
CA
Alter
31,0
Geschlecht
F
Eingang
31.01.2022
Impfdatum
29.01.2022
Beginn
29.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Feeling of body temperature change Injection site erythema Injection site pain Injection site swelling Injection site warmth Lymphadenopathy Pain of skin Sensitive skin Sinus headache Sinus pain

Symptomtext

Raised red skin at injection site measuring 2.75" x 1.57" and increasing slowly. Painful, warm to touch. No itching. Have drawn circle around to validate start of size. Skin sensitivity on arms, legs, back, buttocks (similar to mild sunburn sensation), still ongoing. Scalp sensitivity/tenderness for 24 hours (has stopped). Sinus headache/pain when coughing only or bending over. Swollen lymph nodes in left armpit area, still ongoing. Feelings of hot/cold but no fever ongoing. Dizziness started approx. 25 min. while moving head too quickly or standing too quickly and continued approx. until 36 hours. Treating with Tylenol, ice, vitamins.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Birth control- JUNEL FE 1 MG-20MCG Tablet
Allergien
NKA
Vorherige Impfungen
1st Dose Moderna Covid19 on 07/20/21, age 30, lot# 041C21A. Dizzy within 20 minutes of vaccine lasting 4 hours. Waited 45 minute

VAERS 2074980

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21A

mild
Staat
CA
Alter
32,0
Geschlecht
F
Eingang
30.01.2022
Impfdatum
28.01.2022
Beginn
29.01.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary pain

Symptomtext

My right armpit hurts

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
No
Vorherige Impfungen
-

VAERS 2074449

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
59,0
Geschlecht
F
Eingang
29.01.2022
Impfdatum
23.01.2022
Beginn
27.01.2022
Tage bis Beginn
4,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Injection site rash Pain Pyrexia

Symptomtext

Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Chills-Mild, Systemic: Fever-Mild, Additional Details: patient said she had chills,fever and body ache within first 24-48 hours of receiving vaccine then on 01/27/2022 noticed a 2-4 inch rash on her left arm at vaccine site. she feels fine otherwise.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2071816

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
WA
Alter
65,0
Geschlecht
F
Eingang
28.01.2022
Impfdatum
26.01.2022
Beginn
26.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Body temperature increased Chills Diarrhoea Headache Night sweats Vomiting

Symptomtext

Violent chills for over 6 hours, then a temperature that spiked up to 104, followed by vomiting and diarrhea for 12 hours and then night sweats and a severe headache. Remained in bed for over 30 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Fibromyalgia Osteoarthritis
Andere Medikamente
Multi vitamin, Diclonifec, Elderberry
Allergien
Peniciilin, Tetracyclin, Sulfa, Codeine, Demerol, Trulicity, eggs, gluten, toothpaste and shampoo ingrediants
Vorherige Impfungen
Moderna vax 1 and 2. Agec64, same results as dose 3 with exception did not spike fever over 101. All were Moderna.

VAERS 2071076

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
61,0
Geschlecht
M
Eingang
28.01.2022
Impfdatum
25.01.2022
Beginn
26.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Pyrexia

Symptomtext

Fever. (Also, muscle soreness at site of injection.) [ caused to miss a day of work ]

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
January 27, 2022: 7:5xAM: 100.0 F fever (oral thermometer); January 27, 2022: 7:0xPM: 100.4 F fever (oral thermometer);
Aktuelle Erkrankungen
possible covid or 'low level' covid;
Vorgeschichte
none (except for hypothyroid)
Andere Medikamente
synthroid
Allergien
none
Vorherige Impfungen
-

VAERS 2065694

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
VA
Alter
25,0
Geschlecht
F
Eingang
26.01.2022
Impfdatum
25.01.2022
Beginn
26.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Pyrexia Vomiting

Symptomtext

5:30pm 1/25/2022 received vaccination 4:00am 1/26/2022 woke up with fever, took 1000mg acetaminophen 5:30am 1/26/2022 had diarrhea & threw up 6:30am 1/26/2022 drank a few sips of Sprite, ate a few saltine crackers. Fever 100 Fahrenheit 10:00am 1/26/2022 had diarrhea & threw up 10:30am 1/26/2022 took 50mg Dramamine. Ate a few spoons of apple sauce, drank a few sips of ginger ale, drank a few sips of Gatorade. Fever 101 Fahrenheit 12:30pm 1/26/2022 had diarrhea & threw up 2:00pm 1/26/2022 drank a few sips of Gatorade, reported reaction to pharmacy, fever 102 Fahrenheit

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Sinus infection 12/20/2021 - 1/15/2022. Antibiotics taken 1/6/2022-1/15/2022.
Vorgeschichte
Hemophilia A mild Childhood asthma, stopped around age 8
Andere Medikamente
Sronyx birth control I also took acetaminophen at 4:00am 1/26/22 and Dramamine at 11:00am 1/26/22
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2062534

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
KS
Alter
31,0
Geschlecht
M
Eingang
25.01.2022
Impfdatum
22.01.2022
Beginn
23.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site warmth Peripheral swelling Rash

Symptomtext

Started to break out in a rash on his wrist, hands feet and a little on his back. At the injection sight it is 102 degrees. Both hands have started to swell.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site warmth
Hospital-Tage
-
Labordaten
no
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
no
Allergien
penicillin, sulfa drugs and nickel
Vorherige Impfungen
-

VAERS 2057828

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
70,0
Geschlecht
F
Eingang
23.01.2022
Impfdatum
22.01.2022
Beginn
22.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Additional Details: Lightheaded. Had patient sit with head down forward. Resolved within 15 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2057821

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

mild
Staat
NY
Alter
65,0
Geschlecht
F
Eingang
23.01.2022
Impfdatum
19.01.2022
Beginn
20.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site pruritus Injection site swelling Vaccination site reaction

Symptomtext

Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Possible COVID arm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2038391

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21A

mild
Staat
IN
Alter
30,0
Geschlecht
F
Eingang
16.01.2022
Impfdatum
15.01.2022
Beginn
16.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary pain Injection site pain Malaise Oedema peripheral Pain Pyrexia

Symptomtext

Fever, body aches, severe pain in the injection site for over 24 hours, axillary pain and swelling and general malaise

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Wellbutrin, Junel birth control, and Allegra
Allergien
Azithromycin, codeine, sulfa
Vorherige Impfungen
-

VAERS 2702233

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
NY
Alter
24,0
Geschlecht
M
Eingang
25.10.2023
Impfdatum
28.01.2022
Beginn
11.03.2022
Tage bis Beginn
42,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Antiacetylcholine receptor antibody Antibody test negative Asthenia Blood folate normal CSF cell count normal CSF protein normal CSF test normal Cerebral atrophy Computerised tomogram head abnormal Decubitus ulcer Dysphagia Electromyogram abnormal Failure to thrive Flow cytometry Gastrostomy Infected skin ulcer Magnetic resonance imaging head normal Magnetic resonance imaging spinal abnormal

Symptomtext

26 y.o. male with spastic quadriplegic cerebral palsy, previously high-functioning and self-sufficient prior to decline in 2022, that 6 weeks after covid vaccination, developed global weakness, dysphagia (to point that required new PEG tube), with secondary weight loss of 100lbs, pressure ulcers complicated by infection, and overall failure to thrive.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Antiacetylcholine receptor antibody
Hospital-Tage
-
Labordaten
- LP CSF studies (neg): flow cytometry, protein, cell counts, culture, paraneoplastic panel - AChR Abs (neg) - CT head 8/5/22 mild diffuse atrophy - MRI brain w/o 8/6/22 normal - MRI C spine w/o 8/8/22 minor foraminal narrowing C6-C7 - B12, folate, thiamine normal - EMG/NCS 1/31/23: "Overall, these findings support the presence of a severe left ulnar neuropathy at the elbow, and mild chronic neurogenic process affecting C6-8 innervated left arm muscles. no clear evidence of progressive motor neuron disease "
Aktuelle Erkrankungen
no
Vorgeschichte
Spastic quadriplegia from cerebral palsy
Andere Medikamente
Aripiprazole, Baclofen, buspirone, omeprazole, propranolol, scopolamine, sertraline
Allergien
morphine
Vorherige Impfungen
-

VAERS 2655012

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
50,0
Geschlecht
M
Eingang
11.07.2023
Impfdatum
13.04.2022
Beginn
07.07.2023
Tage bis Beginn
450,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

HOSPITALIZATION

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2654279

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 042J21A

gering
Staat
-
Alter
38,0
Geschlecht
F
Eingang
10.07.2023
Impfdatum
01.02.2022
Beginn
19.04.2023
Tage bis Beginn
442,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Obstructive sleep apnoea syndrome

Symptomtext

ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE 4/3/2023 BMI 45-49.9 ADULT

Weitere VAERSDATA-Felder
Praegender Schweregrund
Obstructive sleep apnoea syndrome
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2640339

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
98,0
Geschlecht
F
Eingang
02.06.2023
Impfdatum
06.02.2022
Beginn
31.10.2022
Tage bis Beginn
267,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Moderna 6/13/21 lot# 047C21A; Moderna 7/11/21 lot# 053C21A; Moderna 2/16/22 Lot# 042J21A

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2637374

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
75,0
Geschlecht
F
Eingang
26.05.2023
Impfdatum
08.02.2022
Beginn
21.09.2022
Tage bis Beginn
225,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Myocardial ischaemia

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE DEMAND ISCHEMIA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial ischaemia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2635462

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
54,0
Geschlecht
F
Eingang
23.05.2023
Impfdatum
24.01.2022
Beginn
01.12.2022
Tage bis Beginn
311,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Neuropathy peripheral

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE PERIPHERAL NEUROPATHY

Weitere VAERSDATA-Felder
Praegender Schweregrund
Neuropathy peripheral
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2629168

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
81,0
Geschlecht
F
Eingang
09.05.2023
Impfdatum
17.02.2022
Beginn
06.01.2023
Tage bis Beginn
323,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Moderna 3/18/21 Lot# 002B21A; Moderna 4/15/21 Lot# 025B21A; Moderna 2/17/22 Lot# 042J21A

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2617724

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
30,0
Geschlecht
M
Eingang
19.04.2023
Impfdatum
11.02.2022
Beginn
29.07.2022
Tage bis Beginn
168,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Hypersensitivity

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ALLERGIC REACTION, INIT

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypersensitivity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2596889

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
TX
Alter
58,0
Geschlecht
M
Eingang
15.03.2023
Impfdatum
13.03.2023
Beginn
13.03.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product storage error

Symptomtext

Pfizer-BioNTech Bivalent COVID-19 Vaccine EUA: case resulting in invalid dose given Patient has previously received Moderna Vaccines on 3/4/2021, 4/1/2021, and 1/28/2022. Patient received Pfizer-BioNTech Bivalent vaccine on 3/13/2023 at 08:45AM. Pt inadvertently received vaccine from vial opened on 03/10/2023 since 15:30PM. Error was found while documenting on 3/13/2023. No harm came to patient. Patient has been contacted, is doing well, and will return for revaccination per Pfizer and CDC recommendations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
DM2, HLD, HTN, Obesity, OSA on CPAP, urinary frequency
Andere Medikamente
aspirin, dapagliflozin, fenofibrate, lisinopril, metformin, metoprolol, pravastatin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2588669

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
70,0
Geschlecht
M
Eingang
28.02.2023
Impfdatum
21.03.2022
Beginn
09.11.2022
Tage bis Beginn
233,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Moderna 4/13/21 Lot# 025B21A; Moderna 5/27/21 Lot# 033C21A; Modena 3/21/222 Lot# 042J21A

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2585570

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MO
Alter
67,0
Geschlecht
F
Eingang
22.02.2023
Impfdatum
17.02.2022
Beginn
14.01.2023
Tage bis Beginn
331,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Decreased appetite Gastrointestinal disorder Nasal congestion Parosmia Respiratory symptom Taste disorder

Symptomtext

Upper respiratory symptoms nasal congestion bowel problems ill taste for food lack of appetite food smelled like ammonia.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Decreased appetite
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Chronic hip and lower back pain
Andere Medikamente
Gabapentin
Allergien
None
Vorherige Impfungen
-

VAERS 2578016

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
78,0
Geschlecht
F
Eingang
08.02.2023
Impfdatum
14.11.2022
Beginn
29.12.2022
Tage bis Beginn
45,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury COVID-19 Encephalopathy Hypernatraemia Influenza Mental status changes SARS-CoV-2 test positive Screaming Sedation Somnolence

Symptomtext

"Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: ""78-year-old female with dementia who presents with acute encephalopathy, somnolence. Suspect influenza with over-sedation. Wean down psychotropic medications. Her mental status improved although she did have outbreaks of yelling. Tamiflu x5 days. Hypernatremia and AKI resolved with IV fluids and was stable without IV fluids. Recommend outpatient neuropsych testing and psychiatric consultation. I suspect progression of patient's dementia is causing many of her symptoms. Incidentally tested positive for COVID on day of discharge, was negative on admission. Question if false positive as she had no change in her respiratory status."""

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute kidney injury
Hospital-Tage
5,0
Labordaten
Covid PCR dectected on 01/03/2023
Aktuelle Erkrankungen
-
Vorgeschichte
Cardiovascular High blood pressure Hyperlipidemia Bilateral pulmonary embolism (HCC) Hypotension Endocrine Type 2 diabetes mellitus with stable proliferative retinopathy of both eyes, without long-term current use of insulin (HCC) Psychological Late onset Alzheimer's dementia with behavioral disturbance (HCC) Respiratory Influenza A Acute respiratory failure with hypoxia (HCC) Urinary AKI (acute kidney injury) (HCC) Other Retinopathy, hypertensive, right eye Obesity (BMI 30.0-34.9) Benign familial tremor Osteoporosis Weakness Chronic midline low back pain without sciatica Hypernatremia Viral sepsis (HCC) Toxic metabolic encephalopathy
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet Take 1 tablet by mouth every 4 (four) hours as needed for Pain. aluminum-magnesium hydroxide-simethicone (MAALOX) 200-200-20 mg/5 mL suspension Take 30 mLs by mouth every 4 (four) hours as needed for I
Allergien
No Know Allergies
Vorherige Impfungen
-

VAERS 2571550

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 042J21A

gering
Staat
CA
Alter
65,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
23.02.2022
Beginn
23.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022) and NO ADVERSE EVENT (No adverse event) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022). No concomitant product reported by reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 23-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022. No treatment medication reported by reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 ( Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live significant follow-up received. Narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571547

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
27,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022) and NO ADVERSE EVENT (No adverse event) in a 27-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022). No concomitant product reported by reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 22-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022. No treatment medication reported by reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live significant follow-up received. Patient information added. Product details added. Narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571544

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
58,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 58-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 23-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant Follow up Appended; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571543

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
63,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 63-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 23-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up has been appended.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571541

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WA
Alter
65,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 65-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 23-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up has been appended.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571532

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
44,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 23-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022 Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571531

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
25,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant Medication use information was not provided by reporter. Pharmacist reports that the more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date. Patient received vaccine at Pharmacy. The lot 042J21A beyond use date of the vaccine was reported as 17 February 2022. NDC number was reported. Treatment Medication use information was not provided by reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow up received that contains significant information includes updated patient details, suspect product details and updated narrative.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571492

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
62,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product storage error

Symptomtext

Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 62-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant products were not provided. Treatment medication were not reported. It was reported that there was a mistake given during phone call regarding lot 012H21B. That lot was not affected, but lot 042J21A should have been reported with a BUD of Feb 17, 2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up contains no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571488

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
59,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product storage error

Symptomtext

Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 59-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant products were not provided. Treatment medication were not reported. It was reported that there was a mistake given during phone call regarding lot 012H21B. That lot was not affected, but lot 042J21A should have been reported with a BUD of Feb 17, 2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up contains no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571470

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
40,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
10.03.2022
Beginn
10.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 10-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication information provided. Patient age was 40 years 2 months. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date. Before use date reported was 17-Feb-2022. No treatment information provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Significant follow up received: Patient information and vaccination details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571469

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
22,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
08.03.2022
Beginn
08.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 22-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 08-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). No concomitant medication was reported. Patient received vaccine from lot 042J21A with a BUD of 17-Feb-2022. The time for expiry date was reported as 12 am. No treatment medication was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571467

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
54,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
08.03.2022
Beginn
08.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). No concomitant medication was reported. Patient received vaccine from lot 042J21A with a BUD of 17-Feb-2022. The time for expiry date was reported as 12 am. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow Up contains updated narrative.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571466

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
36,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 36-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant Live Follow up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571464

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
AZ
Alter
61,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). No concomitant medication was reported. Patient received vaccine from lot 042J21A with a BUD of 17-Feb-2022. The time for expiry date was reported as 12 am. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live followup received contains updated narrative.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571463

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
32,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 32-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot 042J21A was reported as 17-Feb-2022. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Significant Live Follow up received narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571461

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
31.01.2023
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 46-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot 042J21A was reported as 17-Feb-2022. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Significant Live Follow up received narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571460

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
53,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication information was provided. Patient age was 53 years 4 months. Beyond use date was reported as 17-Feb-2022. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 days beyond use date. No treatment medications were provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Significant follow up received: Patient information and vaccination details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571459

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
43,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot 042J21A was reported as 17-Feb-2022. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Significant Live Follow up received narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571458

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
56,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication information was provided. Beyond use date was reported as 17-Feb-2022. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 days beyond use date. No treatment medications were provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Non Significant follow Up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571456

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
23,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication information was provided. Beyond use date was reported as 17-Feb-2022. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 days beyond use date. No treatment medications were provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Significant follow up received: Patient information and vaccination details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571455

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
AZ
Alter
44,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot 042J21A was reported as 17-Feb-2022. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Significant Live Follow up received narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571452

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
52,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot 042J21A was reported as 17-Feb-2022. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Significant Live Follow up received use by date of the vaccine was added.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571451

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
56,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; BUD was reported as 18-Feb-2022 and vaccine was administered on 23-Dec-2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (BUD was reported as 18-Feb-2022 and vaccine was administered on 23-Dec-2021) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (BUD was reported as 18-Feb-2022 and vaccine was administered on 23-Dec-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (BUD was reported as 18-Feb-2022 and vaccine was administered on 23-Dec-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (BUD was reported as 18-Feb-2022 and vaccine was administered on 23-Dec-2021). Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received contains additional no new information was received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571449

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
47,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022) and NO ADVERSE EVENT (No adverse event) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022). Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received contains additional no new information was received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571447

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
54,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022) and NO ADVERSE EVENT (No adverse event) in a 54-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022). Concomitant product use was not provided by the reporter. Treatment information was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571431

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
56,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
28.02.2022
Beginn
28.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). No concomitant information was reported. BUD reported as 17Feb2022. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non-significant follow-up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571430

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
71,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
28.02.2022
Beginn
28.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). No concomitant information was reported. BUD reported as 17Feb2022. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant FU

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571429

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
AZ
Alter
73,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 73-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). No concomitant information was reported. BUD reported as 17Feb2022. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant Live Follow up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571422

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
22,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication information was provided. Patient age was 22 years and 6 months. Beyond use date was reported as 17-Feb-2022. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 days beyond use date. No treatment medications were provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Significant follow up received: Patient information and vaccination details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571421

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
58,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no ad; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no ad). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no ad) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 days beyond use date. Beyond use date for lot was 17-Feb-2022 and patient received vaccine on 04-Mar-2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Non Significant follow Up received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571420

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
37,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no adverse event) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 day beyond use date. Beyond use date for lot was 17-Feb-2022 and patient received vaccine on 04-Mar-2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571417

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
OR
Alter
-
Geschlecht
M
Eingang
31.01.2023
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no ad; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no ad). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no ad) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 day beyond use date. Beyond use date for lot was 17-Feb-2022 and patient received vaccine on 04-Apr-2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Non Significant follow Up received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571402

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
OR
Alter
-
Geschlecht
F
Eingang
31.01.2023
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no adverse event) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 day beyond use date. Beyond use date for lot was 17-Feb-2022 and patient received vaccine on 04-Mar-2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Non Significant follow Up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571401

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
39,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
03.03.2022
Beginn
03.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no ad; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Mar-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no ad). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no ad) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 day beyond use date. Beyond use date for lot was 17-Feb-2022 and patient received vaccine on 03-Mar-2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non Significant follow Up received; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571396

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
51,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
03.03.2022
Beginn
03.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 51-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Patient received the vaccine at a Pharmacy. No concomitant medication reported. No treatment medication reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up document received on 24-Jan-2023 no new significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571379

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
65,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
03.03.2022
Beginn
03.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 65-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). No concomitant medication was reported. No treatment medication was reported. Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date. Patient received dose from lot 042J21A with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up received: Narrative was updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571377

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
55,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 55-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). No concomitant medication was reported. No treatment medication was reported. Patient was administered with Moderna vaccine which were beyond the 30 day beyond use date. Patient received vaccine from lot 042J21A with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up received: Narrative was updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571376

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
65,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 65-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). No concomitant medication was reported. No treatment medication was reported. Patient was administered with Moderna vaccine which were beyond the 30 day beyond use date. Patient received vaccine from lot 042J21A with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up received: Narrative was updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571375

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
63,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
02.03.2022
Beginn
02.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 63-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Mar-2022, the patient received third dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. Most recent FOLLOW-UP information incorporated above includes:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571373

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
38,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 38-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received third dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant Follow up received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571372

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
57,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received third dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant Follow up received; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571367

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
36,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
02.03.2022
Beginn
02.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 17-Feb-2022. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571366

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
59,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 17-Feb-2022. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571361

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
54,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
02.03.2022
Beginn
02.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 17-Feb-2022. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571358

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
24,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 17-Feb-2022. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571356

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
57,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 17-Feb-2022. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added. Case narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571352

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
AZ
Alter
59,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. No treatment medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-significant follow-up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571350

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
67,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. No treatment medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-significant follow-up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571348

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
60,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. No treatment medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-significant follow-up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571343

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
33,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
28.02.2022
Beginn
28.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; lot 042J21A should have been reported with a BUD of Feb 17, 2022.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (lot 042J21A should have been reported with a BUD of Feb 17, 2022.) and NO ADVERSE EVENT (No adverse event) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (lot 042J21A should have been reported with a BUD of Feb 17, 2022.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (lot 042J21A should have been reported with a BUD of Feb 17, 2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (lot 042J21A should have been reported with a BUD of Feb 17, 2022.). No concomitant medication was provided by reporter. No treatment information was provided by the reporter. NDC- 0777-273-10 This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-significant follow-up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571340

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
51,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
28.02.2022
Beginn
28.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. No treatment medicine were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received contains no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571338

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
82,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. No treatment medicine were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up consists of non significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571337

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
59,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
23.02.2022
Beginn
23.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 59-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. No treatment medicine were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live FU consists of non significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571336

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
35,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
23.02.2022
Beginn
23.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 35-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The lot number for the monovalent vaccines with their corresponding BUD dates were 027C21A (BUD - 21-May-2021), 053C21A (BUD - 01-Jul-2021), 939902 (BUD - 02-Sep-2021), 011F21A (BUD - 04-Nov-2021), 012H21B (BUD - 23-Dec-2021), 056M21A (BUD - 12-May-2022), 082B22A (BUD - 08-Sep-2022). The lot numbers for the bivalent vaccines with their corresponding BUD dates and the interval period of administration. 052D22A (BUD - 17-Nov-2022), dates of administration 18-Nov-2022 to 28-Nov-2022, 023H22A, (BUD - 15-Dec-2022), dates of administration 16-Dec-2022 to 20-Dec-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up information received contains non-significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571335

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
62,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
23.02.2022
Beginn
23.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no ad; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (no ad) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no ad). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (no ad) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no ad) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The lot number for the monovalent vaccines with their corresponding BUD dates were 027C21A (BUD - 21-May-2021), 053C21A (BUD - 01-Jul-2021), 939902 (BUD - 02-Sep-2021), 011F21A (BUD - 04-Nov-2021), 012H21B (BUD - 23-Dec-2021), 056M21A (BUD - 12-May-2022), 082B22A (BUD - 08-Sep-2022). The lot numbers for the bivalent vaccines with their corresponding BUD dates and the interval period of administration. 052D22A (BUD - 17-Nov-2022), dates of administration 18-Nov-2022 to 28-Nov-2022, 023H22A, (BUD - 15-Dec-2022), dates of administration 16-Dec-2022 to 20-Dec-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up information received contains non-significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571334

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
30,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
28.02.2022
Beginn
28.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 30-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The lot number for the monovalent vaccines with their corresponding BUD dates were 027C21A (BUD - 21-May-2021), 053C21A (BUD - 01-Jul-2021), 939902 (BUD - 02-Sep-2021), 011F21A (BUD - 04-Nov-2021), 012H21B (BUD - 23-Dec-2021), 056M21A (BUD - 12-May-2022), 082B22A (BUD - 08-Sep-2022). The lot numbers for the bivalent vaccines with their corresponding BUD dates and the interval period of administration. 052D22A (BUD - 17-Nov-2022), dates of administration 18-Nov-2022 to 28-Nov-2022, 023H22A, (BUD - 15-Dec-2022), dates of administration 16-Dec-2022 to 20-Dec-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live ollow-up information received contains non-significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master Case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571319

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
61,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
23.02.2022
Beginn
23.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.). No concomitant medications were provided. Lot 042J21A should have been reported with a BUD of 17-Feb-2022. No treatment medication was provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up received with Updated narrative.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:MASTER CASE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571317

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
AZ
Alter
56,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
28.02.2022
Beginn
23.02.2022
Tage bis Beginn
-
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The lot number for the monovalent vaccines with their corresponding BUD dates were 027C21A (BUD - 21-May-2021), 053C21A (BUD - 01-Jul-2021), 939902 (BUD - 02-Sep-2021), 011F21A (BUD - 04-Nov-2021), 012H21B (BUD - 23-Dec-2021), 056M21A (BUD - 12-May-2022), 082B22A (BUD - 08-Sep-2022). The lot numbers for the bivalent vaccines with their corresponding BUD dates and the interval period of administration. 052D22A (BUD - 17-Nov-2022), dates of administration 18-Nov-2022 to 28-Nov-2022, 023H22A, (BUD - 15-Dec-2022), dates of administration 16-Dec-2022 to 20-Dec-2022. Treatment information was not provided. [an_linked_ref_type] Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up information received contains Patient information added. On 24-Jan-2023: Live follow-up information received contains non-significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704664:Master case US-MODERNATX, INC.-MOD-2023-704558:Master case US-MODERNATX, INC.-MOD-2023-704441:Master case US-MODERNATX, INC.-MOD-2023-704560:master case US-MODERNATX, INC.-MOD-2023-704653:Master case US-MODERNATX, INC.-MOD-2023-704494:Master case US-MODERNATX, INC.-MOD-2023-704473:Master case US-MODERNATX, INC.-MOD-2023-704620:Master case US-MODERNATX, INC.-MOD-2023-704648:Master case US-MODERNATX, INC.-MOD-2023-704450:MASTER CASE US-MODERNATX, INC.-MOD-2023-704698:Master case US-MODERNATX, INC.-MOD-2023-704685:Master case US-MODERNATX, INC.-MOD-2023-704707:Master case US-MODERNATX, INC.-MOD-2023-704713:Master case US-MODERNATX, INC.-MOD-2023-704472:Master case US-MODERNATX, INC.-MOD-2023-704715:Master case US-MODERNATX, INC.-MOD-2023-704475:Master case US-MODERNATX, INC.-MOD-2023-704694:Master case US-MODERNATX, INC.-MOD-2023-704478:Master case US-MODERNATX, INC.-MOD-2023-704719:Master case US-MODERNATX, INC.-MOD-2023-704724:Master case US-MODERNATX, INC.-MOD-2023-704725:Master case US-MODERNATX, INC.-MOD-2023-704709:Master case US-MODERNATX, INC.-MOD-2023-704481:Master case US-MODERNATX, INC.-MOD-2023-704476:Master case US-MODERNATX, INC.-MOD-2023-704543:Master case US-MODERNATX, INC.-MOD-2023-704669:Master case US-MODERNATX, INC.-MOD-2023-704580:Master case US-MODERNATX, INC.-MOD-2023-704569:Master case US-MODERNATX, INC.-MOD-2023-704588:Master case US-MODERNATX, INC.-MOD-2023-704668:Master case US-MODERNATX, INC.-MOD-2023-704585:Master case US-MODERNATX, INC.-MOD-2023-704561:Master case US-MODERNATX, INC.-MOD-2023-704714:Master case US-MODERNATX, INC.-MOD-2023-704562:Master case US-MODERNATX, INC.-MOD-2023-704496:Master case US-MODERNATX, INC.-MOD-2023-704591:Master case US-MODERNATX, INC.-MOD-2023-704662:Master case US-MODERNATX, INC.-MOD-2023-704502:Master case US-MODERNATX, INC.-MOD-2023-704618:Master case US-MODERNATX, INC.-MOD-2023-704586:Master case US-MODERNATX, INC.-MOD-2023-704680:Master case US-MODERNATX, INC.-MOD-2023-704733:Master case US-MODERNATX, INC.-MOD-2023-704469:Master case US-MODERNATX, INC.-MOD-2023-704483:Master case US-MODERNATX, INC.-MOD-2023-704509:Master case US-MODERNATX, INC.-MOD-2023-704522:Master case US-MODERNATX, INC.-MOD-2023-704540:Master case US-MODERNATX, INC.-MOD-2023-704587:Master case US-MODERNATX, INC.-MOD-2023-704706:Master case US-MODERNATX, INC.-MOD-2023-704689:Master case US-MODERNATX, INC.-MOD-2023-704734:Master case US-MODERNATX, INC.-MOD-2023-704671:master case US-MODERNATX, INC.-MOD-2023-704722:Master case US-MODERNATX, INC.-MOD-2023-704727:Master case US-MODERNATX, INC.-MOD-2023-704672:Master Case US-MODERNATX, INC.-MOD-2023-704486:Master case US-MODERNATX, INC.-MOD-2023-704712:Master case US-MODERNATX, INC.-MOD-2023-704565:Master case US-MODERNATX, INC.-MOD-2023-704482:Master case US-MODERNATX, INC.-MOD-2023-704581:Master case US-MODERNATX, INC.-MOD-2023-704583:Master case US-MODERNATX, INC.-MOD-2023-704710:Master case US-MODERNATX, INC.-MOD-2023-704691:Master case US-MODERNATX, INC.-MOD-2023-704696:Master case US-MODERNATX, INC.-MOD-2023-704700:Master case US-MODERNATX, INC.-MOD-2023-704754:Master case US-MODERNATX, INC.-MOD-2023-704728:Master case US-MODERNATX, INC.-MOD-2023-704731:Master case US-MODERNATX, INC.-MOD-2023-704670:Master Case US-MODERNATX, INC.-MOD-2023-704717:Master case US-MODERNATX, INC.-MOD-2023-704705:Master case US-MODERNATX, INC.-MOD-2023-704546:Master case US-MODERNATX, INC.-MOD-2023-704621:Master case US-MODERNATX, INC.-MOD-2023-704678:master case US-MODERNATX, INC.-MOD-2023-704629:Master case US-MODERNATX, INC.-MOD-2023-704606:Master case US-MODERNATX, INC.-MOD-2023-704651:Master case US-MODERNATX, INC.-MOD-2023-704637:Master case US-MODERNATX, INC.-MOD-2023-704649:master case US-MODERNATX, INC.-MOD-2023-704657:Master case US-MODERNATX, INC.-MOD-2023-704573:Master case US-MODERNATX, INC.-MOD-2023-704708:Master case US-MODERNATX, INC.-MOD-2023-704667:Master case US-MODERNATX, INC.-MOD-2023-704721:Master case US-MODERNATX, INC.-MOD-2023-704695:Master case US-MODERNATX, INC.-MOD-2023-704723:Master case US-MODERNATX, INC.-MOD-2023-704589:Master case US-MODERNATX, INC.-MOD-2023-704704:Master case US-MODERNATX, INC.-MOD-2023-704711:Master case US-MODERNATX, INC.-MOD-2023-704497:Master Case US-MODERNATX, INC.-MOD-2023-704559:Master case US-MODERNATX, INC.-MOD-2023-704638:Master case US-MODERNATX, INC.-MOD-2023-704505:Master case US-MODERNATX, INC.-MOD-2023-704484: US-MODERNATX, INC.-MOD-2023-704504:Master case US-MODERNATX, INC.-MOD-2023-704477:Master case US-MODERNATX, INC.-MOD-2023-704503:Master case US-MODERNATX, INC.-MOD-2023-704619:Master case US-MODERNATX, INC.-MOD-2023-704498:Master Case US-MODERNATX, INC.-MOD-2023-704611:Master case US-MODERNATX, INC.-MOD-2023-704674:Master case US-MODERNATX, INC.-MOD-2023-704732:Master case US-MODERNATX, INC.-MOD-2023-704625:Master case US-MODERNATX, INC.-MOD-2023-704676:Master case US-MODERNATX, INC.-MOD-2023-704735:Master case US-MODERNATX, INC.-MOD-2023-704843:Master Case US-MODERNATX, INC.-MOD-2023-704821:Master case US-MODERNATX, INC.-MOD-2023-704878:Master case US-MODERNATX, INC.-MOD-2023-704802:Master case US-MODERNATX, INC.-MOD-2023-704817:Master case US-MODERNATX, INC.-MOD-2023-704814:Master case US-MODERNATX, INC.-MOD-2023-704688:Master Case US-MODERNATX, INC.-MOD-2023-704931:Master case US-MODERNATX, INC.-MOD-2023-704842:Master case US-MODERNATX, INC.-MOD-2023-704840:Master Case US-MODERNATX, INC.-MOD-2023-704811:Master case US-MODERNATX, INC.-MOD-2023-704839:Master case US-MODERNATX, INC.-MOD-2023-704804:Master case US-MODERNATX, INC.-MOD-2023-704838:Master Case US-MODERNATX, INC.-MOD-2023-704718:Master case US-MODERNATX, INC.-MOD-2023-704738:Master case US-MODERNATX, INC.-MOD-2023-704683:Master case US-MODERNATX, INC.-MOD-2023-704624:Master case US-MODERNATX, INC.-MOD-2023-704823:Master case US-MODERNATX, INC.-MOD-2023-704826:Master case US-MODERNATX, INC.-MOD-2023-704824:Master case US-MODERNATX, INC.-MOD-2023-704825:Master case US-MODERNATX, INC.-MOD-2023-704938:Master case US-MODERNATX, INC.-MOD-2023-704890:Master case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2570607

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
78,0
Geschlecht
M
Eingang
30.01.2023
Impfdatum
16.02.2022
Beginn
26.01.2023
Tage bis Beginn
344,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 Vaccines NO Manufacturer listed on any of the vaccines; Moderna listed on form only because form will be rejected if no manufacturer listed; DO NOT SEND FOLLOW UP REQUEST FOR MANUFACTURER; NOT LISTED IN STATE DATABASE 2/26/21 Lot# 001a21A; 3/26/21 Lot# 006B21A; 2/16/22 Lot# 042J21A

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
covid +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2539026

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
84,0
Geschlecht
F
Eingang
21.12.2022
Impfdatum
07.01.2021
Beginn
25.09.2022
Tage bis Beginn
626,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Bacterial test negative COVID-19 Chest X-ray abnormal Computerised tomogram head normal Computerised tomogram spine Fall Haemorrhage Head injury Lethargy Lung opacity SARS-CoV-2 test positive Urine analysis normal White blood cell count normal

Symptomtext

This is a 85y.o. female with PMH significant for dementia, alzheimers, depression, hypothyroidism who presents to hospital for fall and head injury. History gathered for paramedics and family. Patient from SKLD, baseline A&Ox1-2. Had unwitnessed fall with bleeding in the back of head. She was placed on C collar. During ED eval, COVID positive, placed in isolation. UA + WBC, negative for bacteria. Was started on IV rocephin in EC. Cervical CT showed no acute fracture. Chest xray showed left sided patchy opacity. Head CT showed no acute hemorrhage. Patient was RRT due to lethargy. And her night time risperidone dose was reduced with good improvement. Met with hospice and will follow up with community hospice needs. Patient also tested positive for COVID, was seen by ID, and no txt needed since respiratory status is stable. Discharged in a stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bacterial test negative
Hospital-Tage
5,0
Labordaten
9/25 SARS-CoV-2 (COVID-19).
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2508336

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
75,0
Geschlecht
M
Eingang
15.11.2022
Impfdatum
25.10.2021
Beginn
20.09.2022
Tage bis Beginn
330,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Mental status changes SARS-CoV-2 test positive

Symptomtext

09/20/22 presents to ED for "AMS". PMHx of "HTN, CVA, AAA s/p repair, NSTEMI and heart murmur"

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
09/20/22 SARS-CoV-2 (COVID-19) detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2492281

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
70,0
Geschlecht
M
Eingang
28.10.2022
Impfdatum
25.02.2022
Beginn
27.10.2022
Tage bis Beginn
244,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID breakthrough case

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID positive test 10/27/22
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2425272

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
56,0
Geschlecht
M
Eingang
31.08.2022
Impfdatum
01.08.2022
Beginn
17.08.2022
Tage bis Beginn
16,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive

Symptomtext

Pt tested positive for COVID on 08/17/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2424043

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
65,0
Geschlecht
F
Eingang
30.08.2022
Impfdatum
22.03.2022
Beginn
14.08.2022
Tage bis Beginn
145,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient tested positive for COVID-19 on 08/14/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2419378

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
45,0
Geschlecht
F
Eingang
24.08.2022
Impfdatum
24.02.2022
Beginn
01.02.2022
Tage bis Beginn
-
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Biopsy endometrium normal Blood test Heavy menstrual bleeding Menstruation irregular Polymenorrhoea Post procedural haemorrhage Thyroid disorder Vaginal haemorrhage

Symptomtext

Just after my first booster in February I had a normal period and it was 7 days. It is normally 19-21 days in between. In March it was 28 days since last period. In April it was 13 days since last one and then I had a second cycle that lasted 7 days. In May it was 18 days since last one. In May I had blood work because of the issue with so many menstrual cycles. My thyroid numbers were under active. I had a biopsy in May and and the spotting began due to the biopsy and then I started my period and it was heavy at times. My biopsy was normal. Blood work was all normal except for thyroid numbers.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Biopsy endometrium normal
Hospital-Tage
-
Labordaten
Blood panel, thyroid abnormal; Endometrial Biopsy, normal.
Aktuelle Erkrankungen
N/A
Vorgeschichte
Eczema; Hay fever
Andere Medikamente
CBD tincture
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2412473

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MO
Alter
55,0
Geschlecht
F
Eingang
16.08.2022
Impfdatum
05.04.2022
Beginn
15.07.2022
Tage bis Beginn
101,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Alcohol withdrawal syndrome Anal incontinence Confusional state Hypovolaemia Interchange of vaccine products Rhabdomyolysis

Symptomtext

7/15/2022 patient presented to ER after children found her at home on the couch covered in feces. Admitted to the hospital for confusion, rhabdomyolysis, hypovelemia, and alcohol withdrawal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Alcohol withdrawal syndrome
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2399281

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
66,0
Geschlecht
F
Eingang
02.08.2022
Impfdatum
02.05.2022
Beginn
30.07.2022
Tage bis Beginn
89,0
Dosis
4
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 SARS-CoV-2 test positive

Symptomtext

I contracted Covid on July 30, 2022 (a bit over 3 months after receiving my 4th Moderna inoculation)

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
At home antigen test
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Multi vitamin
Allergien
None
Vorherige Impfungen
-

VAERS 2374851

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
OR
Alter
65,0
Geschlecht
M
Eingang
20.07.2022
Impfdatum
19.04.2022
Beginn
25.06.2022
Tage bis Beginn
67,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Cough SARS-CoV-2 test positive

Symptomtext

06/25/2022 I caught Covid. Severe cough. 4 days. I also took PAXLOVID ( Renal lower dose)

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Positive Covid 06/25/22
Aktuelle Erkrankungen
None
Vorgeschichte
HTN , DM2, Diabetic neuropathy, ortho arthritis
Andere Medikamente
Allopurinol, Alpha-Lipoic Acid, Amlodipine, Aspirin, Carvedilol, Duloxetine, Lisinpril
Allergien
NKA
Vorherige Impfungen
-

VAERS 2370648

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
71,0
Geschlecht
F
Eingang
15.07.2022
Impfdatum
12.04.2022
Beginn
23.05.2022
Tage bis Beginn
41,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Computerised tomogram abnormal Retinal detachment Retinopexy Surgery Visual impairment Vitreous floaters

Symptomtext

I have had a history of retinal issues. But this was different because it required immediate surgery. I had some floaters in my right eye but it wasn't major. On Monday May 23, 2022 I woke up and it was a blob coming from the inside corner of my right eye moving over. I had it for a couple of weeks first thing in the morning but it would go away. This day it got bigger and didn't go away. I was diagnosed with detached retina in my right eye and had surgery on the May 24, 2022. The surgery was successful and my eye healed. Then July 5, 2022, I had the curtain coming down from the top of my right eye. I was diagnosed with detached retina again in my right eye. I had surgery again to repair retina on July 6, 2022. As of today the surgery appears to be successful.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Computerised tomogram abnormal
Hospital-Tage
-
Labordaten
Physical Eye Exams; CAT scans on my eye
Aktuelle Erkrankungen
N/A
Vorgeschichte
Asthma; Bronchiectasis; Cyst in Pancreas;
Andere Medikamente
Lipitor; Wixela Inhaler; Pro Biotic; Multi Vitamin; CoQ10; Phytoceramides
Allergien
N/A
Vorherige Impfungen
-

VAERS 2325465

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
FL
Alter
62,0
Geschlecht
M
Eingang
21.06.2022
Impfdatum
17.06.2022
Beginn
17.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Expired vaccine administered

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none needed
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2325165

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
FL
Alter
62,0
Geschlecht
M
Eingang
21.06.2022
Impfdatum
17.06.2022
Beginn
17.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Dose administered after manufacturer date of expiry; Received expired first booster dose after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired first booster dose after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Dose administered after manufacturer date of expiry) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: J&J COVID-19 Vaccine (First Dose) on 28-Oct-2021. Past adverse reactions to the above products included No adverse event with J&J COVID-19 Vaccine. On 17-Jun-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired first booster dose after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Dose administered after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired first booster dose after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Dose administered after manufacturer date of expiry) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. No treatment information was reported. On 17-Jun-2022, patient received expired first booster dose of Moderna COVID-19 vaccine. Vial was removed from freezer at 10AM on 17-Jun-2022. 1 dose / 1 dose administered after manufacturer date of expiry. The vial did not undergo any temperature excursions. Patient was on way back to the vaccination site to be re-vaccinated. Re-vaccination was kept on hold, until Tier 2 team reaches out for regarding the urgent case.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2322744

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
17.06.2022
Impfdatum
12.05.2022
Beginn
12.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Patients received the vaccine after the expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received the vaccine after the expiry date) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received the vaccine after the expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received the vaccine after the expiry date) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. Reporter stated that the date on packing slip that comes with the vaccine was not a correct expiration date and reporter also used the CIR (City Immunization registry) portal, where they store their documentation inventory and find out that the date on the portal is also not accurate, after that reporter used the Look up tool on the Moderna website, the tools told her the vaccine was expired. Reporter wanted to know the lot number 042J21A have been extended and reporter thought the expiration date was 31-Dec-2069. The vial didn't undergone temperature excursions. No treatment information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2314053

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
55,0
Geschlecht
F
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Moderna vaccine was given after published expiration date. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
patient reported no illness at time of vaccination
Vorgeschichte
Prediabetes, hyperlipidemia
Andere Medikamente
none
Allergien
penicillin
Vorherige Impfungen
-

VAERS 2314050

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
57,0
Geschlecht
F
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Moderna vaccine was given after published expiration date. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
patient reported no illness at the time of vaccination
Vorgeschichte
COPD, Seizures, osteopenia, arthritis and anemia
Andere Medikamente
symbicort, proair, depakote, ferrous sulfate, folic acid, vitamin d, vitamin b12, omeprazole
Allergien
codeine, sulfacetamide, penicillin
Vorherige Impfungen
-

VAERS 2312462

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
42,0
Geschlecht
F
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product storage error

Symptomtext

Moderna vaccine was given after published expiration date. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
patient reported no illness at the time of vaccination
Vorgeschichte
Diabetes, Hyperlipidemia, HTN, anemia, schizophrenia, depression, anxiety
Andere Medikamente
Olanzapine ,bupropion ,sertraline, mirtazaprine, omega 3,meloxicam, Baclofen, Ferrous sulfate, Lisinopril, omeprazole, semglee, vitamin D, Gabapentin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2311488

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
35,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product storage error

Symptomtext

Moderna vaccine expired 04/29/2022 and was given to patient on 05/02/2022. No adverse reaction at the time of vaccination or 15 min after administration. Vaccine was tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Patient reported no illness at the time of vaccination
Vorgeschichte
Autistic disorder, ADHD, Diabetes, Anxiety and obesity
Andere Medikamente
Fioricet, Metformin, welchol, lisinopril
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2311488

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
35,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product storage error

Symptomtext

Moderna vaccine expired 04/29/2022 and was given to patient on 05/02/2022. No adverse reaction at the time of vaccination or 15 min after administration. Vaccine was tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Patient reported no illness at the time of vaccination
Vorgeschichte
Autistic disorder, ADHD, Diabetes, Anxiety and obesity
Andere Medikamente
Fioricet, Metformin, welchol, lisinopril
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2311274

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
CA
Alter
60,0
Geschlecht
F
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product storage error

Symptomtext

expired moderna vaccine was given. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
patient reported no illness at time of vaccination
Vorgeschichte
HTN, depression,hypothyroidism,diabetic neuropathy,visual impairment, ischemic optic neuropathy, gastroparesis
Andere Medikamente
Omeprazole,victoza,atorvastatin,metformin,miralax,levemir,humo
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2311274

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
60,0
Geschlecht
F
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product storage error

Symptomtext

expired moderna vaccine was given. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
patient reported no illness at time of vaccination
Vorgeschichte
HTN, depression,hypothyroidism,diabetic neuropathy,visual impairment, ischemic optic neuropathy, gastroparesis
Andere Medikamente
Omeprazole,victoza,atorvastatin,metformin,miralax,levemir,humo
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2311273

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
58,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product storage error

Symptomtext

expired moderna vaccine was given. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
PATIENT REPORTED NO ILLNESS AT TIME OF VISIT
Vorgeschichte
-
Andere Medikamente
zonisamide,vitamin d, tizanidine, lyrica,levetiracetam, omega
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2311273

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
58,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product storage error

Symptomtext

expired moderna vaccine was given. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
PATIENT REPORTED NO ILLNESS AT TIME OF VISIT
Vorgeschichte
-
Andere Medikamente
zonisamide,vitamin d, tizanidine, lyrica,levetiracetam, omega
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2311272

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
82,0
Geschlecht
F
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Moderna vaccine was given after published expiration date. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Patient reported no illness at the time of vaccination
Vorgeschichte
anxiety, hypothroidism ,depression, seizures, renal insufficiency, neurosyphilis, neuropathy
Andere Medikamente
omeprazole ,levetiracetam, Vitamin D, Proair, omega3, magnesium, Levothyroxine, sertraline ,memantine, trazadone,
Allergien
Aspirin
Vorherige Impfungen
-

VAERS 2311272

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
82,0
Geschlecht
F
Eingang
09.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Moderna vaccine was given after published expiration date. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Patient reported no illness at the time of vaccination
Vorgeschichte
anxiety, hypothroidism ,depression, seizures, renal insufficiency, neurosyphilis, neuropathy
Andere Medikamente
omeprazole ,levetiracetam, Vitamin D, Proair, omega3, magnesium, Levothyroxine, sertraline ,memantine, trazadone,
Allergien
Aspirin
Vorherige Impfungen
-

VAERS 2312984

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
70,0
Geschlecht
M
Eingang
08.06.2022
Impfdatum
06.04.2022
Beginn
01.06.2022
Tage bis Beginn
56,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines 3/13/21 Moderna Lot# 010A21A 4/10/21 Moderna Lot# 025B21A 12/1/21 Moderna Lot#067F21A 4/6/22 Moderna Lot#042J21A

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
6/1/22 COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2311275

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
55,0
Geschlecht
F
Eingang
07.06.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

2 vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated; Vaccine administered after date of expiry to 1 patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to 1 patient) and PRODUCT STORAGE ERROR (2 vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated) in a 55-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 23-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 23-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to 1 patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (2 vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to 1 patient) and PRODUCT STORAGE ERROR (2 vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant information was reported. It was reported that the 2 vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated. The total number of vials were 2. The vial was not initially stored in the refrigerator. The vial did not undergo any temperature excursions. This case was linked to MOD-2022-582455, MOD-2022-582637, MOD-2022-582638, MOD-2022-582640, MOD-2022-582644 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2311265

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
57,0
Geschlecht
F
Eingang
07.06.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated; Vaccine administered after date of expiry to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to patient) and PRODUCT STORAGE ERROR (vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to patient) and PRODUCT STORAGE ERROR (vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Vial was not initially stored in the refrigerator. Vial did not undergo any temperature excursions. No treatment information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2309302

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
67,0
Geschlecht
F
Eingang
04.06.2022
Impfdatum
25.02.2022
Beginn
29.05.2022
Tage bis Beginn
93,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive

Symptomtext

covid+

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2308030

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
NY
Alter
83,0
Geschlecht
M
Eingang
03.06.2022
Impfdatum
11.05.2022
Beginn
11.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered SARS-CoV-2 test

Symptomtext

The patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022.) in an 83-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 11-May-2022 at 2:18 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 11-May-2022 at 2:18 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022.) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Dec-2020, SARS-CoV-2 test: positive (Positive) Positive. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant drugs were not reported. The patient had not taken any prescriptions, over the counter medication, dietary supplement or herbal remedies at the time of vaccination and also not had any acute illness at the time of vaccination and up to 1 month before. Hcp reported they administer a vaccine that expired on the 29Apr2022 to less 5 patients which was the dose administered after 30-day Use By Date or after manufacturer date of expiry. Number of vials and date the vial was initially stored in the refrigerator were unknown. The vial did not undergo any temperature excursions. The event does not caused the patient to seek the medical care. It was unknown if the event most likely caused by Mrna-1273 and the patient experienced a similar events in the past. Treatment details were not given. This case was linked to MOD-2022-573908 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
Test Date: 20201213; Test Name: Rapid COVID-19 test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2308029

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
NY
Alter
55,0
Geschlecht
F
Eingang
03.06.2022
Impfdatum
11.05.2022
Beginn
11.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022) in a 55-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042j21a) for COVID-19 vaccination. It was unknown whether patient was diagnosed or had tested positive for Covid -19 It was unknown whether patient had acute illness at the time of vaccination and upto one month prior. It was unknown whether patient had chronic or long standing health conditions. On 11-May-2022 at 8:00 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 11-May-2022 at 8:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant drugs were not reported. Hcp reported they administered a vaccine that expired on the 29Apr2022 to less 5 patients. It was unknown on which date the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions Treatment details were not given. This case was linked to MOD-2022-573908 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: It was unknown whether patient was diagnosed or had tested positive for Covid -19. It was unknown whether patient had acute illness at the time of vaccination and up to one month prior. It was unknown whether patient had chronic or long standing health conditions.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2294498

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
57,0
Geschlecht
F
Eingang
25.05.2022
Impfdatum
17.05.2022
Beginn
20.05.2022
Tage bis Beginn
3,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

PATIENT RECEIVED EXPIRED MODERNA VACCINE. NO ADVERSE EVENTS EXPERIENCED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2294497

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
63,0
Geschlecht
F
Eingang
25.05.2022
Impfdatum
17.05.2022
Beginn
20.05.2022
Tage bis Beginn
3,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

PATIENT RECEIVED EXPIRED MODERNA VACCINE. NO ADVERSE EVENTS EXPERIENCED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2294494

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
66,0
Geschlecht
M
Eingang
25.05.2022
Impfdatum
17.05.2022
Beginn
20.05.2022
Tage bis Beginn
3,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

PATIENT RECEIVED EXPIRED MODERNA VACCINE. NO ADVERSE EVENTS EXPERIENCED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2294488

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
53,0
Geschlecht
M
Eingang
25.05.2022
Impfdatum
16.05.2022
Beginn
20.05.2022
Tage bis Beginn
4,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

PATIENT RECEIVED EXPIRED MODERNA VACCINE. NO ADVERSE EVENTS EXPERIENCED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
DIABETES AND HIGH BLOOD PRESSURE
Andere Medikamente
PATIENT IS TAKING MEDICATIONS FOR DIABETES AND HIGH BLOOD PRESSURE
Allergien
NKA
Vorherige Impfungen
-

VAERS 2294476

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
60,0
Geschlecht
F
Eingang
25.05.2022
Impfdatum
10.05.2022
Beginn
20.05.2022
Tage bis Beginn
10,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

PATIENT RECEIVED EXPIRED MODERNA VACCINE. PATIENT EXPERIENCED NO ADVERSE SYMPTOMS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
HIGH BLOOD PRESSURE
Andere Medikamente
PATIENT IS TAKING MEDICATIONS FOR HIGH BLOOD PRESSURE, HYPERLIPIDEMIA, AND ANXIETY
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2294359

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
33,0
Geschlecht
M
Eingang
25.05.2022
Impfdatum
26.05.2021
Beginn
21.05.2022
Tage bis Beginn
360,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Localised infection SARS-CoV-2 test positive

Symptomtext

5/20 34y.o. male with past medical history most significant for IVDU presents with chief complaint of left toe infection

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
5/20 SARS-CoV-2 by NAA, Detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2293198

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
57,0
Geschlecht
M
Eingang
24.05.2022
Impfdatum
10.05.2022
Beginn
20.05.2022
Tage bis Beginn
10,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

PATIENT RECEIVED VACCINE THAT'S EXPIRED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
HYPOTHYROIDISM, HYPERLIPEDEMIA
Andere Medikamente
N/A
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2293194

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
55,0
Geschlecht
F
Eingang
24.05.2022
Impfdatum
10.05.2022
Beginn
20.05.2022
Tage bis Beginn
10,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

PATIENT RECEIVED VACCINE THAT'S EXPIRED - NO ADVERSE EFFECTS REPORTED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
HEALTHY
Andere Medikamente
NONE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2292918

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
NC
Alter
67,0
Geschlecht
F
Eingang
24.05.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product expiration date issue

Symptomtext

Moderna vaccine vial expired on 04/29/22, expiration located on box not vial. Nurse pulled and discarded vial. Contacted Moderna and report made and lot analysis sent. Analysis of involved lot # maintained activity necessary to protect against the SARS-COV-2 (Covid-19) virus at the time of administration. RN and FNP made aware. Not necessary to notify patient or repeat dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2287490

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
50,0
Geschlecht
M
Eingang
20.05.2022
Impfdatum
01.05.2022
Beginn
01.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Expired dose stored in refrigerator/ administered expired dose to the patient; Patient received expired dose of Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of Moderna vaccine) and PRODUCT STORAGE ERROR (Expired dose stored in refrigerator/ administered expired dose to the patient) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. The previous history of COVID-19 vaccination was unavailable. In May 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In May 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of Moderna vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired dose stored in refrigerator/ administered expired dose to the patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of Moderna vaccine) and PRODUCT STORAGE ERROR (Expired dose stored in refrigerator/ administered expired dose to the patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication information was not provided by the reporter. Patient received second booster dose. The date when the vial was initially stored in the refrigerator was the same date that the dose was administered. The vial did not undergo any temperature excursions. The pharmacist thought the expiration date was 2069, like it was printed on the vial but the expiry date was 29-Apr-2022. Treatment information was not provided by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: The previous history of COVID-19 vaccination was unavailable.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2287198

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
69,0
Geschlecht
M
Eingang
20.05.2022
Impfdatum
01.04.2022
Beginn
14.05.2022
Tage bis Beginn
43,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive

Symptomtext

Confirmed Outbreak 1st Dose - Moderna - 007M20A 010A21A 2nd Dose - Moderna 017F21A 3rdDose - Moderna 042J1A - 4th Dose - Moderna

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Confirmed COVID Test - 5/14/2021
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2287174

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
AR
Alter
83,0
Geschlecht
F
Eingang
20.05.2022
Impfdatum
06.04.2022
Beginn
11.05.2022
Tage bis Beginn
35,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19

Symptomtext

hospitalization with covid after being fully vaccinated and booster X2.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
Deep Vein Thrombosis, Fracture, Hypertension and Renal Disease
Andere Medikamente
unknown
Allergien
morphine, warfarin sodium, nitrofurantoin, oxycodone
Vorherige Impfungen
-

VAERS 2286586

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
53,0
Geschlecht
M
Eingang
20.05.2022
Impfdatum
16.05.2022
Beginn
16.05.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired doses administered to 8 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 8 patients) in a 53-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-May-2022, the patient received fourth dose of mRNA-1273 (Spikevax) (unknown route) .25 milliliter. On 16-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 8 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 8 patients) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication reported. No treatment medication reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282857

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
VA
Alter
59,0
Geschlecht
F
Eingang
18.05.2022
Impfdatum
30.03.2022
Beginn
30.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282856

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
VA
Alter
75,0
Geschlecht
M
Eingang
18.05.2022
Impfdatum
30.03.2022
Beginn
30.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282855

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
68,0
Geschlecht
F
Eingang
18.05.2022
Impfdatum
28.03.2022
Beginn
28.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282853

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
NC
Alter
30,0
Geschlecht
M
Eingang
18.05.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282852

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
58,0
Geschlecht
M
Eingang
18.05.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282850

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
61,0
Geschlecht
F
Eingang
18.05.2022
Impfdatum
28.03.2022
Beginn
28.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2273559

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
59,0
Geschlecht
F
Eingang
18.05.2022
Impfdatum
28.03.2022
Beginn
28.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2280957

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
53,0
Geschlecht
F
Eingang
17.05.2022
Impfdatum
25.03.2022
Beginn
25.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2280947

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
23,0
Geschlecht
F
Eingang
17.05.2022
Impfdatum
27.03.2022
Beginn
27.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2280945

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
21,0
Geschlecht
M
Eingang
17.05.2022
Impfdatum
27.03.2022
Beginn
27.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2280941

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
NY
Alter
35,0
Geschlecht
F
Eingang
17.05.2022
Impfdatum
26.03.2022
Beginn
26.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2280940

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
58,0
Geschlecht
F
Eingang
17.05.2022
Impfdatum
26.03.2022
Beginn
26.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2273548

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
VA
Alter
56,0
Geschlecht
F
Eingang
17.05.2022
Impfdatum
25.03.2022
Beginn
25.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278594

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
59,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
08.04.2022
Beginn
08.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278593

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
60,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
08.04.2022
Beginn
08.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278591

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
70,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
08.04.2022
Beginn
08.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278588

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
87,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
08.04.2022
Beginn
08.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278584

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
81,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
08.04.2022
Beginn
08.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278581

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
73,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278577

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
71,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
08.04.2022
Beginn
08.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278575

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
69,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278572

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
80,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278569

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
75,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278565

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
68,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278563

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
67,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278556

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
57,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278551

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
87,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278545

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
73,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278542

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
83,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278538

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
84,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Unevaluable event

Symptomtext

None stated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278535

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
89,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278531

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
72,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278529

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
77,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278526

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
75,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278509

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
61,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278506

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
78,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278503

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
77,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278501

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
80,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278498

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
72,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278496

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
66,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278494

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
74,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278491

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
64,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278489

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
54,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278487

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
37,0
Geschlecht
U
Eingang
16.05.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278482

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
42,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278479

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
74,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278475

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
90,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278470

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
22,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
24.03.2022
Beginn
24.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278459

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
44,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
24.03.2022
Beginn
24.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278450

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
45,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
24.03.2022
Beginn
24.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278011

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
GA
Alter
57,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
01.05.2022
Beginn
01.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

received expired doses of the Moderna COVID19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired doses of the Moderna COVID19 vaccine) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042j21a) for COVID-19 vaccination. No Medical History information was reported. In May 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired doses of the Moderna COVID19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received expired doses of the Moderna COVID19 vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. The type of dose was reported as a booster dose. Each vial was thawed the day before the appointment 3-May-2022, 07-May-2022 and 10-May-2022 Dates of administration of vaccine were 11-May2022, 4-May-2022, 8-May-2022 The vial did not undergo any temperature excursions. No treatment information were provided. This case was linked to MOD-2022-565522, MOD-2022-565551 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 12-May-2022: Significant follow-up received : Added patient demographics and type of dose as booster.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2277930

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
GA
Alter
30,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Received expired doses of the Moderna COVID19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired doses of the Moderna COVID19 vaccine) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired doses of the Moderna COVID19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired doses of the Moderna COVID19 vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. The date of administration 11-May-2022, 04-May-2022 and 08-May-2022. Each vial (3 vails) was thawed the day before the appointment i.e. 03-May-2022, 07-May-2022 and 10-May-2022. The vial did not undergo temperature excursion. No treatment medications were provided. This case was linked to MOD-2022-565558, MOD-2022-565522 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 12-May-2022: Live Follow-up document received on 12-May-2022 contains significant information include patient details and suspect dose details added.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2277929

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
GA
Alter
34,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
01.05.2022
Beginn
01.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Patient received expired dose of the Moderna COVID19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna COVID19 vaccine) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042j21a) for COVID-19 vaccination. No Medical History information was reported. In May 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna COVID19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna COVID19 vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported. Patient received booster dose. It was reported that each vial was thawed the day before the appointment 3-May-2022, 07-May-2022 and 10-May-2022 and date of administration of vaccine was reported as 04-May-2022, 08-May-2022 and 11-May-2022. Treatment information was not reported. This case was linked to MOD-2022-565551, MOD-2022-565558 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 12-May-2022: Followup received contains significant information. Added patient demographics, start date, dose number, dosage text of vaccine, event start date and updated inarrative supplement.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2276409

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
30,0
Geschlecht
F
Eingang
13.05.2022
Impfdatum
15.03.2022
Beginn
15.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2276408

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WY
Alter
76,0
Geschlecht
F
Eingang
13.05.2022
Impfdatum
15.03.2022
Beginn
15.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

temperature excursion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2275455

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
VA
Alter
68,0
Geschlecht
F
Eingang
13.05.2022
Impfdatum
30.03.2022
Beginn
30.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2273554

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
VA
Alter
53,0
Geschlecht
F
Eingang
12.05.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2271590

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
GA
Alter
30,0
Geschlecht
M
Eingang
11.05.2022
Impfdatum
08.05.2022
Beginn
11.05.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event

Symptomtext

No symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2271584

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
GA
Alter
57,0
Geschlecht
M
Eingang
11.05.2022
Impfdatum
04.05.2022
Beginn
11.05.2022
Tage bis Beginn
7,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event

Symptomtext

No symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2271572

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
GA
Alter
34,0
Geschlecht
M
Eingang
11.05.2022
Impfdatum
11.05.2022
Beginn
11.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event

Symptomtext

No symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2270572

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
NC
Alter
-
Geschlecht
M
Eingang
11.05.2022
Impfdatum
06.05.2022
Beginn
06.05.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine moved from freezer to fridge on 6-May-2022 with expiration date of 29-Apr-2022; Patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and PRODUCT STORAGE ERROR (Vaccine moved from freezer to fridge on 6-May-2022 with expiration date of 29-Apr-2022) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 06-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine moved from freezer to fridge on 6-May-2022 with expiration date of 29-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and PRODUCT STORAGE ERROR (Vaccine moved from freezer to fridge on 6-May-2022 with expiration date of 29-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. Vaccine moved from freezer to fridge on 06-May-2022. No adverse events were noted. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2268534

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
NC
Alter
-
Geschlecht
F
Eingang
10.05.2022
Impfdatum
06.05.2022
Beginn
06.05.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

patient received expired vaccine; Product Storage error; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) and PRODUCT STORAGE ERROR (Product Storage error) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 06-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) and PRODUCT STORAGE ERROR (Product Storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) and PRODUCT STORAGE ERROR (Product Storage error) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications details were not reported by the reporter. Product moved from freezer to fridge on 06-MAY-2022. Treatment details was not reported by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2266797

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
60,0
Geschlecht
F
Eingang
07.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Patient was administered with expired dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Number of doses/ vials administered 13doses from 2 vials. Date the vial was initially stored in the refrigerator was unknown. The vial had not undergone any temperature excursion. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2266796

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
64,0
Geschlecht
M
Eingang
07.05.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired doses administered to 13 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information provided. Number of doses/vials was 13 doses from 2 vials. Date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. It was unknown if the patient experienced any symptoms. No treatment medication information provided

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2266795

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
47,0
Geschlecht
F
Eingang
07.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired doses administered to 13 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided. Date the vial was initially stored in the refrigerator was not known. The vial did not undergo any temperature excursions. It was unknown if any of the patients experienced any symptoms. Treatment medication was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265693

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
DE
Alter
-
Geschlecht
U
Eingang
06.05.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Dose administered after manufacturer date of expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. One of the medical assistants or nurses gave a Moderna COVID-19 vaccination after its expiration date. The expiration date tool states it is 29 Apr 2022 and they administered it on 03 May 2022. Vial did not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265642

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
06.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine was expired on 29-Apr-2022, refrigerated on 03-May-2022 and administered on 04-May-2022; Administered with an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and PRODUCT STORAGE ERROR (Vaccine was expired on 29-Apr-2022, refrigerated on 03-May-2022 and administered on 04-May-2022) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022 at 9:30 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2022 at 9:30 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 29-Apr-2022, refrigerated on 03-May-2022 and administered on 04-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and PRODUCT STORAGE ERROR (Vaccine was expired on 29-Apr-2022, refrigerated on 03-May-2022 and administered on 04-May-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. On 04-May-2022, one patient was administered expired booster dose of Moderna Covid-19 vaccine. The vial was initially stored in refrigerator on 03-May-2022 at 11am and the vial did not undergo any temperature excursions. No treatment medications was reported. Most recent FOLLOW-UP information incorporated above includes: On 04-May-2022: Live follow up received contains Significant information of Updated details about the expired vial received.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265623

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
06.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Patient received an expired vaccine which got expired on 29-Apr-2021; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine which got expired on 29-Apr-2021) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine which got expired on 29-Apr-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine which got expired on 29-Apr-2021) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided by reporter. It was patient's 2nd dose. The patient was fine, has not reported any side effects. The date in which the vial was initially stored in the refrigerator was reported as it came directly from freezer on 02-May-2022. The vial did not undergo any temperature excursions. No treatment medications were provided by reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265622

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
54,0
Geschlecht
M
Eingang
06.05.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired doses administered to 13 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant product use was provided. Date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. It was unknown if the patient experienced any symptoms. No treatment medication was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265621

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
51,0
Geschlecht
F
Eingang
06.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired dose administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. It was unknown if the patient experienced any symptoms. No treatment medications was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265620

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
75,0
Geschlecht
M
Eingang
06.05.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

patients where vaccinated on 2May2022 and 3May2022 with expired doses of Moderna COVID-19 Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients where vaccinated on 2May2022 and 3May2022 with expired doses of Moderna COVID-19 Vaccine) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients where vaccinated on 2May2022 and 3May2022 with expired doses of Moderna COVID-19 Vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients where vaccinated on 2May2022 and 3May2022 with expired doses of Moderna COVID-19 Vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant drug was reported. It was reported that 13 patients were vaccinated on 2-May-2022 and 3-May-2022 with expired doses of Moderna COVID-19 Vaccine. The vial did not undergo any temperature excursions It is unknown if any of the patients experienced any symptoms. No treatment drug was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265619

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
80,0
Geschlecht
F
Eingang
06.05.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Received vaccine expired on 29-Apr-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine expired on 29-Apr-2022) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine expired on 29-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine expired on 29-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the vial did not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265618

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
51,0
Geschlecht
M
Eingang
06.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired dose administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial did not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265617

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
69,0
Geschlecht
U
Eingang
06.05.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Vaccinated with expired dose of Moderna COVID-19 Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccinated with expired dose of Moderna COVID-19 Vaccine) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccinated with expired dose of Moderna COVID-19 Vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccinated with expired dose of Moderna COVID-19 Vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Patient was administered with 0.25 ml of vaccine on 03-May-2022 (Expiry: 29-Apr-2022). It was unknown if the patient experienced any symptoms. The vial didn't undergo any temperature excursions. Date the vial was initially stored in the refrigerator was unknown. No treatment information was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265616

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
75,0
Geschlecht
F
Eingang
06.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired dose administered to patient / Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient / Dose administered after 30-day Use By Date or after manufacturer date of expiry) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient / Dose administered after 30-day Use By Date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient / Dose administered after 30-day Use By Date or after manufacturer date of expiry) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant product use was reported. The reporter stated that the patient was vaccinated on 02-May-2022 with expired doses of Moderna COVID-19 Vaccine. The dose was administered after 30-day Use by Date or after manufacturer date of expiry. The date when the vial was initially stored in the refrigerator was unknown. Reportedly, the vial didn't undergo any temperature excursions. It was unknown if the patient had experienced any symptoms. No treatment information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265615

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
78,0
Geschlecht
F
Eingang
06.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Dose administered after 30-day Use By Date or after manufacturer date of expiry; Expired doses administered to 13 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) and PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) and PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Vial did not undergo any temperature excursions. No relevant concomitant medications were reported. No treatment information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265614

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
79,0
Geschlecht
M
Eingang
06.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired doses administered to 13 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information provided. Date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. It was unknown if the patient experienced any symptoms. No treatment medication information provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2264485

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
70,0
Geschlecht
F
Eingang
05.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired dose administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. vial didn't undergo any temperature excursions No Concomitant Products were reported. No Treatment information was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2260128

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
72,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
19.02.2022
Beginn
25.04.2022
Tage bis Beginn
65,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Fall SARS-CoV-2 test positive

Symptomtext

04/25/22 presents to EC ED for "fall". PMHx of "schizophrenia"

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
04/25/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2256237

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
28.04.2022
Impfdatum
25.04.2022
Beginn
25.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Beyond the 30 day use by date, 22Apr2022; Inadvertently administered to a patient an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Inadvertently administered to a patient an expired dose of the Moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Beyond the 30 day use by date, 22Apr2022) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Apr-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 25-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Inadvertently administered to a patient an expired dose of the Moderna COVID-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Beyond the 30 day use by date, 22Apr2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Inadvertently administered to a patient an expired dose of the Moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Beyond the 30 day use by date, 22Apr2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. The vaccine was administered to the patient around lunch time on 25-Apr-2022 probably at 12 noon. The vial was stored in refrigerator on 23-Mar-2022. The vial doesn't undergone any temperature excursion. It was reported that it would be the second dose of vaccine. No treatment medications was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2250134

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
27,0
Geschlecht
F
Eingang
25.04.2022
Impfdatum
25.04.2022
Beginn
25.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Administered on 04/25/22, expiration date 04/22/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No know illness prior to vaccine
Vorgeschichte
-
Andere Medikamente
Effexor
Allergien
PCN-rash
Vorherige Impfungen
-

VAERS 2246195

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
TX
Alter
74,0
Geschlecht
M
Eingang
21.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood pressure decreased Feeling abnormal Vision blurred

Symptomtext

2 hours after vaccine, felt poorly and blurry vision. Nurse called to home. Blood pressure less than 70/40. Provided supportive care with oral fluids and rest. After 3 hours, all vitals returned to normal and felt "fine" again.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blood pressure decreased
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
CHF, COPD
Andere Medikamente
Hydrocodone, Hydralazine, Amlodipine, ASA, Buspirone (taken in the am)
Allergien
Morphine, PCN, Loratadine, shellfish
Vorherige Impfungen
-

VAERS 2243743

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
NY
Alter
49,0
Geschlecht
M
Eingang
20.04.2022
Impfdatum
30.03.2022
Beginn
30.03.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration

Symptomtext

Patient was given a booster of Moderna COVID vaccine on 3/30/22 which was too early. Due to late reporting (delay in data transfer. data had been referenced to verify eligibility for booster. During an audit it was discovered that the 1/19/22 booster administration information did not transfer in a timely fashion thus making it look like he was eligible for his booster on 3/30/22. Outpatient clinic treatment team leader notified patient and reminded him to contact his doctor.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2236152

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
52,0
Geschlecht
F
Eingang
15.04.2022
Impfdatum
02.04.2022
Beginn
15.04.2022
Tage bis Beginn
13,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration

Symptomtext

Patient received Moderna booster 1 on 12/17/21 and received Moderna booster 2 on 04/2/22 - 15 days earlier than recommended

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2233916

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
NY
Alter
16,0
Geschlecht
F
Eingang
14.04.2022
Impfdatum
31.03.2022
Beginn
31.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Pt of 16 years old was given booster dose of .25mL Moderna covid vaccine on 03/31/2022. Was not noted until audit on 4/12/22. Notified Moderna on 04/13/22, spoke with patients parent on 04/13/22 to assess for symptoms/side effects/adverse events which patient was negative for. Moderna response not received at time of VAERS report submission.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
allergic rhinitis, dysuria nos
Vorgeschichte
Seasonal Allergies and adjustment disorder
Andere Medikamente
Hydroxyzine HCl, Fluticasone propionate, melatonin, loratidine
Allergien
NKA
Vorherige Impfungen
-

VAERS 2231643

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IA
Alter
16,0
Geschlecht
M
Eingang
13.04.2022
Impfdatum
06.04.2022
Beginn
06.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient given Moderna vaccine, which is not approved for persons under the age of 18. No known adverse events from this vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
no
Vorgeschichte
unknown
Andere Medikamente
unkown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2231342

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
16,0
Geschlecht
M
Eingang
13.04.2022
Impfdatum
12.04.2022
Beginn
12.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

A 16-year old patient was inadvertently administered dose 1 of MODERNA vaccine by volunteer vaccinator. Patient had no immediate adverse reaction, incident was discussed with Mom, counseled on monitoring, management and next doses to be scheduled .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223300

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
49,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
08.04.2022
Beginn
08.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration No adverse event

Symptomtext

Patient received booster dose (0.25ml) 16 days earlier than recommended time frame. No adverse reactions were noted at the time of administration. Primary series completed 11/24/21. Booster administered 04/08/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2213404

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
AK
Alter
20,0
Geschlecht
F
Eingang
03.04.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration Interchange of vaccine products Underdose

Symptomtext

Patient arrived for appointment and requested a "Moderna booster." Screening personnel failed to notice that patient had recently received her first dose of Pfizer vaccine in the primary COVID-19 vaccine series on 09 Mar 2022. Patient inadvertently received a booster 0.25mL dose of Moderna vaccine per her verbal request instead of the appropriate Pfizer second primary series dose. Once error was identified, patient had already left vaccination site. Patient contacted and notified of error. Corrective action per CDC's guidance was to administer another 0.25mL dose of Moderna vaccine same day to make a full 0.5mL dose of Moderna and patient would be considered to have a complete primary mixed series. Patient was able to return and received a second dose of 0.25mL Moderna vaccine. When reviewing record to submit a patient safety report, it was observed that it had only been 23 days since first dose of Pfizer, and patient did not meet minimum spacing of 28 days for a mixed primary series. This dose was given 5 days too early. Recommendation is to repeat dose 4 weeks later to ensure patient is protected. No known adverse events at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208932

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
80,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that date the vial was initially stored in the refrigerator was on 31-Jan-2022. The vial did not undergo any temperature excursions. No treatment medications were reported. This case was linked to MOD-2022-525860 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208781

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
62,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Date the vial was initially stored in the refrigerator was 31Jan2022 and Administered on 09Mar2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 31Jan2022 and Administered on 09Mar2022) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 31Jan2022 and Administered on 09Mar2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 31Jan2022 and Administered on 09Mar2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Reporter stated that the vial was initially stored in the refrigerator on 31-Jan-2022 and the vial did not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208780

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
60,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment information was unknown. This case was linked to MOD-2022-525860 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208779

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
45,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 09-Mar-2022; Moderna COVID-19 vaccine that was beyond 30 day use by date was given to patient.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to patient.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 09-Mar-2022) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to patient.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to patient.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 09-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that date the vial was initially stored in the refrigerator on 31-Jan-2022. The vial did not undergo any temperature excursions. No treatment medications were reported. This case was linked to MOD-2022-525860 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208778

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
50,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vial was initially stored in the refrigerator on 31 Jan 2022 and administered on 09 Mar 2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31 Jan 2022 and administered on 09 Mar 2022) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31 Jan 2022 and administered on 09 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31 Jan 2022 and administered on 09 Mar 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported by the reporter. No treatment medication was reported by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208776

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
60,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Date the vial was initially stored in the refrigerator 31-Jan-2022, Date(s) of administration of vaccine 09-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 31-Jan-2022, Date(s) of administration of vaccine 09-Mar-2022) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 31-Jan-2022, Date(s) of administration of vaccine 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 31-Jan-2022, Date(s) of administration of vaccine 09-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. On 31-Jan-2022 the vial was initially stored in the refrigerator. The vials did not undergo any temperature excursions. This case was linked to MOD-2022-525860, MOD-2022-525834, MOD-2022-525851, MOD-2022-525860, MOD-2022-525866, MOD-2022-525870, MOD-2022-525874, MOD-2022-525880, MOD-2022-525890, MOD-2022-525893, MOD-2022-525896, MOD-2022-525903, MOD-2022-525906, MOD-2022-525912, MOD-2022-525915, MOD-2022-525918 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208775

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
61,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication list was not provided. It was reported tat the patient took half dose booster. Vial was initially stored in the refrigerator on 31-Jan-2022. It was reported that the vial did not undergo any temperature excursions. Treatment information was not provided. This case was linked to MOD-2022-525860 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208774

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
49,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
09.03.2022
Beginn
28.03.2022
Tage bis Beginn
19,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information provided. Date the vial was initially stored in the refrigerator: 31Jan2022. The vial did not undergo any temperature excursions. No treatment information provided. This case was linked to MOD-2022-525860 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208772

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
38,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients; Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients) and PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients) in a 38-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients) and PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Vial did not undergo temperature excursions. It was reported that date the vial was initially stored in the refrigerator was on 31-Jan-2022. Treatment information was not provided. This case was linked to MOD-2022-525860 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208770

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
71,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022) in a 71-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that date the vial was initially stored in the refrigerator was on 31-Jan-2022. No temperature excursion. No treatment medications were reported. This case was linked to MOD-2022-525860 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208768

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
85,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in an 85-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information provided. No treatment medication information provided. Date the vial was initially stored in the refrigerator was 31 Jan 2022 The vial did not undergo any temperature excursion. This case was linked to MOD-2022-525860.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208767

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
78,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.). On an unknown date, the patient PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication list was not provided. It was reported that the patient took half dose booster. Vial was initially stored in the refrigerator on 31-Jan-2022. It was reported that the vial did not undergo any temperature excursions. Treatment information was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208766

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
61,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
16.03.2022
Beginn
28.03.2022
Tage bis Beginn
12,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. It was reported that date the vial was initially stored in the refrigerator was 31-Jan-2022. This case was linked to MOD-2022-525834, MOD-2022-525860, MOD-2022-525870, MOD-2022-525874, MOD-2022-525880, MOD-2022-525890, MOD-2022-525893, MOD-2022-525896, MOD-2022-525900, MOD-2022-525903, MOD-2022-525912, MOD-2022-525915, MOD-2022-525860 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208765

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
60,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Treatment information was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208764

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
63,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Vial did not undergo temperature excursions. It was reported that date the vial was initially stored in the refrigerator was 31-Jan-2022. No treatment medications were reported. This case was linked to MOD-2022-525860.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2206764

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
27,0
Geschlecht
M
Eingang
30.03.2022
Impfdatum
11.03.2022
Beginn
11.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

This dose was a booster after an initial Janssen dose. The dose should have been 0.25ml, however, a 0.5ml dose was given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2206291

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
23,0
Geschlecht
U
Eingang
30.03.2022
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022) in a 23-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product information was not provided. The vial was initially stored in the refrigerator on 31-Jan-2022. Treatment information was not provided. This case was linked to MOD-2022-525860 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2201792

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
25,0
Geschlecht
F
Eingang
28.03.2022
Impfdatum
18.02.2022
Beginn
28.02.2022
Tage bis Beginn
10,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Erythema nodosum Nodule Swelling Tenderness

Symptomtext

10 days after receiving my booster, I developed bilateral red, tender nodules on my shins and calves as well as swelling in my ankles, calves, and knees. No other symptoms were present. The reaction appeared to be erythema nodosum. The number of nodules increased during the first 2 days and remained consistent for 2 weeks and then started to decrease during week 3. The swelling lasted for four weeks and will come back after standing for long periods of time. I took ibuprofen occasionally, wore compression stockings, and elevated my legs when possible.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
No other illnesses around the time of vaccination
Vorgeschichte
No chronic health conditions
Andere Medikamente
Portia - birth control, daily for 5 years, Zyrtec - daily for 10 years, Vitamin C gummies - daily for 1 year, Vitamin D - daily for 1 year
Allergien
NKDA, Allergic to shellfish, pollen, dust, cats
Vorherige Impfungen
-

VAERS 2201691

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
33,0
Geschlecht
F
Eingang
28.03.2022
Impfdatum
25.03.2022
Beginn
26.03.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Contusion Swelling

Symptomtext

Patient received Moderna Booster shot Friday and experienced swelling on right side of neck (shot administered in right arm) the following day, Saturday. Also experienced bruising in right leg -describing it as comparable to a varicose vein. Patient worked Saturday and Sunday (12 hour shifts). We have not seen actual swelling on neck or leg. Have asked patient to send us pictures or come by. Patient states today, swelling has gone down but not completely resolved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Contusion
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2194688

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 042j21a

gering
Staat
NC
Alter
47,0
Geschlecht
M
Eingang
23.03.2022
Impfdatum
23.03.2022
Beginn
23.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Underdose

Symptomtext

Patient scheduled for second dose of Moderna vaccine. Patient received booster dose (0.25ml.) instead of (0.5ml) dose which was the appropriate dose by RN. Phone call was made to the patient at 1205pm and voicemail message was left. Patient has not returned call as of this report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2187734

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
NY
Alter
16,0
Geschlecht
M
Eingang
18.03.2022
Impfdatum
26.01.2022
Beginn
26.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

It is documented that the patient received the Moderna Booster vaccine, but they are under 18 at time of getting it. Appointment was made for Moderna as well

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2184154

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
42,0
Geschlecht
M
Eingang
17.03.2022
Impfdatum
28.01.2022
Beginn
28.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered Interchange of vaccine products

Symptomtext

Participant received Janssen on 10/29/2021, at vaccine clinic partnered by Rehab Facility and Clinic, RN administered primary dose of Moderna at 0.5mL vs booster dose Moderna 0.25 mL on 1/28/2021. RN informed participant of error after vaccine clinic, denied SE. Instructed to monitor for symptoms. Participant verbalized understanding of plan of care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
N/A.
Aktuelle Erkrankungen
None noted
Vorgeschichte
hx hep , opioid use hx
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2182290

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CO
Alter
17,0
Geschlecht
F
Eingang
16.03.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Patient under age of 18 received Moderna vaccine, which is not approved for patients >18 years old. Pt reports no adverse medical effects from vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Depot-provera injection
Allergien
None
Vorherige Impfungen
-

VAERS 2177153

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
CA
Alter
16,0
Geschlecht
F
Eingang
12.03.2022
Impfdatum
12.03.2022
Beginn
12.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

This patient is a 16yo who was given the Moderna vaccine for 1st dose at a different clinic, when presented to this clinic brought in card, asked for Moderna and was given the 2nd dose as a Moderna which is and unauthorized age group 12-17

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Skin infection
Vorgeschichte
DMII, Asthma,
Andere Medikamente
Lantus, Humalog, Metformin, Ertugliflozin, Albuterol
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2174827

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
12.03.2022
Impfdatum
26.02.2022
Beginn
26.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

administered the Moderna vaccine about 36 hours after the use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered the Moderna vaccine about 36 hours after the use by date) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 26-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered the Moderna vaccine about 36 hours after the use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered the Moderna vaccine about 36 hours after the use by date) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. The reporter was a pharmacist. Concomitant medication of the patient was not reported. Date the vial was initially stored in the refrigerator was on 25-Jan-2022 and the vial did not undergo any temperature excursions. The reporter did not have more information about the patient. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2173760

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
31,0
Geschlecht
F
Eingang
11.03.2022
Impfdatum
11.03.2022
Beginn
11.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event

Symptomtext

No symptoms or adverse events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2173114

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
11.03.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Received a vaccine after the 30-day Use By Date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a vaccine after the 30-day Use By Date) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a vaccine after the 30-day Use By Date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a vaccine after the 30-day Use By Date) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The caller wanted to look up for an expiration date of a Moderna Covid-19 vaccine Lot number 042J21A. Agent entered Moderna's look up tool an provide the caller the expiration date 29Apr2022. Then, the caller asked how to proceed with a patient that received a vaccine after the 30-day Use By Date. No concomitant medication was provided by the reporter. No treatment was provided by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2168687

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
HI
Alter
66,0
Geschlecht
F
Eingang
09.03.2022
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

Due to misinformation, a 4th booster dose(0.25 ml) of the Moderna vaccine was administered to the patient on 3/4/2022. There were no acute signs and symptoms that occurred at the time of the event. The patients case manager, family, and primary care provider were informed of the event. Multiple follow up interactions were done and the patient's caregiver reported no adverse reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Schizophrenia, depression
Andere Medikamente
Abilify 5 mg, clozapine 100 mg, clozapine 200 mg, clozapine 50 mg, sertraline 50 mg
Allergien
N/A
Vorherige Impfungen
-

VAERS 2168128

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CO
Alter
23,0
Geschlecht
M
Eingang
09.03.2022
Impfdatum
07.03.2022
Beginn
07.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event

Symptomtext

No adverse event. Patient stated he felt fine. Advised patient of common side effects. Patient was advised to contact the clinic if symptoms worsen or new symptoms show.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
not known
Vorgeschichte
not known
Andere Medikamente
No know medication
Allergien
No know allergies
Vorherige Impfungen
-

VAERS 2165698

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
14,0
Geschlecht
M
Eingang
08.03.2022
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Child is under 18 years of age. He was administered Moderna vaccine which is not approved for under 18. He previously had the 2 doses of Pfizer vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
NOT KNOWN
Vorgeschichte
NOT KNOWN
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2165645

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
52,0
Geschlecht
M
Eingang
08.03.2022
Impfdatum
21.02.2022
Beginn
21.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165642

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
27,0
Geschlecht
F
Eingang
08.03.2022
Impfdatum
21.02.2022
Beginn
21.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165638

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
59,0
Geschlecht
F
Eingang
08.03.2022
Impfdatum
21.02.2022
Beginn
21.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165627

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
51,0
Geschlecht
F
Eingang
08.03.2022
Impfdatum
21.02.2022
Beginn
21.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165621

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
36,0
Geschlecht
M
Eingang
08.03.2022
Impfdatum
21.02.2022
Beginn
21.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165123

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
08.03.2022
Impfdatum
21.02.2022
Beginn
21.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error Product temperature excursion issue

Symptomtext

Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival; Total duration of the excursion refrigerated temps for max of 4 hrs; They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge); This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge)), PRODUCT STORAGE ERROR (Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival) and PRODUCT TEMPERATURE EXCURSION ISSUE (Total duration of the excursion refrigerated temps for max of 4 hrs) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 21-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 21-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival) and PRODUCT TEMPERATURE EXCURSION ISSUE (Total duration of the excursion refrigerated temps for max of 4 hrs). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge)), PRODUCT STORAGE ERROR (Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival) and PRODUCT TEMPERATURE EXCURSION ISSUE (Total duration of the excursion refrigerated temps for max of 4 hrs) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. Vial was moved to fridge on 19-Jan-2022.Temperature was fluctuated Frozen-refrigerated and again re frozen. Frozen vails removed and transported ate refrigerated temperature and refrozen at time of arrival. Total duration of excursion refrigerated temperature for max 4 hours. Temperature reached to 8 degrees Celsius. Vials size was 5.5 mL and 7.5 Ml. Partially thawed liquid state at the time of excursion. No treatment drug were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165118

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
08.03.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error Product temperature excursion issue

Symptomtext

They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival; They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival). At the time of the report, PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial was moved to the fridge on 19 Jan 2022 and administered post 30 days from the initial storage at 2 degree Celsius to 8 degree Celsius. It was unknown if the vial was undergone a previous temperature excursion. The storage condition at the time of the excursion was frozen storage/refrigerated storage. The state of the vaccine at the time of the excursion was partially thawed/liquid. The maximum temperature reached was 8?C. the total duration of the excursion refrigerated temps for max of 4 hours. The temperature fluctuations occurred as frozen-refrigerated and refrozen. No treatment information was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165094

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
08.03.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error Product temperature excursion issue

Symptomtext

They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival; They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported Vial was moved to fridge on 19 Jan 2022. It was reported that the vaccines were frozen, shipped in refrigerated temperature and then refroze for storage once arrive at facility. The facility thought that the vials are received frozen from Moderna so they had unpacked them and put them back into the facility freezer. They just recently found out that the vials are received in refrigerated temperatures and not frozen. They have been accidentally administering refrozen vials to their patients. Temperature was fluctuated Frozen-refrigerated and again re frozen. Total duration of excursion refrigerated temperature for max 4 hours. Temperature reached to 8 degrees Celsius. Vials size was 5.5 mL and 7.5 Ml. Partially thawed liquid state at the time of excursion No treatment drug were reported. This case was linked to MOD-2022-496015, MOD-2022-501703 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165077

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
08.03.2022
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error Product temperature excursion issue

Symptomtext

They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival; They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vials were frozen, shipped in refrigerated temperature and then refroze for storage once arrive at facility. On 19 Jan 2021 vaccine was moved to fridge and vaccine administered past 30 days from the initial storage at 2 degree Celsius to 8 degree Celsius. The facility thought that the vials were received frozen from Moderna, so they have been unpacking them and putting them back into the facility freezer. They just recently found out that the vials are received in refrigerated temperatures and not frozen. They have been accidentally administering refrozen vials to their patients. No treatment medications were reported. This case was linked to MOD-2022-496015 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2164979

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IL
Alter
25,0
Geschlecht
F
Eingang
08.03.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired booster dose administered more than 12 hours post puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired booster dose administered more than 12 hours post puncture) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired booster dose administered more than 12 hours post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired booster dose administered more than 12 hours post puncture) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial was initially stored in the refrigerator on 15-feb-2022. Date and time vial was first punctured: 21-feb-2022 at unknown time. Vial was stored post puncture in refrigerator. Vials did not undergo any temperature excursion. Punctured vial was kept in the refrigerator 3 hours more than 12 hours post puncture. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2163125

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
50,0
Geschlecht
M
Eingang
07.03.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2163124

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
70,0
Geschlecht
M
Eingang
07.03.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

On the day of administration, vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022 and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2163123

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
57,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2163121

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
43,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2163119

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
65,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2162823

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
48,0
Geschlecht
M
Eingang
07.03.2022
Impfdatum
16.02.2022
Beginn
16.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2162820

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
67,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
16.02.2022
Beginn
16.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2162806

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
73,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration, the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration".

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2162802

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
70,0
Geschlecht
M
Eingang
07.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2162800

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
48,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2162795

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
27,0
Geschlecht
M
Eingang
07.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2162790

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
79,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2162786

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
42,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2162784

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
45,0
Geschlecht
M
Eingang
07.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2162778

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
67,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2157855

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
VA
Alter
16,0
Geschlecht
F
Eingang
04.03.2022
Impfdatum
23.02.2022
Beginn
23.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

16-year-old given Moderna as first dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2157600

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
OH
Alter
17,0
Geschlecht
F
Eingang
04.03.2022
Impfdatum
03.03.2022
Beginn
03.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient was seeing her PCP for a physical. Patient was given a Moderna vaccine before the age of 18. No adverse reactions were noted. Patient was assessed by nursing staff after vaccine was given. Patient tolerated vaccine well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Depression
Andere Medikamente
Etonogestrel Implant
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2155049

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
LA
Alter
49,0
Geschlecht
F
Eingang
03.03.2022
Impfdatum
12.02.2022
Beginn
12.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Limb injury

Symptomtext

Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Limb injury
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2154979

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WA
Alter
26,0
Geschlecht
F
Eingang
03.03.2022
Impfdatum
04.02.2022
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

No adverse reaction. Immunization was given 5 days early.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Sprintec (28) 0.25 mg-35 mcg tablet
Allergien
none
Vorherige Impfungen
-

VAERS 2152584

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
17,0
Geschlecht
M
Eingang
02.03.2022
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Interchange of vaccine products Product administered to patient of inappropriate age

Symptomtext

PATIENT REQUESTED AND RECEIVED A MODERNA COVID VACCINE BOOSTER. PATIENT HAD PREVIOUSLY RECEIVED 2 DOSES OF PFIZER AT APPROPRIATE INTERVALS. PATIENT IS 17 YEARS OLD. MODERNA COVID VACCINE IS CURRENTLY APPROVED/RECOMMENDED FOR PATIENTS 18 YEARS OLD AND ABOVE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151840

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
49,0
Geschlecht
M
Eingang
02.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151826

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
20,0
Geschlecht
F
Eingang
02.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151825

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
76,0
Geschlecht
F
Eingang
02.03.2022
Impfdatum
14.02.2022
Beginn
14.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151822

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
36,0
Geschlecht
F
Eingang
02.03.2022
Impfdatum
14.02.2022
Beginn
14.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151819

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
41,0
Geschlecht
F
Eingang
02.03.2022
Impfdatum
14.02.2022
Beginn
14.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151270

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
17,0
Geschlecht
M
Eingang
01.03.2022
Impfdatum
24.01.2022
Beginn
24.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

This individual was less than 18 years of age at the time of vaccination. His age on the application form list as 18 hoverer, the Date of Birth is listed as August 12, 2004.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2148584

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
TX
Alter
17,0
Geschlecht
M
Eingang
28.02.2022
Impfdatum
01.02.2022
Beginn
01.03.2022
Tage bis Beginn
28,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Patient received Moderna underage; eligibility is 18 years old; patient was 2 weeks shy from 18 year old at the time of vaccination for his booster shot

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
none known
Allergien
none known
Vorherige Impfungen
-

VAERS 2148524

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
TX
Alter
12,0
Geschlecht
F
Eingang
28.02.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Error: Patient Too Young for Vaccine Administered-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2148407

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
20,0
Geschlecht
M
Eingang
28.02.2022
Impfdatum
14.02.2022
Beginn
14.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered Product storage error

Symptomtext

On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manfacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, andFebruary 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2148375

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
76,0
Geschlecht
F
Eingang
28.02.2022
Impfdatum
05.02.2021
Beginn
18.12.2021
Tage bis Beginn
316,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

event occurred after 2nd vaccine; breakthrough case admssion

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
12/18/21 COVID+
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146244

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
52,0
Geschlecht
M
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. Reporter called to report they gave 26 doses after the 30-day use by date. It was reported that the vial was initially stored in the refrigerator on 14 Jan 2022. The dates of vaccine administration were 14 Feb 2022, 15 Feb 2022, 16 Feb 2022, 18 Feb 2022, 21 Feb 2022. The vial did not undergo any temperature excursions. No treatment medications were provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146243

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
36,0
Geschlecht
M
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Total 26 doses/vials were reported. Dates of administration of vaccine were 14 ,15 , 16 , 18 and 21-FEB-2022. The vials did not undergo any temperature excursions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146242

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
70,0
Geschlecht
M
Eingang
26.02.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Pharmacist stated that they gave 26 doses after the 30-day use by date and would like to know if those doses were viable or not. The date when the vial was initially stored in the refrigerator was 14-Jan-2022. The vial did not undergo any temperature excursions. The date(s) of administration of vaccine were as follows: 14-Feb-2022, 15-Feb-2022, 16-Feb-2022, 18-Feb-2022, 21-Feb-2022. No treatment information was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146240

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
50,0
Geschlecht
M
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided The vaccine was administered on 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. The vial was initially stored in the refrigerator on 14Jan2022. No treatment medication was provided

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146229

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
48,0
Geschlecht
M
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication reported. No treatment information was provided. Reporter stated that vial does not undergo any temperature excursions. The vial was initially stored in the refrigerator on 14Jan2022 The administration of vaccine was 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146228

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
71,0
Geschlecht
M
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant products were reported. Date the vial was initially stored in the refrigerator on 14-JAN-2022. Patient took booster dose in February 2022. No Treatment information was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146227

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
26.02.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided by reporter. No treatment medication was provided by reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146225

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
27,0
Geschlecht
M
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications details were reported. Pharmacist reported that they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator : 14Jan2022 Date(s) of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.Vial did not undergo any temperature excursions. No treatment information details were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146224

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
45,0
Geschlecht
M
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant products were reported Pharmacist reported that they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator : 14Jan2022 Date(s) of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.Vial did not undergo any temperature excursions. No treatment information was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146223

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
20,0
Geschlecht
M
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

doses administered past the 30-day use by date; Dose administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered past the 30-day use by date) and PRODUCT STORAGE ERROR (doses administered past the 30-day use by date) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered past the 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered past the 30-day use by date) and PRODUCT STORAGE ERROR (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that the vial was initially stored in the refrigerator on 14-Jan-2022. The administration of vaccines were 14-Feb-2022, 15-Feb-2022, 16-Feb-2022, 18-Feb-2022, 21-Feb-2022. No concomitant medications were reported. The vial had not undergone any temperature excursions. No treatment medications were reported. This case was linked to MOD-2022-492833 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146222

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
-
Geschlecht
F
Eingang
26.02.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Pharmacist called because they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Dose administered after 30-day Use by Date or after manufacturer date of expiry Total number of doses/vials was 26. On 14-Jan-2022, the vial was initially stored in the refrigerator. Date(s) of administration of vaccine on 14-Feb-2022, 15-Feb-2022, 16-Feb-2022, 18-Feb-2022 and 21-Feb-2022. vial did not undergo any temperature excursions. No treatment drug were reported. No concomitant medication were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146221

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
27,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment medications were provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146220

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
51,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

This spontaneous case reported by a pharmacist, describes the occurrence of administered expired product (administered past the 30-day use-by-date) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 042J21A) for COVID-19 immunization. No medical history reported. February 2022, patient received the third dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. February 2022, patient administered expired product (administered past the 30-day use-by-date). At the time of the report, administered expired product (administered past the 30-day use-by-date) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. Reportedly, 26 doses given after the 30-day use-by-date. It was reported the vial was initially stored in the refrigerator on Jan 14, 2022. The dates of vaccine administration were Feb 14, 2022; Feb 15, 2022; Feb 16, 2022; Feb 18, 2022 and Feb 21, 2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146219

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
57,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported by reporter. Patient took booster dose. On 14-Jan-2022 the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. No treatment medication was reported by reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146218

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
43,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information was provided. The vial was initially stored in the refrigerator 14Jan2022. The vaccine was administered on 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. No treatment medication information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146216

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
65,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Reporter called to report they gave 26 doses after the 30-day use by date. It was reported that the vial was initially stored in the refrigerator on 14 Jan 2022. The dates of vaccine administration were 14 Feb 2022, 15 Feb 2022, 16 Feb 2022, 18 Feb 2022, 21 Feb 2022. No treatment medication was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146208

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
67,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Date the vial was initially stored in the refrigerator: 14Jan2022 Dates of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. No concomitant and treatment medication details

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146207

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
73,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Date the vial was initially stored in the refrigerator on 14Jan2022. Reporter stated that vial does not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146206

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
-
Geschlecht
F
Eingang
26.02.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant and treatment drugs were reported. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator: 14Jan2022. Dates of administration of vaccine reported as 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146205

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
79,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2021
Tage bis Beginn
-
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Pharmacist reported that they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator : 14Jan2022 Date(s) of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.Vial did not undergo any temperature excursions. No concomitant products were reported. No treatment information was reported. .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146204

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
48,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant products were reported Pharmacist reported that they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator : 14Jan2022 Date(s) of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.Vial did not undergo any temperature excursions. No treatment information was reported. .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146203

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
-
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The vial was initially stored in the refrigerator included 14Jan2022. The administration of vaccine included 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. The vial did not undergo any temperature excursions. No concomitant medications were reported. No treatment medications were reported. This case was linked to MOD-2022-492833 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146199

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
66,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2021
Beginn
01.02.2022
Tage bis Beginn
365,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Reporter called to report they gave 26 doses after the 30-day use by date. It was reported that the vial was initially stored in the refrigerator on 14 Jan 2022. The dates of vaccine administration were 14 Feb 2022, 15 Feb 2022, 16 Feb 2022, 18 Feb 2022, 21 Feb 2022. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146198

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
36,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that vial initially stored in the refrigerator on 14 Jan 2022 and did not undergo temperature excursions. No concomitant medications were reported. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2146185

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
41,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. vial was initially stored in the refrigerator on 14-jan-2022. Date(s) of administration of vaccine was 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. Pharmacist reported that they gave 26 doses after the 30-day use by date. No treatment information was provided

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2145981

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
39,0
Geschlecht
M
Eingang
26.02.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

a 39-year-old patient received expired booster dose of Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (a 39-year-old patient received expired booster dose of Moderna COVID-19 vaccine) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (a 39-year-old patient received expired booster dose of Moderna COVID-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (a 39-year-old patient received expired booster dose of Moderna COVID-19 vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Did the vial undergo any temperature excursions was given No Expiration date :31-DEC-1969 Date the vial was initially stored in the refrigerator: 13-JAN-2022 No concomitant drug information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2145897

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 042J21A

gering
Staat
-
Alter
87,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
04.03.2021
Beginn
14.01.2022
Tage bis Beginn
316,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Event occurred after 2nd vaccine; breakthrough case admission

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
1/14/2022 COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2144395

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
59,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
18.03.2021
Beginn
22.02.2022
Tage bis Beginn
341,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

event occurred after 3rd vaccine; breakthrough case admission

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
2/22/202 COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2140341

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
-
Alter
44,0
Geschlecht
M
Eingang
25.02.2022
Impfdatum
16.02.2022
Beginn
16.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Patient received J&J on 3/9/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2138953

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
77,0
Geschlecht
F
Eingang
25.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided by reporter. Pharmacist gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Dose administered after 30-day Use By Date or after manufacturer date of expiry. Date the vial was initially stored in the refrigerator 14-Jan-2022. Date(s) of administration of vaccines were reported as 14-Feb-2022, 15-Feb-2022, 16-Feb-2022, 18-Feb-2022, 21-Feb-2022. The vial did not undergo any temperature excursions. Treatment medication was not provided by reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2132396

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
67,0
Geschlecht
M
Eingang
22.02.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered

Symptomtext

PATIENT RECEIVED 0.5MLS INSTEAD OF 0.25MLS OF VACCINE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
LUPUS, ASTHMA
Andere Medikamente
PLAQUENIL, SYMBICORT, PERCOCET
Allergien
NONE
Vorherige Impfungen
-

VAERS 2131359

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MN
Alter
15,0
Geschlecht
F
Eingang
22.02.2022
Impfdatum
09.02.2022
Beginn
09.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

MODERNA VACCINE ADMINISTERED TO A PATIENT YOUNGER THAN 18 YEARS OF AGE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE REPORTED
Vorgeschichte
NONE REPORTED
Andere Medikamente
NOT AWARE OF ANY
Allergien
NO KNOWN DURG ALLERGY
Vorherige Impfungen
-

VAERS 2130727

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
41,0
Geschlecht
M
Eingang
22.02.2022
Impfdatum
17.02.2022
Beginn
17.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

3 patients received Moderna Covid-19 vaccine from vial punctured more than 12 hours ago; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 patients received Moderna Covid-19 vaccine from vial punctured more than 12 hours ago) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer and Pfizer. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. On 17-Feb-2022 at 10:45 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2022 at 10:45 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (3 patients received Moderna Covid-19 vaccine from vial punctured more than 12 hours ago). At the time of the report, EXPIRED PRODUCT ADMINISTERED (3 patients received Moderna Covid-19 vaccine from vial punctured more than 12 hours ago) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. No treatment drug details was reported. Pharmacist is not aware of any other adverse event complaints. The vial was initially stored in the refrigerator on 07-Feb-2022. The vial had no temperature excursions. This case was linked to MOD-2022-487948, MOD-2022-487957 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 17-Feb-2022: Follow up received contains no new information.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2129816

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
PR
Alter
76,0
Geschlecht
F
Eingang
21.02.2022
Impfdatum
19.02.2022
Beginn
19.02.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Administration error: A 76-year-old woman with a first series of Modera and a booster dose of Moderna, is inoculated with a fourth dose of 0.5ml of Moderna on February 19, 2022, an action which was not consulted with the leading professionals in charge of vaccination and did not follow the established guidelines for the booster dose of patients with immunological compromise.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
Rheumatoid arthritis
Andere Medikamente
Plaquenil 200mg daily, ATACAND, CADUAL 20mg, LINZESS, Neurontin 300mg, KEVZARA. 200mg q. 14 days
Allergien
NAK
Vorherige Impfungen
-

VAERS 2129324

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
39,0
Geschlecht
M
Eingang
21.02.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

The Dose was administered past the expiration/beyond use date

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2122773

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
69,0
Geschlecht
F
Eingang
18.02.2022
Impfdatum
17.02.2022
Beginn
17.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Error: Improper Storage (temperature)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2122772

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
41,0
Geschlecht
M
Eingang
18.02.2022
Impfdatum
17.02.2022
Beginn
17.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Error: Improper Storage (temperature)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2122771

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
22,0
Geschlecht
F
Eingang
18.02.2022
Impfdatum
17.02.2022
Beginn
17.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Error: Improper Storage (temperature)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2116695

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
64,0
Geschlecht
M
Eingang
16.02.2022
Impfdatum
11.02.2022
Beginn
11.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Interchange of vaccine products

Symptomtext

Patient came to clinic on 2/11/22 for 2nd dose of COVID vaccine. At the time of appointment pt. did not have vaccine card. Pt. was scheduled for Moderna vaccine therefor Moderna was given. Upon submitting charges staff noticed patient had received Pfizer as 1st dose. Medical provider was made aware as well as the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Leg cramps Heroin addiction Heroin use Constipation, slow transit Impacted cerumen of right ear Serum creatinine raised Elevated blood urea nitrogen Decreased GFR Drug abuse Homeless
Vorgeschichte
Chronic HTN
Andere Medikamente
AMLODIPINE 5MG Aspir-Low 81 mg tablet,delayed release lisinopril 20 mg tablet
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2109492

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
NY
Alter
32,0
Geschlecht
F
Eingang
13.02.2022
Impfdatum
12.02.2022
Beginn
12.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect product formulation administered

Symptomtext

Error: Wrong Vaccine Formulation (ex. different manufact. initial and booster)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2104475

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
ME
Alter
46,0
Geschlecht
F
Eingang
11.02.2022
Impfdatum
09.02.2022
Beginn
09.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired vaccine dose administered/Dose administered >12 hours post puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered/Dose administered >12 hours post puncture) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer vaccine on 02-Jun-2021 and Pfizer vaccine on 23-Jun-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine and Pfizer vaccine. On 09-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 09-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered/Dose administered >12 hours post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered/Dose administered >12 hours post puncture) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Reporter stated that their facility administered an expired booster dose of Moderna COVID-19 vaccine to 1 patient. The vaccine was given at 10am EST on 09-Feb-2022 from a vial that expired yesterday, 08-Feb-2022 at11:30pm. She stated that only 1 dose was given from after it was expired which was a booster dose. Dose was administered after 12 hours post puncture. Date the vial was initially stored in the refrigerator was on 08-Feb-2022, Date and time vial was first punctured was on 08-Feb-2022 at 8:30am, Date and time of administration of vaccine was on 09-Feb-2022 at 10am EST, the vial was stored post puncture in Fridge, the vial did not undergo temperature excursions. No treatment information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2102353

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
TX
Alter
52,0
Geschlecht
F
Eingang
10.02.2022
Impfdatum
04.02.2022
Beginn
06.02.2022
Tage bis Beginn
2,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Nodule Peripheral swelling Skin discolouration Swelling

Symptomtext

Received shot on a Friday and symptoms showed up on Sunday. Swelling upper quadrant of shoulder, knot around lymphnodes, cheek turned yellow and left arm swollen. She received Moderna all three shots.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nodule
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
N/A
Allergien
None
Vorherige Impfungen
-

VAERS 2101880

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
62,0
Geschlecht
F
Eingang
10.02.2022
Impfdatum
10.02.2022
Beginn
10.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Client jerked arm away during injection of 3rd dose, only received partial dose, though only small amt lost (appears to have rec'd half or more of 0.5 ml dose).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
H/o Melanoma w/ chemotherapy, Longtime smoker
Vorgeschichte
Smoker >30 yr
Andere Medikamente
Unk
Allergien
None
Vorherige Impfungen
-

VAERS 2099378

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
PA
Alter
48,0
Geschlecht
M
Eingang
09.02.2022
Impfdatum
08.02.2022
Beginn
09.02.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Hypoaesthesia

Symptomtext

THE NEXT MORNING AFTER PATIENT GOT MODERNA VACCINE HE HAS NUMBNESS ON BOTH OF HIS HAND. WHOLE LEFT HAND HAS NUMBNESS AND IN THE RIGHT HAND HE HAS NUMBNESS FROM FINGERS TO HALF WAY TO PALM

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypoaesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2098741

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
ME
Alter
46,0
Geschlecht
F
Eingang
09.02.2022
Impfdatum
09.02.2022
Beginn
09.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

The vaccine was given 2/9/22 at 10am from a vial that was opened 2/8/22 and expired at 1130pm on 2/8/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Nasal congestion
Vorgeschichte
hyperlipids, Well controlled DM
Andere Medikamente
Glipizide, Fexofenadine
Allergien
Amlodipine, Metformin, Sulfa, Vicodiin
Vorherige Impfungen
-

VAERS 2098623

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
62,0
Geschlecht
M
Eingang
09.02.2022
Impfdatum
08.02.2022
Beginn
08.02.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too High-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2092589

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
SC
Alter
58,0
Geschlecht
M
Eingang
07.02.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered No adverse event

Symptomtext

No adverse reaction was noted. Pt. received Moderna booster on 1/11/22 -pt. didn't make us aware, didn't have card available, and it wasn't in his chart under Immunizations . We gave a second Moderna booster today (2/7/22). Pt. was in the office for an office visit . Denies any complaints at present. Dr. was made aware. No new orders was made.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Diabetes Hypertension Vitamin D deficiency Hyperlipidemia Asymptomatic HIV infection
Vorgeschichte
-
Andere Medikamente
Norvasc Lipitor Biktarvy Steglatro Basaglar Humalog Losartan/HCTZ Metformin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2092064

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
IA
Alter
68,0
Geschlecht
M
Eingang
07.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Vaccine was administrated more than 12 hours after first puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated more than 12 hours after first puncture) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated more than 12 hours after first puncture). On 01-Feb-2022, EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated more than 12 hours after first puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. The patient had not reported any symptoms after the administration of the vaccine. No treatment information was provided by the reporter. Date the vial was initially stored in the refrigerator was 31-Jan-2022; date(s) and time(s) vial was first punctured was 31-Jan-2022 at 9 am; the vaccine was administered in the morning of 01-Feb-2022; the vial was the vial stored in the fridge at correct range temperature post puncture and the vial did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F): as per reporter the nurse took the vial out of the freezer on Friday night and put it on the fridge, which was on appropriate range temperature, then the first puncture was made on 31-Jan-2022 at 9 o'clock.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2091776

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21A

gering
Staat
PR
Alter
23,0
Geschlecht
M
Eingang
06.02.2022
Impfdatum
04.02.2022
Beginn
04.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Nurse requests Moderna 0.5ml vaccine for the second dose. She proceeds to inoculate the patient from Janssen primary series since the patient had requested to do the mix match with Moderna. Which the one that was suppose to be was a Moderna booster dose of 0.25ml according to the CDC.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2091706

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
28,0
Geschlecht
F
Eingang
06.02.2022
Impfdatum
05.02.2022
Beginn
05.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered

Symptomtext

Error: Wrong dose of vaccine - too low.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2091501

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
NY
Alter
16,0
Geschlecht
M
Eingang
05.02.2022
Impfdatum
05.02.2022
Beginn
05.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Moderna first dose given to a 16-year-old. No adverse reactions to report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Morbid obesity; high triglycerides; high serum cholesterol
Vorgeschichte
Morbid obesity; high triglycerides; high serum cholesterol
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2091474

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MD
Alter
52,0
Geschlecht
F
Eingang
05.02.2022
Impfdatum
05.02.2022
Beginn
05.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Ageusia Anxiety Chest discomfort Cold sweat Feeling hot Hot flush Skin warm Tongue disorder

Symptomtext

5 minutes after receiving vaccine became warm and clammy. Thought it was hot flash. Hx of HBP. BP 180/120 HR 86 and Pulsox99 started felling better and BP 174/110 but then began with chest tightness and warmth. Very clammy as well. Very anxious initially at entrance because had reactions of tongue thickness with loss of taste for one week after both Pfizer vaccines. 911 called and pt transported to hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ageusia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
High BP
Andere Medikamente
Lisinopril
Allergien
None
Vorherige Impfungen
-

VAERS 2090805

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
WA
Alter
67,0
Geschlecht
M
Eingang
05.02.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too High-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2087365

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
14,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
31.01.2022
Beginn
31.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

inadvertently administered booster to 14 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inadvertently administered booster to 14 year old) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 31-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inadvertently administered booster to 14 year old). On 31-Jan-2022, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inadvertently administered booster to 14 year old) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant medications were reported. No Treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2085214

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MI
Alter
13,0
Geschlecht
F
Eingang
03.02.2022
Impfdatum
27.01.2022
Beginn
27.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Not age indicated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2083058

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21a

gering
Staat
OH
Alter
17,0
Geschlecht
M
Eingang
02.02.2022
Impfdatum
31.01.2022
Beginn
31.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient was given Moderna as first dose even though not approved for ages <18. No adverse effects noted at time of administration or follow-up period of 5 hours later.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2080270

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
57,0
Geschlecht
F
Eingang
01.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

PATIENT REQUESTED 'BOOSTER' AND PRESENTED A VACCINE CARD WITH TWO VACCINE DOSES (3/18/21 AND 4/15/21) I ADMINISTERED WHAT I BELIEVED TO BE HER 3RD SHOT OR BOOSTER AS IT WOULD BE 5 MONTHS FROM THE SECOND AND APPROPRIATE. SHE ASKED WHAT TO EXPECT FROM THE BOOSTER AND WE DISCUSSED. AFTER WHILE REPORTING TO THE STATE RECORD-KEEPING SITE, IT WAS DISCOVERED SHE HAD ALREADY GOTTEN A BOOSTER AT ANOTHER PHARMACY AT 8/29/21 WHICH SHE HAD CONCEALED FROM US. THE ONE THAT I GAVE WAS ACTUALLY A 4TH WHICH SHE DID NOT QUALIFY FOR.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
PT STATES NO HEALTH CONDITIONS OR TREATMENTS THAT MADE HER MODERATELY OR SEVERELY IMMUNOCOMPROMISED, NO HISTORY OF MYOCARDITIS OR PERICARDITIS, NO TREATMENT WITH MONOCLONAL ANTIBODIES OR CONVALESCENT SERIUM, NEVER DIAGNOSED WITH MIS-C OR MIS-A, NO HISTORY OF GUILLIAN-BARRE SYNDROME, NO BLEEDING DISORDER, NOT PREGNANT OR BREASTFEEDING, AND HAS NOT RECEIVED HEMATOPOIETIC CELL TRANSPLANT OR CAR-T-CELL THERAPIES. NO TREATMENT FOR CANCER OR HIV, NO ORGAN TRANSPLANT OR IMMUNOSUPPRESSIVE THERAPY OR HIGH DOSE CORTICOSTEROIDS.
Andere Medikamente
UNKNOWN
Allergien
UNKNOWN
Vorherige Impfungen
-

VAERS 2079528

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
CA
Alter
24,0
Geschlecht
F
Eingang
01.02.2022
Impfdatum
28.01.2022
Beginn
28.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypoaesthesia

Symptomtext

At 15 post vaccination patient complained of numbness in her left arm. Patient denied chest pain, dizziness, difficulty breathing, blurred vision or pain. Patient was evaluated by RN, vitals obtained, no signs of swelling, arm elevated at heart level. Patient alert and oriented, Range of motion within normal range. Circulation check at fingers conducted, all within normal range. Vital within normal range. Patient observed for 30 additional minutes. Vital repeated at 10:20am, all within normal range. Patient verbalized numbness is less, circulation check normal. Patient left observation area at 10:30 with no signs of distress. Patient advised to continue to monitor any change in symptoms on contact clinic or PCP with any changes. Patient verbalized understanding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypoaesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Milk
Vorherige Impfungen
-

VAERS 2071564

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042J21A

gering
Staat
MA
Alter
-
Geschlecht
U
Eingang
28.01.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

2 booster doses administered past 12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 booster doses administered past 12 hours post puncture) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (2 booster doses administered past 12 hours post puncture). On 25-Jan-2022, EXPIRED PRODUCT ADMINISTERED (2 booster doses administered past 12 hours post puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication reported. No treatment information was provided. 1st booster was administered 25Jan2022 at 10:35 AM and the 2nd booster was administered 25-Jan-2022 at 11:45 AM. Date the vial was initially stored in the refrigerator: 18-Jan-2022 at 7:05 AM. Date and time vial was first punctured: 24-Jan-2022 at 9:20AM. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F): 24-Jan-2022 9:20 AM until 10:35 AM 25-Jan-2022 and until 2nd administration at 11:45 AM 25-Jan-2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2065258

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
MA
Alter
24,0
Geschlecht
F
Eingang
26.01.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (temperature)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2065257

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042j21a

gering
Staat
MA
Alter
53,0
Geschlecht
M
Eingang
26.01.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Error: Improper Storage (temperature)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-